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ABSTRACT 
Karlene Sellani Lavelle: Effects of Lifestyle Exposures and  
Body Mass Index on Sperm Quality Parameters of Fertile Men  
(Under the direction of Andrew F. Olshan, Ph.D.) 
 
The reproductive potential of human males depends upon the production of a 
sufficient number of healthy, functional spermatozoa.  Spermatogenesis, the complex 
process of sperm production, maturation and transit through the male reproductive tract is 
vulnerable to disruption, which can occur at any time during the spermatogenetic cycle.  
Some sperm quality studies have reported unfavorable trends in male reproductive health 
indicators, and lifestyle exposures and excess body adiposity have been implicated.  The 
primary aim of this dissertation research was to evaluate the etiologic role of three prevalent 
lifestyle exposures (cigarette smoking, alcohol consumption and caffeine intake) and excess 
body adiposity, as measured by body mass index (BMI), on clinically relevant markers of 
testicular function and germ cell DNA integrity and maturity among fertile men.   
To address our study aims we analyzed data from a community study of 229 fertile 
men 18 to 40 years of age.  A standardized telephone interview was used to collect data on 
lifestyle exposures and potential confounders.  Sperm count, concentration, and 
morphology, as well as markers of DNA damage and chromatin maturity from the sperm 
chromatin structure assay, were evaluated from a single semen sample provided by each 
study participant.  We used linear and logistic regression to assess the relationship between 
lifestyle exposures, BMI and the five sperm outcomes.   
Our results did not reveal significant decrements in sperm outcomes associated with 
smoking status (current, former, never) or BMI, after confounder adjustment.  Unexpectedly,
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former smokers had significantly lower proportions of immature sperm cells compared to 
non-smokers (-2.8%; 95% Confidence Limits (CL): -4.7%, -0.9%), and obese men (BMI ≥ 
30) exhibited significantly higher sperm concentrations than men of normal weight (BMI 
18.5-24.9) (16.2%; 95% CL: 2.0%, 32.3%).  Sperm outcomes were generally more favorable 
among alcohol drinkers than non-drinkers.  Conversely, men whose daily caffeine intake 
exceeded 300 milligrams had significantly lower proportions of morphologically normal 
sperm cells compared with non-caffeine drinkers (2.8%; 95% CL: -4.9%, -0.6%).  Results 
suggest that lifestyle exposures and BMI vary considerably with respect to their independent 
effects on clinically-relevant markers of testicular function and germ cell DNA integrity 
among fertile men.  
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 CHAPTER 1:  BACKGROUND 
 
A.  Human male reproductive system  
1.  Overview 
The human male reproductive system consists of primary organs and accessory 
structures that function together through neuro-endocrine regulation, with the primary 
purpose of producing and delivering functional spermatozoon to the female reproductive 
tract for fertilization of the female gamete.  Human male reproduction is a highly integrated, 
complex, and sensitive system, which as a result renders it vulnerable to numerous 
environmental insults.  At the individual level reproductive fitness is important to overall 
health and well-being of the man; at the population level reproductive fitness is vital to 
offspring health and species survival.  Understanding male reproductive anatomy and the 
physiology of sperm development and transportation is necessary for establishing potential 
mechanisms through which toxicants may act to disrupt normal testicular function.    
 
 
2.  Human male reproductive anatomy  
The anatomical constituents that form the human male reproductive system include a 
pair of testes, a network of secretory ducts (epididymis, vas deferens) and other accessory 
structures (seminal vesicles, prostate, penis).  See Figure 1.1.  The primary organ of male 
reproduction is the testis, which produces both the male gamete through spermatogenesis 
and the male sex hormones through steroidogenesis.  Spermatogenesis and 
steroidogenesis occur in two structurally and functionally separate compartments within the 
testis. The interstitial compartment contains the Leydig cells, which are the source of 
testicular testosterone.  The tubular compartment consists of the narrowly coiled 
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seminiferous tubules and they form the bulk of the testes. The seminiferous tubules 
preserve the male stem cell and contain gametes in various stages of development, in 
addition to the supporting Seratoli’s cells (190, 259).  
Along the superior and posterior margins of the testes lies a tightly coiled single 
tubule called the epididymis.  The vas deferens (or ductus deferens) is a fibromuscular 
tubule that begins with the end of the epididymis and continues to the prostate gland.  
Adjoining the vas deferens and posterior to the urinary bladder are the seminal vesicles, 
which form an ejaculatory duct that empty into the urethra.  Inferior to the bladder wall is a 
firm, dense structure called the prostate.  Extending from the bladder to the tip of the penis 
is the urethra, a single lumen tubule.  The penis is the final organ of male reproduction and 
is located anterior to the scrotum and contains two lateral corporeal bodies necessary to 
produce an erection, and the urethra, which is located in the central portion of the penis.   
 
3.  Testicular and post testicular physiology  
Spermatogenesis is the elaborate process of male germ cell division and 
differentiation that in adulthood results in the daily production of millions of fully-
differentiated and highly-specialized male gametes (190). This process that begins during 
adolescence and continues throughout adulthood originates during embryonic development 
when primitive germ cells migrate to the base of the seminiferous epithelium in the 
developing testes and differentiate into spermatogonia.  The spermatogonia and their 
supporting Sertoli’s cells proliferate from infancy to puberty to establish a stem cell 
population sufficient to maintain normal sperm production in adult life.  Sertoli cells have 
numerous critical functions, including provision of the structural framework of the 
seminiferous tubule, secretion of regulatory proteins that regulate spermatogenesis, 
maintenance of the blood-testis barrier and production and secretion of a unique tubular 
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fluid.  At puberty, the Leydig cells, another important constituent present in the interstitium of 
the testes, differentiate and produce testosterone stimulating mitotic division of the male 
germ cells and signaling the beginning of adult spermatogenesis (189).   
Spermatogenesis takes place within the seminiferous tubules in a series of three 
cyclical, ongoing stages:  (1) mitotic division of spermatogonia, (2) meiotic division of 
spematocytes and (3) differentiation of spermatids.  There are two forms of the diploid 
spermatagonia, type A and type B, each of which has different functions. Type A, which can 
be further subdivided into pale and dark, constitute the pool of self-renewing stem cells.  In 
the first stage of spermatogenesis, type A pale spermatagonia differentiate to form type B 
spermatoginial cells, which divide by mitosis to form two primary spermatocytes.  In the 
second stage, primary spermatocytes undergo two meitotic celluar divisions, the first of 
which results in two secondary spermatocytes and the second of which, through meiosis, 
results in four haploid spermatids.  The final stage, called spermiogenesis, involves 
significant differentiation and morphological changes of the spherical spermatid which 
undergoes progressive nuclear elongation, chromatin condensation, formation of the 
acrosome, and development of the flagellum.  When spermiogenesis is complete, 
spermatozoa are released into the lumen of the seminiferous tubules where they leave the 
testis and migrate to the epididymis (189, 190).   
Sperm that are released into the lumen of the seminiferous tubules are immature and 
not capable of fertilization.  A series of post testicular events completes the maturation 
process.  Maturation begins when the spermatozoa reach the head of the epididymis, which 
in addition to promoting sperm maturation provides protection, facilitates transportation and 
serves as the primary storage site for sperm until ejaculation. (190).  During epididymal 
maturation, sperm also acquire motility potential.  Muscular contractions of the vas deferens 
during ejaculation propel mature sperm from the epididymis to the urethra where they mix 
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with seminal fluid from the seminal vesicles and prostate gland for release as semen 
through the penile urethra.  
The spermatogenic process described above, beginning with mitotic divisions, 
meiosis and differentiation of immature germ cells to the release of mature spermatozoa 
capable of fertilizing the female ovum requires approximately 3 months (Figure 1.2).  Given 
the degree of complexity, precision in timing and sequencing events and the duration 
necessary to complete a spermatogenic cycle (approximately 84-86 days), spermatogenesis 
is considered to be one of the most intricate processes of cell differentiation that occurs in 
the tissue of adult humans (190, 259).  It is for these reasons that the male reproductive 
tract is markedly vulnerable to environmental insults and hormonal imbalances.   
 
 
B. Potential mechanisms of toxicity and sites of testicular vulnerability  
The human testis is regarded as highly sensitive to the effects of potentially toxic 
substances, particularly in comparison to other species (89).  In addition to the complexity 
and precision of human spermatogenesis described above, this heightened vulnerability is 
also due to several characteristics unique to human spermatozoa. The first factor is the 
relatively low efficiency and quality of sperm production in human males. There is also 
evidence suggesting that human males have a narrow margin of fertility due to low 
spermatogenic reserve and therefore are more likely than other mammals to exhibit 
alterations in testicular function even in the presence of low-dose exposures (78). Human 
males also have significantly fewer Sertoli cells and smaller testicles relative to body size 
compared with other mammalian species (259).  In addition, human males have a high 
prevalence of sperm morphologic abnormalities.  Finally, relative to females, males have a 
higher rate of heritable, de novo mutations, which are thought to arise as a consequence of 
the larger number of cell divisions that occur during spermatogenesis (67).  The unique 
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features of human sperm production and the resulting male gamete not only illustrate the 
potential for reproductive toxicity in the human male and the genetic and reproductive 
implications, but also point to the caution that must be used when interpreting and applying 
data from toxicologic studies of other species to understand effects in human males.  
Moreover, the difficulty in extrapolating animal data to human conditions suggests that more 
epidemiologic investigations such as the research described in this dissertation are 
warranted.   
A reproductive toxicant has been defined as an agent that acts to disrupt the “normal 
flow of matter, energy, or information within or between cells or organs in the reproductive 
system” (141).  A male reproductive toxicant can act directly, indirectly or in combination to 
produce testicular injury and impair spermatogenesis.  Direct toxic mechanisms are those 
that by virtue of their chemical reactivity or structural similarity to endogenous molecules 
impact the anatomical constituents of the testis (141).  Chemically reactive compounds exert 
toxicity through direct interactions with target structures such as macromolecules (RNA and 
DNA) or organelles, altering important biologic processes necessary for normal reproductive 
functioning (141). Compounds with chemical structures similar to the endogenous 
compounds found in the testicular environment can also exert direct toxic effect, but through 
a different mechanism.  These foreign compounds interfere with normal testicular 
functioning by either imitating the action of or competing for receptor sites of natural 
nutrients or hormones, triggering inappropriate or blocking normal physiologic responses in 
the targeted structures.  Indirect mechanisms of toxicity alter spermatogenesis and 
steriodogenesis by interfering with endocrine regulation and cell signaling (141).   
  As part of describing the direct and indirect mechanistic pathways through which 
potential toxicants can act to disrupt normal testicular functioning, it is important to consider 
the reproductive targets upon which the agents act, as well as the significance of such 
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action.  All testicular and post testicular events are susceptible to disruption, the results of 
which can be observed in corresponding changes in sperm count, concentration, 
morphology, and chromatin structure.  Spermatagonia, the primordial male germ cell, and 
young spermatids appear to be more susceptible to toxicants than other more mature cells 
as they are outside of the blood-testis barrier formed by the tight junctions between the 
supporting Sertoli cells.  In theory, this renders the stem cells vulnerable to toxicants whose 
molecules are not small enough to permeate the barrier (20).  A toxicant that acts to disrupt 
spermatogonia, the progenitor of the male germ cell, could dramatically and permanently 
affect spermatogenesis.   In contrast, injury to the secondary spermatocytes and spermatids 
temporarily arrest spermatogenesis, resulting in transient declines in the quantity and quality 
of mature spermatozoa.  However, transient changes will not be observed in standard 
semen analysis if sufficient transit time (between 12 and 50 days) is not considered in the 
observation period.  Sertoli cell injury can be as devastating to male reproductive function as 
direct action to the germ cells (39) and they too are susceptible to toxic insult.  Sertoli cells 
are necessary for the communication and regulation of all spermatogenic cells.  Damage to 
these cells can be observed in seminal changes within days of injury and last for the entire 
spermatogenic cycle.  In addition, the damage may be irreversible if enough Sertoli cells are 
affected because these cells do not proliferate after puberty.   
Male reproductive toxicants can also disrupt spermatogenesis indirectly by interfering 
with endocrine regulation.  Disruption of Leydig cell function can alter testosterone 
secretions, compromising Sertoli cell function and sequential stages of spermatogenesis.  
Unlike Sertoli cells, however, Leydig cells continue to proliferate after puberty and the supply 
could be replenished when the insulting agent was removed (209).  Supporting structures 
such as the epididymis, vans deferens and accessory glands are also potential targets for 
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reproductive toxicants.  Toxic injury to the epididymis could affect the mature spermatozoon 
in storage and transit.   
Finally, the chromatin consisting of the male genetic material (DNA) and associated 
proteins can be damaged at several stages in the process of spermatogenesis resulting in 
nuclear condensation defects, DNA strand breaks, chromosomal breakage or aneupoloidy.  
Spermatids and spermatozoa appear to be highly vulnerable to chemical mutagens 
following meiosis, when de novo point mutations and chromosomal structural 
rearrangements arise preferentially (67).  In addition, because DNA lesions are immune to 
repair once the spermatozoon has reached the late spermatid stage they can accumulate 
and persist through fertilization whereby the genetic damage is transmitted to the embryo 
(135).  Although the exact mechanisms of DNA damage are uncertain at this time, the 
theories receiving the most attention are abnormal chromatin packaging, apoptosis and 
generation of reactive oxygenation species (ROS) (4).  Spermatozoa are particularly 
susceptible to damage induced by excessive ROS because their plasma membranes 
contain large quantities of polyunsaturated fatty acids and their cytoplasm contains low 
concentrations of scavenging enzymes.  In addition, spermatozoa have limited intrinsic 
antioxidant capability and must rely on the seminal fluid for protection (201).   
Despite the knowledge gained from animal studies and theoretical mechanisms 
based on our knowledge of male reproductive anatomy and physiology, our understanding 
of mechanistic pathways continues to evolve.  There are several obstacles in ascertaining 
the site of injury or mechanism of toxicity.  Most notable is the physical interaction that 
transpires between sperm cells at all stages of differentiation, which occurs under the 
regulation of the supporting Sertoli cells and chemical signaling through hormonal regulation 
(78).  Moreover, while several toxicants are thought to act at very specific sites, the ultimate 
adverse response may be very non-specific either because a toxicant sets in motion a 
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cascade of events that causes change and disruption in down-regulated testicular structures 
or because the dose and duration of the toxicant are large enough to cause injury at multiple 
sites (73).  Ejaculated spermatozoa thus represent the end product of an integrated process 
of induction and accumulation of toxic insults that may have altered production, structure or 
genetic integrity of the male germ cell line (281).  Nonetheless, whatever the proximate 
cause and mechanism of injury, the ultimate manifestation will likely be alterations in the 
quality and quantity of spermatozoa (141) or genetic integrity (176).  Sperm quality and 
quantity are evaluated as part of a standard semen analysis; newer markers such as the 
sperm chromatin structure assay provide information of DNA damage and maturity.  An 
overview of these measures is provided in the next section.   
 
C.  Ejaculatory measures for evaluating male reproductive function and toxicity 
1.  Standard semen analysis  
Quantitative semen analysis is a routine, well-established laboratory technique for 
evaluating male reproductive status (270) and is the method that was used for this 
dissertation research.  Semen analysis is conducted for clinical purposes as part of the initial 
evaluation of male infertility, and in epidemiologic research to assess potential toxic effects 
of an environmental agent (78).  The strength of a semen analysis lies in its ability to 
simultaneously evaluate pathophysiologic conditions of testicular function and 
spermatogenic activity, patency of the reproductive tract, activity of accessory glands and 
ejaculatory ability (168). This method also provides additional information regarding 
essential hormonal and supporting cellular functions such as those of the highly important 
Sertoli and Leydig cells necessary for normal spermatogenetic activity.  While the goal of a 
clinical workup is to accurately predict fertility for an individual, for research purposes the 
primary objective is to quantify the absolute and relative effects on specific parameters in 
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relation to the putative toxicant(s) under consideration.  Alterations in biomarkers of sperm 
quality after exposure to environmental toxicants are considered to be an indication of 
increased reproductive risk (274), which does not require that the marker be associated with 
fertility status (78).   
Standard biological markers evaluated as part of a quantitative semen analysis are 
measurements of seminal volume, determination of spermatozoal concentration and 
calculation of the total number of spermatozoa present in the ejaculum, which is calculated 
by multiplying the total volume by the sperm concentration (190).  Qualitative assessment 
has traditionally focused on morphological appearance and progressive motility of sperm.   
Each parameter can provide insights into various aspects of spermatogenesis and, as such, 
provides clues as to where and when a toxic insult may have occurred, though the 
interpretation of this can be diminished for reasons discussed earlier.  Nonetheless, certain 
parameters elucidate the functioning of specific structures or biochemical events better than 
others.  For example, total sperm count is revealing about spermatogenesis overall, while 
sperm morphology is revealing about spermiogenesis, the process of differentiation that 
transforms the spermatid into a mature spermatozoa (208).   
There are no universally accepted standards for the basic parameters that are 
measured as part of a semen analysis, however, there are references published by the 
World Health Organization (WHO) and these can be used for comparisons of individuals as 
well as populations (270).  When interpreting a semen analysis it is also important to 
consider the results in light of factors that can influence the amount of seminal plasma, such 
as length of sexual abstinence and amount of foreplay (190).  Another consideration is the 
reliability of a single semen sample.  This issue has been raised in the literature due to 
significant within-subject variability and, as such, a single semen specimen may not provide 
as accurate a picture of the average results that would be obtained if multiple samples were 
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taken over time (110).  However, intra-class correlations tend to be good such that those 
with high counts tend to stay relatively high and those with low counts remain low, reducing 
the possibility of bias due to outcome misclassification (207).  
 
2.  Sperm Chromatin Structure Assay  
A highly compact nuclear structure consisting of DNA, RNA and heterogeneous 
nucleoproteins, sperm chromatin undergoes substantial reorganization during sperm 
maturation, which is necessary for the protection and transmission of the male genome 
during transit through the male and female reproductive tracts (3, 205).  There is growing 
evidence that variations in the highly organized nuclear architecture of sperm chromatin play 
a critical role in male reproductive function (3), including potential fertilizing capacity of 
spermatozoa, embryonic development and paternal gene activity (205).  Conventional 
sperm quantity and quality parameters, however, do not provide important information on 
the status of the genetic material in sperm nuclei, which can be altered even in the absence 
of findings from standard sperm measures (285).  
Among the methods available to evaluate sperm DNA integrity, the Sperm Chromatin 
Structure Assay or SCSA is considered to be one of the most stable, robust and objective 
(59, 177). An indirect measure of DNA fragmentation, SCSA uses flow cytometry to 
measure the susceptibility of sperm nuclear DNA to denaturation in situ following physical 
induction through acid staining with Acridine Orange (57). The extent of DNA denaturation 
following acid induction is determined by measuring the metachromic shift from green 
(native DNA) to red (denatured DNA) fluorescence (59), which occurs only in sperm cells 
with structurally altered chromatin (222).  The SCSA results in two parameters: (1) 
percentage of spermatozoa with high DNA stainability (% HDS), a marker of immature 
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spermatozoa, with normal chromatin and (2) the percentage of DNA fragmentation (% DFI) 
in mature sperm; %DFI has been the more utilized of the two parameters (3).   
Although SCSA is an indirect measure of DNA strand breaks, the preponderance of 
data shows high correlations between percentage DFI values and the proportion of positive 
cells observed with direct assessment of DNA damage such as the COMET or TUNEL 
assays (59).  In addition, data from clinical studies have consistently observed a threshold 
value of 30% DFI at which point there is a significant decline in fertility potential and 
increased risk of miscarriage (58, 125, 201).  Moreover, defective sperm chromatin structure 
is related to subfertility independent of sperm number, morphology and motility (3), which 
suggests that the parameters obtained from the SCSA reflect different biological 
characteristics of spermatozoa, extending the information provided by standard measures of 
semen quantity and quality (221).  Finally, relative to the standard measures, SCSA 
parameters demonstrate significantly less intra-individual variability over time.  
The SCSA is considered to be a highly sensitive and precise measure of DNA 
damage useful for epidemiologic studies designed to fully characterize male reproductive 
health effects resulting from exposure to potential environmental toxicants (60, 221).  To 
date, it has been effectively used in epidemiologic investigations of men exposed to air 
pollution, polychlorinated biphenyls and other persistent organic pollutants, pesticides, lead, 
styrene and solvents (22, 182, 197, 204, 222).  Few epidemiologic studies, however, have 
used SCSA parameters to study the effects of lifestyle behaviors on sperm quality.  The 
present study has benefitted from incorporating a marker of DNA damage and the ability to 
describe how lifestyle factors may alter the genetic material contained in the male germ cell.  
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D. Temporal trends in measures of male reproductive health and functioning  
Reproduction is an important biologic event that requires healthy reproductive 
functioning of both a male and female in order to be successful.  For the male, one of the 
primary factors believed to effect reproductive capability is the quality and quantity of his 
sperm. (106, 284).  Spermatozoal quantity, however, appears to have undergone significant 
changes over the past century, as mounting data suggest that sperm quantity trends, as well 
as other indicators of male reproductive fitness, are increasingly unfavorable.  Although 
these negative trends were first identified in the 1970s and 1980s (152, 167) their potential 
significance was largely overlooked by the scientific community until 1992 when Carlsen and 
colleagues reported a fifty-percent reduction in sperm concentration over the period 1940 to 
1990 (27).  More recent studies have substantiated the observations of Carlsen’s seminal 
work (231, 232), which together support the contention of some investigators that an 
international fertility crisis may be looming (45, 102, 217).  
Complementary surveillance data on male disease and dysfunction add weight to the 
evidence provided by the sperm quality studies.  Over the past several decades, there has 
been a significant global increase reported in the incidence of testicular cancer, the most 
common neoplasm among men ages 15 to 44 years.  Similarly, have been reported 
increases in the congenital genitourinary malformations known as hypospadias 
(malformation of the male urethra) and cryptorchism (undescended testicle) that arise during 
fetal development (25, 147).  In addition, many countries have experienced declines in 
fertility rates to levels that are incompatible with maintaining current population numbers 
(132, 266).  Finally, it is important to note that these phenomena in humans have been 
observed in other species, including fish, birds, wild cats, frogs and alligators, each showing 
various signs of alterations in their reproductive health as well (79, 85).   
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Questions have been raised about factors that may be contributing to the temporal 
and spatial decline in male reproductive health indicators described in the literature.  
Although our understanding of these trends remains limited, what is clear is the potential 
susceptibility of the male reproductive system to a wide variety of toxic substances and the 
importance of identifying exposures that pose the greatest threat to the reproductive health 
of men in order to mitigate their effects.  Etiologic research has focused on two primary 
sources of toxic exposures:  (1) environmental and occupational, and (2) lifestyle factors.   
 
E.  Male reproductive toxicants: environmental and occupational exposures  
Discovery in the mid-1970s that exposure to the nematocide, dibromochloropropane 
(DBCP) severely impaired or destroyed sperm development in exposed workers 
demonstrated that the male reproductive system was more susceptible to the effects of 
potential toxicants than had been previously recognized (261).  Since then, numerous 
individual compounds and classes of chemicals have been identified as reproductive 
toxicants based on animal models.  Epidemiologic studies, however, usually in the form of 
occupational cohort studies or case-control designs, have identified relatively few 
substances equally deleterious to human reproductive function.  Nonetheless, in addition to 
DBCP, there are several substances that can exert a toxic effect on one or more aspects of 
human male reproductive function.  Most of these toxicants can be classified into seven 
broad categories:  pesticides, heavy metals, endocrine disruptors, solvents and organic 
compounds, physical agents and other pollutants.  These categories are not mutually 
exclusive nor is the list of toxic substances described below exhaustive, but serve rather as 
a general overview of the agents for which there is empirical evidence for potential 
disruption of male reproductive functioning.   
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1. Pesticides  
In addition to DBCP, several other pesticides have shown evidence of testicular 
toxicity in human males, though not nearly as severe.  Studies of ethylene dibromide, a 
constituent of nearly 100 pesticide preparations, reported a range of alterations in sperm 
quality including reduced sperm concentration and motility and semen volume (187) at 
levels far below the standards promulgated by the Occupational Safety and Health 
Administration (234).  Other chlorinated pesticides such as carbaryl, chlordecone (kepone) 
and diphenyltrichloroethane have also been associated with testicular toxicity at low levels.  
Fortunately, most of these pesticides are no longer in use in the United States (64).  
Moreover, some recent studies suggest that second generation, non-persistent pesticides 
have little adverse effect on the reproductive outcomes of farm workers (124), and with the 
possible exception of greenhouse workers (1), do not appear to pose a serious threat to 
reproductive health in human males (22).  However, these findings have varied depending 
on the region of study (161, 204, 233), which may be a reflection of other factors such as the 
type and concentration of the pesticide used and the protective practices employed by 
applicators.   
 
2. Heavy metals 
The reproductive toxicity of exposure to heavy metals has also been investigated.  
Studies of lead have left little doubt of its toxic effects on spermatogenesis and endocrine 
regulation among workers exposed to high levels (i.e. above 75 µg/dL) such as battery 
workers and lead smelters (10).  Although reproductive effects at levels below 75 µg/dL are 
not clear, it does appear that 45 µg/dL is the level below which there are no observable toxic 
effects (22).  Such a threshold suggests that ambient levels (typically low) in the 
environment would not present a reproductive threat to the general population, although 
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workers in direct contact with the metal may still demonstrate serum levels consistent with 
clinical lead intoxication. Other heavy metals such as mercury, haxavalent chromium, 
cadmium and manganese have also been implicated as male reproductive toxicants in 
rodent studies, but the evidence in humans is comparatively limited (73) or inconsistent (64). 
 
3. Endocrine disruptors 
Polychlorinated biphenyls (PCBs), phthalates and dioxins are among the more 
studied of a group of persistent chemicals present at low levels in the environment, and 
which have the potential to alter male reproductive functioning by disrupting normal 
endocrine activity (179).  Epidemiologic studies have examined PCB effects in relation to 
sperm quality parameters, sex hormones, accessory gland and epididymal function, and 
DNA integrity over a range of exposure levels and for several congeners of which there are 
many (88).  Among the sperm quality parameters, the most consistent observation has been 
the inverse relationship between PCBs and sperm motility (53, 87, 237).  Recent evidence 
of PCB effects on epididymal and accessory gland function provide a mechanism by which 
motility may be adversely effected (53).  Studies have also observed relationships with 
levels of gonadotropin and sex-hormone binding globulin and a small, but significant effect 
on %DFI, a measure of DNA damage generated by the SCSA described earlier.  Although 
still not resolved, the latest studies provide additional evidence of the negative effects that 
these persistent pollutants can have on male reproductive functioning.   
Phthalates are another class of hormonally-active chemicals that have been 
associated with reproductive toxicity in animal models.  Unlike persistent pollutants such as 
PCBs, however, phthalates do not bioaccumulate in the environment and are rapidly 
metabolized and eliminated in the human body.  Nonetheless, phthalates pose a potential 
reproductive risk in humans because they are used in a wide variety of consumer products, 
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have multiple exposure routes and are largely unregulated, thereby making it theoretically 
possible to attain physiologic steady-state levels (50).  Few epidemiologic studies have 
examined the effects of phthalate exposure on human sperm quality and the results of these 
studies have been inconsistent, ranging from negative impacts on sperm concentration, 
motility and/or morphology (50, 88) to no observed effects (105), depending on the type of 
phthalates under investigation.   
Fewer epidemiologic studies have focused on dioxins, but those that have observed 
decreases in serum testosterone and other hormones in exposed men (52), as well as 
significant alternations in sex ratios of infants born to exposed men (146). These finding are 
consistent with dioxin’s putative anti-androgenic properties.   
 
4. Solvents and other organic compounds 
Organic solvents such as polyaromatic hydrocarbons, benzene, toluene, 
fluorocarbons, tetrachorethylene and carbon tetrachloride have a wide range of applications 
in numerous industrial and laboratory settings.  Both animal and human studies of 
reproductive effects have focused predominately on pregnancy outcomes, in particular, 
spontaneous abortion, congenital defects and childhood cancer.  Consequently, the 
evidence regarding the effects of organic solvents on outcomes specific to male 
reproductive functioning is limited (33).  What is known comes primarily from high-dose 
occupational studies, but only a fraction of the solvents currently used have been 
investigated and most of these did not indicate strong effects (64).  The exceptions to this 
have been some of the glycol ethers, which have been associated with alterations in 
spermatogenesis (188, 260) and at exposure levels previously considered safe (64).  
Carbon disulfide has been observed to affect both sperm quality and hormonal regulation in 
high doses, but not at low (73).  Most recently, exposure to various mixtures of polyaromatic 
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hydrocarbons has been linked to alterations in sperm count, motility and morphology (44), 
as well as DNA damage (97). 
 
5. Physical agents: ionizing radiation and heat  
The testis is among the most radiosensitive tissues in the body (22).  Unlike the 
weak epidemiologic evidence linking most environmental agents to alterations in male 
reproductive function, ionizing radiation is known to cause significant reductions in sperm 
count, acting primarily to destroy type B spermatogonia, but also effecting spermatocytes as 
well.  Alterations in spermatogenesis have been observed at doses as low as 0.15 Gy, with 
higher doses producing more destructive lesions or permanent injury (157). 
Normal testicular function depends on maintaining a temperature that is two to four 
degrees Celcius below body temperature (236).  It is well-established that external heating 
of the testicles impairs spermatogenesis.  While the exact mechanism of injury is not well 
characterized, experimental studies have demonstrated that spermatocytes are especially 
vulnerable to the effects of increased temperature (22).  Among the numerous factors that 
can potentially raise testicular temperature (e.g. sauna use, occupational environments, 
clothing, and posture), hot occupational settings and extended sedentary work positions 
have most consistently been associated with alterations in sperm quality parameters, with 
studies reporting alterations in count  and morphology (63).   
  
6. Other pollutants 
Air pollution, byproducts of water disinfection/sewage treatment, hazardous waste 
and electromagnetic fields are some examples of other environmental and/or occupational 
exposures that have been studied in relation to sperm quality and other indictors of male 
reproductive health.  Among these, exposure to air pollution has most consistently been 
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associated with alterations in sperm quality.  Secifically, alterations in sperm morphology, 
DNA damage and aneuploidy have been observed (176, 197, 210).   
In summary, there are numerous environmental and occupational substances that 
have the potential to disrupt normal male reproductive function.  Most of the substances that 
disrupted normal spermatogenesis and other essential functions of male reproductive 
physiology in animal studies have not been shown consistently to alter reproductive 
functions in human males.  In the United States, exposure to substances that have been 
clearly linked to poor reproductive outcomes in men have been greatly reduced through 
worker protections (22) and regulatory controls or legislative bans (64). 
 
7.  Other factors that affect male reproduction  
There are many factors that can affect male reproductive function without causing 
injury to the reproductive tract.  Age is one potential factor.  Although aging is known to play 
a large role in the fertility of women, its effect on sperm quality parameters is still being 
clarified.  The weight of the evidence indicates that age is associated with gradual 
diminution of semen volume, and sperm motility and morphology, but less so for sperm 
concentration (11, 55, 175).  In addition, studies that examined indicators for heritable 
consequences have observed significant associations between age and sperm DNA 
fragmentation (% DFI), without increases in percent of immature sperm or aneuploidies 
(221, 275).  At this time, data do not allow conclusions to be drawn regarding the shape of 
the relationship or whether there exists an age threshold at which point alterations in sperm 
parameters occur (111). 
Another factor that appears to have an effect on sperm quality is the period of sexual 
abstinence, although the specific parameters affected and the direction of the relationship 
are still the subject of investigation.  The most consistent observation reported in the 
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literature has been an increase in sperm concentration and semen volume with length of 
abstinence, rising steadily from day two to day seven (127).   Improvements in volume and 
concentration, however, can be accompanied by a deterioration in percent normal 
morphology and motility, but does not seem to occur until after day seven and has not been 
reported consistently (43, 219).  There is also evidence suggesting that the longer mature 
spermatozoa remain in the epididymis the more susceptible is their chromatin to 
denaturation as evidenced by the SCSA, with effects observed after 7 days of sexual 
abstinence (221).  However, alterations in chromatin have not been observed consistently 
(43).   
Numerous other factors have been associated with sperm quality, usually exerting a 
negative impact on measured parameters.  These factors include history of febrile illness 
(26), stress (62, 72), presence of a varicocele (218, 269) and accessory gland infections 
(38), although the influence of sexually transmitted disease is controversial (184).  
Seasonality has also been the subject of investigation and, in general, the overall quality of 
sperm seems to fluctuate with season (9, 126), but the magnitude and season of the 
observed effect has been variable (219), with some studies reporting lowest concentrations 
during the fall months (32) and others reporting highest concentration in the fall; some 
studies have not observed a seasonal trend at all (30).  Although extended sedentary 
positions have a strong biologic basis for observing an effect, this relationship has not borne 
out in the literature (91).  Alkylating antineoplastic agents, however, are well-known 
gonadotoxins, although the extent of injury and recovery are also a function of cancer type 
and pretreatment sperm quality (14).  Other therapeutic medications have also been linked 
to impaired sperm quality (e.g. psychotropics, anabolic steroids), however the effects are 
usually transient and normal reproductive functioning resumes once the drug is 
discontinued.   
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However important may be the role of environmental, occupational and host factors 
in the balance between health and impairment of male reproduction, lifestyle factors may 
also have a significant impact on the health of male reproductive functioning as well.  
Moreover, some researchers believe that effects of exposures in the environment and work 
place are small relative to the effects of some human behaviors on health and reproduction 
(214).   
 
F.  Lifestyle Exposures   
1. Tobacco use 
Cigarette smoking is a general health hazard in which an estimated 23.4% of US 
males currently engage (28).  Cigarette smoking harms nearly every organ in the body, 
increasing the risk for developing numerous pathological conditions, reducing the overall 
health of smokers (244) and causing nearly 440,000 deaths annually (29).  A significantly 
lower proportion (4.5%, 95% Confidence Interval (CI): 4.1-4.9) of US men report current use 
of smokeless tobacco products such as chewing tobacco and moist/dry snuff (153).  
Smokeless tobacco use is also associated with many adverse health effects that include 
several cancers and gum disease (242).  Cigars or pipes are smoked by nearly 7% of the 
adult male population; both activities are risk factors for cancers of the proximal portions of 
the airway and gastro-intestinal tract (245).   
The combustion of tobacco yields approximately 4000 chemical compounds (271).  
Mainstream cigarette smoke can be divided into the particulate phase and the gaseous 
phase (183).  The principal components of the gaseous phase are carbon monoxide, 
nitrogen oxide, ammonia and volatile hydrocarbons. The primary components of the 
particulate phase are nicotine and tar (69).  These major components of tobacco smoke are 
“simultaneously delivered to the active smoker as a complex and dynamic aerosol 
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containing thousands of chemical constituents composed of several billion electrically-
charged semi-liquid particles per cm3… within a mixture of combustion gases” (271).     A 
total of 69 known carcinogens have been identified in tobacco smoke.  These carcinogens 
include ten species of polyaromatic hydrocarbons (PAH), six heterocyclic hydrocarbons, four 
volatile hydrocarbons, three nitrohydrocarbons, four aromatic amines, eight N-heterocyclic 
amines, ten N-nitrosomines, two aldehydes, ten miscellaneous organic compounds, nine 
inorganic compounds and three phenolic compounds (92).   
Mainstream smoke is the smoke released while inhaling from the mouth-end of the 
cigarette, cigar or pipe.  Side-stream smoke is that which is released into the air from the 
burning cone of the cigarette, cigar or pipe between puffs.  The air-diluted mixture of side-
stream smoke and the part of the mainstream smoke that is exhaled by the smoker creates 
the environmental tobacco smoke (ETS) to which both smokers and non-smokers are 
exposed (130).  The composition of ETS, mainstream smoke and side-stream smoke is 
qualitatively identical, but quantitatively can vary greatly (271), with side-stream smoke 
yielding chemical concentrations on an order of magnitude that can be much higher than 
that of mainstream smoke (130).  ETS is classified as a Group A carcinogen under the 
United States Environmental Protection Agency (EPA) carcinogen assessment guidelines 
(240).   
Whether through active or passive smoking, the process of inhalation delivers the 
chemical compounds present in tobacco smoke to the pulmonary vasculature where they 
are absorbed directly into the bloodstream and delivered throughout the body (226).  The 
mutagenic and carcinogenic compounds in tobacco smoke have a broad distribution of 
target organs in the body:  PAH and aza-arenes for lung and bronchi; aromatic amines for 
the bladder; N-nitrosamines for the liver, esophagus and other organs; alkenes have 
multiple target foci (130). Although the exact mechanisms and acting agents have yet to be 
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identified, chemical components of tobacco smoke are also suspected to target the male 
and female reproductive organs, interacting either directly or indirectly with germ cells and 
affecting their function and viability (281).  Among women, smoking has been associated 
with delay in both natural (99) and assisted fecundity (40), early onset of menopause (145), 
and accelerated depletion of ovarian reserve (140).  Once pregnant, cigarette smoking 
significantly increases a woman’s risk for placental problems, intrauterine growth retardation 
and preterm delivery (244).   
The male reproductive system is also a potential target for the chemicals present in 
tobacco smoke.  By-products of tobacco smoke can cross the blood-testis barrier through 
various modes of diffusion and active transport from the arteriae testicularis and Sertoli cells, 
producing concentrations in the seminal plasma proportional to those found in serum (170, 
264, 278).  Although the exact mechanisms of toxicity are not fully understood, data from 
animal and experimental studies have indicated several possible pathways through which 
chemical constituents of cigarette smoke are suspected to alter the physiologic processes of 
normal male reproduction.  Disturbances in hormonal regulation is one possible mechanism.  
In general, data from rat studies have indicated disruption of hormonal regulation, in 
particular reductions in testosterone and androgen-binding protein levels, which suggest 
Leydig and Sertoli cell secretory dysfunction (108, 276). Further evidence of cellular 
degeneration comes from histological examination of the testis in which degeneration and 
reduction in number of the Leydig cells was observed (277). Testicular hormonal alterations 
can occur in the absence of change in serum hormonal levels, suggesting that Leydig and 
Sertoli cell disturbance is not mediated, at least not exclusively, through smoke-induced 
disturbances in hypothalamic-pituitary function (178).   
High concentrations in cigarette smoke of pro-oxidants (e.g. superoxide anioin, 
hydrogen peroxide, hydroxyl radicals) capable of generating reactive oxygenation species 
  
23 
 
(ROS) suggest another mechanistic pathway.  Both the gaseous and particulate phases 
produce oxidants from chemical reactions that occur within the body once the smoke is 
absorbed into the blood stream.  Experimental and animal data have indicated that 
exposure to the constituents of tobacco smoke induces lipid peroxidation (LPO) and free 
radical production, resulting in sperm damage due to secondary oxidant/anti-oxidant 
imbalances from over accumulation of lipid hydroperoxides and other oxidants (11, 185).  A 
related pathway is the initiation of the proinflammatory response, leading to the release of 
cytokines and other chemical mediators that can also generate high levels of ROS (5, 201).  
Tobacco smoke may also impair spermatozoa directly (56) through, for example, covalent 
bonding with DNA to form adducts, leading to the production of defective sperm, infiltration 
of phagocytic leukocytes and the generation of ROS (238). Cigarette smoke also appears to 
act directly on the accessory glands, which are necessary for normal spermiogenesis and 
full functional capacity of the mature spermatozoa (173). 
What seems most probable is that several mechanisms operate jointly, resulting in 
multiple sites of injury. Nonetheless, if tobacco smoke chemicals interfere with human male 
reproductive function, the end result of these putative mechanistic pathways would be 
expressed in alterations in spermatogenesis and ultimately sperm quality.  Epidemiologic 
research to address the etiologic effects of tobacco smoke on a range of seminal 
parameters in humans (both primary and secondary analyses) has generated nearly 90 
published reports (in English) from many different countries (Table A.1 provides results  
organized by year).  However, research methods, including study populations and exposure 
assessment, have varied greatly and so too have results.  
Nearly one-third of the studies that have examined the relationship between cigarette 
smoke and parameters of sperm quality have observed no evidence of adverse effects.  
Although these studies often differed by country, exposure classification, outcome selection 
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and statistical analysis, the majority used cross-sectional designs and obtained subjects 
from infertility clinics (13, 17, 31, 37, 46, 49, 51, 71, 74, 93, 96, 109, 160, 159, 164, 193, 
211, 235, 239, 280).  However, several of the reports of no finding came from the study of 
either healthy volunteers or subjects from a combination of sources (infertility clinics, 
community volunteers) (13, 158, 219, 224, 230, 252) or infertile subjects with normal semen 
parameters (129). A US study of 50 healthy volunteers conducted in 2001 by Wallock et al. 
(256), reported that, although not significant, smokers had a better seminal profile than non-
smoking men.   
The remaining studies suggest that at least for some parameters and among certain 
sub-populations smoking may increase the risk for alterations in spermatogenesis and 
sperm quality.  Like the studies reporting no effect, this collection of results was largely 
obtained from cross-sections of men attending infertility clinics from many different 
countries, using several methods to characterize exposure in relations to a variety of sperm 
quality outcomes.  While there is no clear pattern of sperm quality results that has emerged 
in relation to different methods of classifying exposure to tobacco smoke, it provides an 
outline for discussing the studies that have been conducted on this subject. 
Twenty-six studies used a simple approach to classifying exposure status whereby 
exposure assignment was specified in one of two ways: either smoker v. non-smoker or 
never smoker v. ex-smoker v. current smoker.  Most of these studies observed significantly 
different results for one or two parameters and no meaningful differences by smoking status 
for other measured sperm quality indicators.  Three of the studies that used qualitative 
exposure assessment observed differences in seminal volume only (35, 94, 123); Chia and 
colleagues, however, also reported a non-significant trend in sperm concentration (smokers: 
40.7 ± 3.1; non smokers: 47.3 ± 2.6).  Although there were no differences noted in seminal 
volume, a US study of infertility patients and an Australian study of sperm donors (120, 83) 
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both observed reductions in sperm concentration (60% and 33%, respectively) and 
percentage of motile sperm (23% and 7%, respectively) for smokers compared with non-
smokers, with a much greater magnitude of effect among Kulikauskas’ study group of 
infertility patients.  
Other studies also found differences by smoking status in sperm concentration (24, 
84, 98), though some of the results were not significant (112, 198, 254, 255).  Evans et al., 
(56) reported significant differences in both concentration and morphology.  Ablin (2) did not 
observe differences in morphology, but did report alterations in concentration and motility 
among smokers compared to non-smokers.  On the other hand, Pacifici et al. (170) 
observed a relationship between smoking status and motility only, with a 19% reduction in 
progressively motile sperm for smokers compared to non-smokers.  However, subsequent 
studies reported alterations in smokers’ sperm counts, concentrations and morphologies, as 
well (15, 134).  In a more recent study in which smoking status was defined as having at 
least one cigarette per day, Kunzle et al. (122) described similar results, reporting a 17.5% 
reduction in sperm count, 15.3% reduction in sperm concentration, a 16.6% reduction in 
sperm motility and 11% reduction in normal morphologic forms.  Finally, some researchers, 
limiting the smoking category to heavy smokers only (ranging from ≥ 4 to over 20 cigarettes 
per day as the criterion), described a range of results that included a 57% decrease in 
sperm concentration only (121), a 51% decrease in concentration and 27% decrease in 
normal morphology (148), 5% higher abnormal forms and 33% reduction in motility (213), 
42% decrease in normal forms and 39% decrease in motile sperm (220), 19% decrease in 
motility only (278) and reductions in sperm count, morphology and motility (279).  Results for 
Zavos et al. are described in the summary and limitations section below.  
Other researchers have used the number of cigarettes smoked in a day to develop 
mutually exclusive exposure categories to which study subjects were assigned (e.g. 1-9, 10-
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19, 20+ cigarettes per day).  The 12 studies that used this method of exposure assessment 
generated a range of results similar to those obtained in the studies that used less refined 
exposure categories.  Several studies observed significant differences by the number of 
cigarettes smoked for only one parameter of those measured (7, 165, 169, 175), while 
others described an effect across a wider spectrum of outcomes:  volume, concentration 
and morphology (216), concentration, motility and morphology (5, 144, 201), while still 
others described smoking effects for some combination of two of the measured outcomes: 
count and motility (186), volume and motility (199), volume and concentration (166).   
Continuous measures of tobacco smoke exposure have also been used.  In a cross-
sectional study of 88 US men ages 18 to 35 years Vine et al. (250) observed that continuous 
measures of number of cigarettes smoked each day, years smoked and log-transformed 
cotinine (the metabolite of nicotine) levels to be negatively correlated with seminal quality, 
specifically sperm count, concentration and motility; only duration of smoking was 
associated negatively with morphology (the average magnitude of each of the correlations 
was r=-0.25).  Zhang et al. (282) also observed a relationship between duration of smoking 
and sperm quality, reporting significant reductions in seminal volume, sperm concentration, 
viability and motility in subjects that had smoked 11 to 20 years compared to non-smokers; 
only volume was negatively affected for those having smoked one to eleven years.  Chia et 
al. (34) combined intensity and duration, (cigarette-years) and found significant declines in 
sperm concentration (22% reduction smoker v. non-smoker) and normal morphology (21% 
reduction smoker v. non-smoker), adjusting for medical history, occupational exposure, age 
and testicular volume.  
Several studies reported differential effects across subgroups.  Klaiber et al. (113), 
having stratified smoking effects by fertility status, reported statistically significant results 
among infertile men for all three parameters evaluated (concentration, morphology and 
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motility): (77.2 ± 65.4 v. 140.4 ± 114.1), (25.1% ± 15.9% v. 22.6% ± 8.4%), (53.0% ± 22.4% 
v. 65.7% ± 14.05).  Smoking did not appear to diminish sperm parameters among fertile 
men.  Vine, et al. (250) observed that age modified the relationship between cigarette 
smoking and seminal parameters, as negative effects were observed only for men older 
than 22 years of age, adjusting for alcohol and caffeine intake. Some studies have observed 
that alcohol consumption and caffeine intake accentuate the relationship between cigarette 
smoking and sperm quality.  Marshburn et al. (138) reported that men who consumed more 
than four cups of coffee per day and smoked more than a pack of cigarettes each day 
demonstrated a lower percentage of motility, while smoking alone, no matter how great the 
daily use, did not exert an independent effect among men seeking infertility evaluation.  The 
findings by Marshburn were corroborated by a recent study of 3,976 infertility patients from 
Argentina in which researchers observed that smoking only diminished sperm quality when 
evaluated in conjunction with alcohol consumption (139), with mean sperm concentrations of 
smokers and drinkers 45.3 ± 3.6 compared to men with neither behavior 50.9 ± 0.9; similar 
differences were reported for motility: 39.6 ± 1.6 v. 44.0 ± 0.4 and volume: 2.7 ± 0.1 v. 3.0 ± 
0.0, although the presence of both smoking and drinking did not affect morphology.  In a 
study conducted by Wang et al. (258), data revealed an interaction between smoking and 
exposure to petrochemicals such that men doubly exposed had 31% poorer density and 
29% less total sperm count than those without either exposure.  Smoking alone (measured 
as either status, number of cigarettes smoked or pack years) did not emerge as a negative 
factor except for years of smoking for which there was a negative correlation between years 
smoked and sperm density (r=-0.24, p<.05); this result is nearly identical to the magnitude of 
effects described above (Vine et al., 1996).  
A total of seven case-control studies, with varying exposure assessment, have been 
conducted to identify factors associated with an increased risk for sperm quality 
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disturbances.  Results have been largely consistent with the cross-sectional studies.  In a 
study from Italy that compared 97 infertile men (cases) to two control groups, one with 121 
men of unknown fertility and the other with 105 fertile men, researchers observed elevated 
odds of infertility among men smoking at least 15 cigarettes each day compared to men 
smoking less (grp 1: OR 1.9, 95% CI: 0.9-4.3; grp 2: OR 1.7, 95% CI: 0.3-6.3)(174).  Wong 
et al. (264) also found that the odds of infertility were higher among current smokers than 
non-smokers (OR=1.7, 95% CI:0.9-3.2), although not statistically significant.  In a study of 
218 men of unknown fertility and 240 men of proven fertility from Singapore, results 
indicated elevated odds of being a case for smokers compared to non-smokers, controlling 
for drinking status, age, and occupational group (OR=2.85, 95%CI: 1.91-4.24) (36).  
However, exposure to cigarette smoke did not emerge as a risk factor for decreased sperm 
quality in other case-control studies (23, 76, 158, 265). 
Exposure to cigarette smoke has also been examined in relation to outcomes that 
measure accessory gland function (e.g. fructose levels), hormonal regulation (e.g. seminal 
testosterone) and functional capacity of spermatozoa (e.g. acrosome reaction, penetration 
assays), as well as general indicators of testicular functioning such as presence of 
leukocytes and ROS.  These studies supplement those of standard sperm quality 
parameters, providing additional information about mechanistic pathways, causal 
intermediaries and functional outcomes.  Viewed collectively, the pattern of results for these 
studies does not provide consistent evidence of negative effects related to tobacco smoke 
exposure.  In a sperm function study from Egypt, results indicated that presence of a 
varicocele greatly effects acrosin activity and acrosome reaction, but smoking had little if any 
effect (Mulla et al., 1995), which had been previously observed by Lewin et al. (129). 
However, Close et al. (37) did report better performance in sperm penetration assays in non-
smokers compared to smokers, which was supported by the results of Sofikitis et al. (220) 
  
29 
 
that indicated significantly better function in the hypoosmotic swelling test, penetration 
assay, and acrosin activity (p<.05). Other smoking-related observations have been low 
seminal plasma folate levels (256), oxidant imbalances (67), alterations in accessory sex 
gland markers (173), cytoplasmic retention (134), increase in seminal leukocyte count (37), 
reduction in testicular testosterone (220), increase in ROS (201), increased number of round 
cells (239) and a negative impact on sperm exposed to seminal plasma of smokers (11, 
278).   
It is also possible that smoking may damage the genetic material in the male germ 
cell.  There are three outcome categories that have been evaluated in research testing this 
hypothesis: aneuploidy, an irregular number of chromosomes, adducts formation/oxidative 
damage and DNA integrity.  The five studies that have examined tobacco smoke exposure 
in relation to aneuploidy indicated that smoking was related to an increase in the occurrence 
of aneuploidy for chromosome 8 and aggregate frequency of aneuploid sperm (273), 
chromosome 1 (84), aggregate X, Y and 8 (196) and chromosome 13 (216).  In addition, Shi 
also observed a much higher inter-donor heterogeneity in the frequency of sperm disomy, 
suggesting a genetic component that increases susceptibility to nondisjunction induced by 
smoking during the process of meiosis.  Although a study by Robbins et al. (191) observed a 
smoking-related increase in the frequency of sperm aneuploidy in chromosome XX18, the 
effects were diminished when adjustments were made for alcohol consumption and caffeine 
intake.   
Four studies have examined the presence of DNA adducts in spermatozoa in relation 
to cigarette smoke.  Results have been mixed.  Gallagher et al. (68) did not detect 
differences in adduct formation between smokers and non-smokers, using P-Postlabeling 
Analysis.  Results from a study conducted by Zenzes et al. (280), however, demonstrated 
that benzo(a)pyrene diol epoxide –DNA adducts are higher in sperm of smoking compared 
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to non-smoking men.  Although Horak et al. (95) reported 1.2 times the frequency of bulky 
DNA adducts in smokers compared to non-smokers the differences was not statistically 
significantly, and disappeared completely when continuous measures of cigarette use and 
duration were considered.  Another study from the same year also found no increase in 
germ cell adduct formation among smokers (70). However, a study by Shen et al. (215) 
suggested that cigarette smoke does enhance the extent of oxidative DNA damage, with 
smokers expressing a significantly higher level of 8-OHdG in sperm DNA than non-smokers.  
The results from Shen et al. confirmed those of an earlier study that also reported a 
significant increase (50%) in oxidative DNA damage in smokers compared to non-smokers 
(67).  
Slightly more than a handful of studies have evaluated the effects of smoking on 
DNA fragmentation.  Most results did not indicate a difference between smokers and non-
smokers, regardless of the method used to detect strand breaks, including the Comet assay 
(17), Tunel assay (212) and the SCSA (196, 201).  However, Potts et al. (182), using the 
SCSA, observed that smokers had nearly twice the gradient of DNA denaturation (smokers 
50.1 ± 0.57 to 27.9 ± 3.87, non-smokers 52.0 ± 2.5 to 39.8 ± 6.7) and Sepaniak et al. (211), 
using the Tunel assay, reported a significantly higher percentage of sperm cells with DNA 
fragmentation among smokers compared to non-smokers (32% v. 25.9%; p<.05).  It is 
important to note that all but one of the findings of germ line damage occurred in the 
absence of negative findings in standard sperm markers, suggesting that damaged sperm 
may have the capacity for conception.  
Finally, relatively few studies have examined the effect of other tobacco products on 
any parameters of sperm quality or related biomarkers (15, 46, 173, 200) and no study has 
examined the effects of ETS.   
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2. alcohol consumption 
Alcohol is the most frequently consumed drug in America (241), with nearly 70% of 
US men and 56% of US women 18 years of age or older classified as current drinkers 
(defined as having had at least 12 drinks in the preceding year); adults 25 to 44 years of age 
constitute the largest population of current drinkers (206).  Consumption of large amounts of 
alcohol has been associated with a wide array of adverse physical and social consequences 
that range from cancers (head and neck, digestive tract, and breast) and other physical 
impairments (liver disease, cardiomyopathy) to social and occupational manifestations such 
as accidents, suicide, and crime (243, 267).  Alcohol is also an established teratogen and 
the cluster of abnormalities observed in infants exposed in utero to alcohol is a well-
characterized syndrome (241).  At the same time, there is also evidence to suggest that 
intake of small or moderate amounts of alcohol may be beneficial to certain aspects of 
health, conferring a protective effect against coronary heart disease, sudden death, and 
possibly deterioration of cerebral functioning related to aging (243).   
Given the prevalence of alcohol use, particularly among adults of reproductive age, 
the impact of alcohol consumption on reproductive health has also been an important area 
of study.  Among women, alcohol consumption has been studied in relation to several 
outcomes, particularly fertility. Most epidemiologic investigations of alcohol and fertility 
(fecundity) have not observed a greater time to conception in women that drank alcohol 
compared to those that did not regardless of the type or amount consumed (41, 66, 162, 
163), as long as consumption did not exceed 14 drinks per week (104).  Nonetheless, 
Hakim and colleagues (82) observed a reduction of more than 50% in the number of 
pregnancies among women who consumed any alcohol during a menstrual cycle, although 
these results were not corroborated in a subsequent study (107).  Alcohol may play a 
stronger role in miscarriage.  Researchers reported an increased odds for spontaneous 
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abortion when alcohol is consumed at the time of conception (OR=1.26; 95% CI: 1.19-1.33) 
(90) or during the first trimester of pregnancy (OR=1.26, 95% CI:1.19-1.33) (12). 
Research on the reproductive effects of alcohol consumption among men has 
employed a variety of methodologies.  Studies using animal models and in vitro experiments 
have demonstrated that alcohol, particularly at high doses, exerts a complex, negative 
impact at multiple anatomical locations of the male reproductive system.  Able to penetrate 
into the germinal cell compartment of the testis, alcohol directly disrupts normal testicular 
structure and function.  In one study, rats treated with high-dose alcohol over a five-week 
period demonstrated seminiferous tubule atrophy, germinal epithelial damage, spermatozoal 
fragmentation, micronucleated giant cells and spermatocyte desquamation (114).  Sertoli 
cells also appear to be vulnerable to alcohol, leading to alteration in the blood-testis barrier 
maintained by these supporting cells (283).  The Leydig cells are another critical target, 
which when damaged creates a cascade event that disrupts systemic hormonal balance and 
regulation necessary for normal reproductive functioning (247).  Remodeling of the testicular 
architecture and perturbation of reproductive hormones leads to diminution in quality and 
quantity of spermatozoa.  In general, alterations in straight line velocity and morphology, 
particularly tail defects, have been the most common alterations reported (8, 47).  In 
addition, alterations in functional measures including acceleration in acrosomal loss (6) and 
decrease in fertilizing capacity of spermatozoa (203) have been reported as well.  The 
nature and extent of alcohol-related pathology is dose and duration dependent (263), and 
can occur in both acute and chronic exposure scenarios (143, 246).  Moreover, adverse 
effects of alcohol may not be confined to the male reproductive tract, as researchers have 
observed alterations in genomic imprinting resulting in expression of normally silent paternal 
alleles in the offspring of male rats (18).   
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Human studies have corroborated much of the harmful effects of heavy alcohol 
consumption observed in the animal and experimental studies.  Detailed results of the 
epidemiologic studies can be found in Table A.2.  Men with chronic alcoholism exhibit a 
range of well-documented reproductive pathology that includes testicular atrophy, 
impotence, and diminished sexual interest and secondary sexual characteristics (54).  
Significant hormonal, structural, cytological and seminal alterations (75, 149, 150) are other 
well-established consequences that have been observed even in the absence of more overt 
symtomatology such as impotence (172).  However, while the pattern of reproductive 
consequences associated with chronic alcohol intoxication has become largely predictable, 
alcohol-related effects of moderate intake, a more prevalent and socially-accepted behavior, 
remain unresolved due to a lack of coherence across study findings.  
Inconsistency in the literature is most likely due to a combination of variation in study 
design and methodology including subject selection, exposure assessment and selection of 
outcomes, in addition to biases and lack of adjustment for confounding.  Although the weight 
of evidence suggests that moderate amounts of daily alcohol intake is not detrimental to 
seminal volume or sperm concentration, morphology and motility (23, 37, 48, 76, 138, 158 
160, 230, 252, 265), there is some compelling evidence to the contrary. Manifestations once 
believed to be expressed only as a result of excessive alcohol consumption are now being 
observed among men whose drinking patterns were more consistent with moderate or social 
drinking, defined as no more than two standard drinks per day for men (243).  For example, 
results from an autopsy study of the relationship between spermatogenesis, testicular tissue 
histopathology and moderate alcohol consumption among 195 men aged 35 to 69 years 
indicated that spermatogenic arrest, either full or partial, appears to be a common disorder 
induced by moderate alcohol intake, which was observed in 42% of men with a daily intake 
of 40 to 80 grams (171). Several additional studies have reported similar findings for sperm 
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quality and functional measures.  Gerhard et al. (71) reported better post coital tests and 
fewer round cells in the spermiograms of non-drinkers compared to those ingesting at least 
20 grams per day in a study of 225 men seeking evaluation for infertility.  In a case-control 
study from Italy the following year, infertility cases had higher odds than controls of having 
consumed daily alcohol (1 drink OR=1.3 95% CI: 0.3-5.6; 2-3 drinks OR=1.9 95%CI: 1.7-
10.1; 4+ drinks OR=4.1 95% CI=1.2-?) (174).  Moderate alcohol consumption also emerged 
as a potential risk factor for dyspermia in a more recent case-control study of men from 
Singapore, with cases having slightly greater odds of moderate alcohol consumption than 
controls, controlling for age, smoking and occupation (OR=1.33, 95% CI=0.89-2.00) (36). 
Perhaps the most intriguing results have come from a prospective study conducted 
by Martini et al. (139) of 3,976 men attending an andrology clinic in Argentina.  Although 
results supported earlier studies of a lack of independent effect of moderate alcohol 
consumption on seminal parameters, researchers found that when alcohol consumption and 
cigarette smoking were examined jointly in comparison to neither behavior there was a 
significant reduction in seminal volume (2.7 ± 0.1 v. 3.0 ± 0.0), sperm concentration (45.3 ± 
3.6 v. 50.9 ± 0.9) and motility (39.6 ± 1.6 v. 44.0 ± 0.4); morphology was not effected.  Joint 
effects were first suggested by Marshburn and colleagues in 1992 and except for Martini 
have not been subsequently explored. There is also early evidence suggesting that even 
small amounts of alcohol may act independently to alter chromosomal numbers (191, 192), 
but these results have not been consistently observed (84), and Horak et al. (95) reported a 
lack of association between alcohol intake and bulky DNA adducts in human sperm, but 
amount and type of alcohol consumption were not reported.  
In a study of 182 infertile men from Italy, researchers reported an unexpected, yet 
significant inverse association between daily alcohol consumption and PAH-DNA adducts in 
sperm (70), indicating the potential for alcohol to have beneficial properties on indicators of 
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seminal quality and testicular function.  Other studies have reported protective effects of 
moderate alcohol intake on other seminal parameters as well.  In a study of 1,001 presumed 
fertile men from four European cities, those with moderate alcohol intake (3.6 units per week 
on average), had fewer sperm morphological defects than those consuming large weekly 
amounts (16.1 units per week on average), but the moderate drinkers also had better 
morphology than those not drinking at all (13).  Specifically, percentage of normal forms for 
non-drinkers was 48.3% compared to 52.4% for those consuming 1 to 6 drinks per week 
(p<.01).  In addition, non-drinkers had a higher percentage of cells with retained cytoplasm 
(1.3%) compared to 1.0% for men averaging less than one drink per day and 0.9% for those 
drinking at least one alcoholic beverage each day (p<.05).  In an earlier study of Italian male 
taxi drivers, those consuming 1 to 3 drinks per day were less likely to have a sperm count of 
less than 40 million (18.5% v. 25.1%), less than 40% motility (14.8% v. 21.9%) and less than 
50% of atypical morphologic forms (37.0% v. 62.5%) compared with drivers who did not 
drink at all (63).  There are no reports relating any level of alcohol consumption with the 
SCSA.   
 
3. caffeine intake 
Caffeine is a naturally occurring dietary constituent of numerous beverages and 
foods.  Coffee, tea, soft drinks, cocoa and chocolate, as well as some pharmaceuticals are 
examples of caffeinated products.  Caffeine is believed to be the most frequently ingested 
pharmacologically active substance in the world, with 95% of total caffeine consumption 
occurring in the form of coffee and tea (268).  Given the amount of caffeine that is routinely 
consumed by a large segment of the population, there has been both public and scientific 
interest in elucidating the potential health effects of consuming this prevalent dietary 
  
36 
 
chemical.  Consequently, caffeine has been the subject of extensive toxicologic and 
epidemiologic investigation for over three decades (42).   
Caffeine is rapidly and almost completely absorbed from the gastrointestinal tract 
directly into the bloodstream, reaching maximum concentration at approximately 1.5 hours 
after ingestion.  Once absorbed, caffeine is transported to all organs and fluids throughout 
the body, moving freely in and out of cells and penetrating all physiologic barriers that help 
protect organ tissues from passage of harmful substances, including the blood-testis barrier 
(19).  Primarily metabolized by the liver and excreted by the kidney, caffeine has been 
studied for general toxicity; cardiovascular, skeletal, and behavioral effects; and 
genotoxic/mutagenic and carcinogenic potential.  Female reproductive and developmental 
effects (i.e. delayed conception, spontaneous abortion, gestational size, preterm delivery 
and congenital defects) have been investigated as well.  Based on the vast amount of 
evidence that has accumulated regarding the myriad of potential health effects of caffeine, it 
can be concluded that for the general population of healthy adults moderate caffeine intake 
is not injurious to their health (42, 151), nor does it appear to significantly increase the risk of 
reproductive adversity among women (128).  
The consequences of caffeine intake on male reproductive health, however, are not 
as well characterized; yet early evidence suggests that caffeine may play an important role.  
With the potential for having tremendous clinical significance in assisted reproductive 
medicine, one major area of study has been the impact of caffeine on sperm motility.  Initial 
research in this area took the form of in vitro studies in which investigators administered 
specified doses of caffeine to sperm and measured changes in motility and morphology over 
time.  Results of these studies demonstrated caffeine to be a highly effective agent for 
stimulating motility for both fresh and cryo-stored specimens, with most studies observing 
significant increases in the percentage of motile sperm (80, 136).  However, some studies 
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found that improvements in motility came at the expense of sperm morphology, as 
observations were made of an increase in abnormal forms (86).  Although subsequent 
studies have not observed sperm damage to occur as a result of caffeine administration 
(16), its potential to disrupt morphology or induce mutations has not been fully resolved.   
Moreover, clinical research on the fertility of sperm treated with caffeine has yielded mixed 
results.  Although one study reported twice the number of pregnancies resulting from 
caffeine-treated, inseminated sperm (16) Imoedemhe and colleagues (100) reported an 
adverse affect on fertility with 78% of controls compared to just 35% of the caffeinated 
sperm resulting in fertilization of an oocyte, especially when caffeine doses were greater 
than or equal to 5 mM.   
In contrast to the laboratory and clinical studies, epidemiologic research has been 
conducted to characterize etiologic effects of caffeine on a much broader spectrum of male 
reproductive endpoints.  For detailed study results see Table A.3.  Marshburn et al. (138) 
was the first to explicitly examine the impact of coffee consumption on sperm quality. In this 
cross-sectional study of 546 men of couples attending a North Carolina infertility clinic, 
bivariate results indicated that coffee drinking (none, 1-2 cups/day, ≥ 4 cups/day) was 
positively correlated with improvements in sperm density (76.7 ± 3.7 v. 89.1 ± 3.8 v. 81.4 ± 
5.8) and percent motile forms (59.0 ± 1.5 v. 62.0 ± 1.2 v. 57.0 ± 2.5).  However, when the 
effects of smoking cigarettes and caffeine intake (> 20 cigarettes and ≥ 4 cups/day) were 
analyzed jointly, spermatozoal motility and viability were adversely affected; researchers did 
not report any change in morphology and the joint effects of coffee and alcohol consumption 
did not seem to affect any parameter.  Despite the author’s lack of detail in reporting their 
methods and results, and failure to adjust for age or other potential confounders in their 
analyses, the study generated useful information about how caffeine use may affect semen 
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quality parameters, especially in relation to concomitant behaviors such as smoking and 
alcohol consumption.  
Among the few case-control studies that specifically collected information regarding 
coffee consumption/caffeine intake (23, 174, 265), only the study conducted by Parazzini 
and colleagues observed elevated odds for coffee consumption.  In this study, 97 Italian 
men attending an infertility clinic with proven dyspermia (cases) were compared to two 
separate control groups: one consisting of 121 men attending the infertility clinic, but with 
two normal semen analyses and the another group consisting of fertile men with partners 
that had just delivered a full-term, healthy infant.  Odds for dsypermia were greater for men 
who drank two to three cups of coffee per day compared to men who drank one cup or less 
per day (ORs group1: 1.3, 95%CI: 0.5-2.9; group 2: 1.8, 95%CI: 0.8-4.0), controlling for age, 
education, smoking, and alcohol. Odds of being a case were relatively higher for coffee 
consumption of four or more cups per day relative to those drinking one cup or less each 
day (ORs group1: 4.2, 95%CI: 1.7-10.1; group 2: 3.0 95%CI:1.3-6.9).   
The remaining studies, several of which were exploratory and others that were 
designed to specifically test hypotheses regarding coffee consumption/caffeine intake and 
sperm quality parameters have yielded mixed results.  No association was found with the 
number of cups of coffee ingested per day and sperm quality parameters among 312 
Norwegian men undergoing a fertility evaluation (160), nor was an association observed 
among 330 Brazilian men undergoing voluntary vasectomy (131), and Vine et al. (252) 
observed only a weak association between caffeine intake and 9 morphometric parameters 
among 86 healthy volunteers ages 18 to 35 years.  However, in a study of 500 men 
requesting vasectomy in Brazil, coffee drinking improved the percentage of progressively 
motile sperm from 57.1% (± 16.2%) for non coffee drinkers to 62.4% (± 16.0) for those 
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consuming at least 6 cups of coffee per day, and unlike some earlier studies, no alterations 
in morphology were observed (219).   
Coffee consumption has been also been linked with chromosomal aberrations and 
DNA damage in the male germ cell.  In an observational study of the combined effects of 
smoking, alcohol consumption and caffeine intake on aneuploidy frequency among 45 
healthy volunteers, researchers observed a significant linear increase in the number of 
chromosomal abnormalities associated with caffeine intake measured as the number of 
eight ounce coffee cup equivalents per day (191).  However, no association between coffee 
consumption and DNA adducts has been reported to date (95).   
 
4. Body mass index  
In epidemiologic studies and clinical practice, body fat is most commonly estimated 
by calculating body mass index (BMI), a measure of weight in kg adjusted for height in 
meters squared (65). The underlying assumption of the BMI formula is that fat mass 
accounts for most of the variation seen in weight for persons of the same height (262); 
empirical evidence supports this assumption (77).  In addition, other methods of estimating 
total body fat do not appear to be superior (223, 227).   
The use of self-reported height and weight compared to measured values for 
calculating BMI has been debated in the literature with respect to whether the error pattern 
is random or systematic and if the extent of misclassification bias is substantial (154, 225).  
Systematic error occurs when incorrectly reported height and weight (error) is correlated 
with the true value (e.g. the tendency of overweight individuals to report lower values), and 
there is evidence to suggest that this can occur (180).  However, data also suggest that, on 
average, reporting errors tend to be small and large systematic reporting errors leading to 
extreme misclassification of overweight and obesity are generally confined to specific 
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subgroups, specifically overweight individuals, especially women, individuals over the age of 
60 and underweight men (118, 194); none of these groups are present in the data that will 
be used for the proposed study.  Among men overall, differences between self-reported BMI 
and measured BMI tend to be very small (self-reported BMI (25.8) – measured BMI (26.0) = 
-0.27 (180) and among men ages 20 to 39 years of age, such as those in the cohort for the 
proposed study, probability of correctly classifying overweight and obesity is 94% (118).    
The current standards for defining BMI values fall into four distinct categories of 
kg/m2 for adults: <18.5 = underweight, 18.5-24.9 = healthy weight, 25-29.9 = overweight, 
30+ = obese (119).  National overweight and obesity trends are monitored using data 
collected as part of the National Health and Nutrition Examination Survey (NHANES), the 
most current estimates (2003-2004) for which indicate that 62.2% (%SE 2.1) of men age 20 
to 39 years of age are either overweight or obese and 28.0% (%SE 2.2) are obese (156).   
Although the magnitude of this public health problem is becoming clear, the 
spectrum of health consequences associated with increased adiposity has yet to be fully 
delineated.  Excess body fat is a well-established risk factor for numerous serious health 
conditions including coronary heart disease, hypertension, type II diabetes and several 
cancers (65, 262).  It is only recently, however, that overweight and obesity have been 
examined in relation to reproductive outcomes.  Although several adverse effects (e.g. 
anovulation, infertility, spontaneous abortion) have been linked with overweight and obesity 
among females, (155, 257), much less is known about the effects of excess body adiposity 
on male reproductive functioning.   
To date, relatively few studies have reported on BMI and male reproductive 
endpoints.  Summary of epidemiologic study results can be found in Table A.4.  Three early 
studies focused on sex-related hormones and observed alterations among obese men 
compared to men of normal weight (81, 228, 248).  Subsequently, Jensen et al. 2004 (101) 
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examined BMI in relation to standard markers of sperm quality, as well as serum 
reproductive hormones in a population-based cohort study of 1,558 adolescent men from 
Denmark.  Results indicated alterations in serum hormones corresponding with increasing 
BMI.  In addition, compared to healthy-weight men (20-25 kg/m2), men with BMIs over 25 
kg/m2  (overweight) had reduced total sperm count (23.9%, 95% CI: 4.7-43.2) and sperm 
concentration (21.6%, 95% CI: 4.0-39.4%).  Volume, motility and morphologic forms were 
not affected after statistical adjustment.   
In a study (133) of 72 men attending a reproductive clinic in Iceland (mean age=37 
years), researchers also found an inverse relationship between BMI and sperm 
concentration and count, but only among men with normal sperm quality (r= -0.33, p<.05; r= 
-0.30, p<.05 for concentration and count, respectively).  Other parameters were not 
reported.  In a study of 520 men (mean age=34.6 years) presenting for semen analysis in an 
Atlanta, Georgia based andrology laboratory, Kort, et al. (117) found a significant negative 
relationship between BMI (20-24 kg/m2 = normal weight, 25-30 kg/m2 = overweight, 30+ 
kg/m2 = obese) and a single composite score computed for normal motile sperm (NMS) 
(volume*concentration*%motility*%morphology).  Results indicated that NMS concentrations 
for normal weight men were 18.6 x 106, overweight men 3.6 x 106 and obese men 0.7 x 106.  
BMI was also positively correlated with %DFI, detected using the SCSA, with obese men 
having an average level approaching the threshold of infertility (27.0% ± 3.16%), normal 
weight men with 19% ± 1.96% DFI and overweight men with 25.9% (2.23%) DFI.   
In a study of 274 fertile Hungarian men, researchers observed the highest mean 
sperm concentration among men in normal BMI range, a non-significant reduction in 
concentration among men overweight (BMI 25.1 to 30 kg/m2) (37 ± 12 x 106) and significant 
reductions among obese men (BMI >30 kg/m2) (39 ± 14 x 106) compared to normal weight 
(BMI 20.1 to 25 kg/m2) (29 ± 12 x 106) (116).  No other measures were reported.  In another 
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recent study (61), researchers reported decreasing sperm concentration and serum 
hormone levels (testosterone and estradiol) when oligozoospermic men with BMIs >25 
kg/m2  were compared to oligospermic men with BMIs <25 kg/m2.  Finally, data from the 
Agricultural Health Study of pesticide applicators and their spouses living in Iowa and North 
Carolina were used to examine BMI in relation to fertility. Researchers reported observing 
an increased odds of infertility for a 3-unit increase in BMI relative to men with BMI of 20 to 
22 kg/m2 (reference group), adjusting for smoking, alcohol intake, solvent and pesticide 
exposure and state of residence (OR=1.12, 95% CI:1.01-1.25) (202).   
 
G.  Summary and Limitations of Previous Studies 
Tobacco smoke is the most studied exposure to be examined in the proposed study, 
yet decades of research have failed to provide the evidence needed to make a definitive 
statement about its effects on sperm quality.  Considered collectively, it is challenging to 
describe the pattern of results produced by previous studies due to large variability across 
study populations and numerous methodological limitations, however, there is some 
indication that smoking may alter testicular and post-testicular events, though exactly how 
and for which parameters is undetermined.  There is also some suggestion that the effects 
may be small (251), possibly limited to subgroups (e.g. fertility status) and are likely to act in 
concert with other modifiable behaviors, particularly alcohol consumption and/or caffeine 
intake (138, 139).  The epidemiologic data on alcohol consumption, though much more 
limited, is clearer to the extent that heavy, long-term drinking has been demonstrated to 
severely impair spermatogenic function and hormonal regulation in a cascade of pathologic 
events.  However, the impacts of moderate alcohol consumption, a more prevalent and 
socially-accepted behavior, on sperm count and quality have not been established.  
Moreover, early evidence suggesting that even small amounts may induce aneuploidy, 
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underscores the importance of continued research in this area.  Data on the effects of 
caffeine intake and BMI in relation to sperm quality are limited, but suggestive, although 
there is not enough information to draw conclusions.  Additional research, such as that 
which is described in this dissertation research, is necessary to foster a clearer 
understanding of the effects these prevalent lifestyle factors are having on the reproductive 
health of men.  
Inconsistency in the effects of lifestyle factors reported by previous sperm quality 
studies is likely a function of two primary factors.  The first factor is the heterogeneity in both 
the country of study and source population.  Thirty-three countries are represented in the 
literature. Variation in the source population of study subjects is another consideration, as 
men were recruited from the community, sperm donors clinics, urology offices, hospitals and 
birthing centers, although the majority of subjects (~ 60%) were recruited form infertility 
clinics.  Geographic variation in sperm quality has been reported in the literature (231) and 
could account for some of the inconsistency observed in sperm count and concentration.  
From an exposure standpoint, cultural differences as determinates of socially acceptable 
behaviors may lead to differential reporting by country of study origin.  There may also be 
differences across countries with respect to constituents and production of tobacco and 
alcohol products, which may also explain some of the variability in results.  
Limitations in methodology are also likely to have contributed to the lack of 
consistency in sperm quality study results.  Threats to internal validity are the most 
concerning.  Having the greatest impact on internal validity have been the limitations related 
to biases introduced with respect to subject selection, exposure classification and 
uncontrolled confounders.  Other limitations include lack of consideration for etiologically 
relevant time frame, small sample sizes, crude exposure assessment and probable low 
participation rates.   
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Recruitment of study subjects from infertility clinics introduces the potential for 
selection bias because those that presented themselves for evaluation and treatment 
related to the inability to conceive may also be different with respect to factors associated 
with the exposures of interest.  For example, this population, which by definition had been 
attempting conception for at least one year, may have also abstained from other activities 
such as tobacco smoking and alcohol use; it is also possible that the couple’s infertility is 
due to exposures to other potential toxicants (137).  Nearly two-thirds of the tobacco 
literature comes from cross-sectional studies of men attending infertility clinics.   
Another potential source of selection bias was likely to arise from low participation 
rates.  As this information was rarely, if ever, reported it is not possible to directly make such 
an assessment.  However, sperm quality studies are known to have very low participation 
rates and there is no reason to expect the studies examining the role of lifestyle factors to be 
markedly different.  
Subject selection for case-control studies was problematic as well.  Unfortunately, 
each of the seven studies incorrectly selected subjects for the control group by recruiting 
only subjects with proven fertility, using either men with a pregnant partner or those with a 
normal spermiogram (23, 36, 76, 158, 174, 264, 265).  The inclusion of only healthy men in 
the control group introduces bias in the odds ratio because the control group does not 
represent the base population that gave rise to the cases (181).  Selecting “healthy” controls 
usually leads to an upward bias of the study results (Rothman and Greenland, 1995).   
Differential misclassification of exposure is another possible source of bias 
introduced by sperm quality studies.  In several studies, exposure status (smoker v. non-
smoker) was assigned based on either fertility status or one of the outcome parameters 
measured in the study.  The most typical scenario was selecting the unexposed such that 
they had proven fertility and normal semen analyses according to the standards of the World 
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Health Organization (123, 148, 282).  This leads to a mixing of the effects of fertility and the 
exposure of interest when analyzing the sperm parameter outcomes measured in a study.  
Validity is, to some extent, compromised and conclusions about the etiologic role of lifestyle 
factors on sperm quality parameters are unclear. 
Few studies adjusted for potential confounders, which by definition are factors 
related to both the exposure and outcome.  Sperm count and quality are influenced by many 
factors, which may also be related to lifestyle factors.  Age, duration of abstinence, presence 
of medical conditions, occupational exposures and other lifestyle habits are some of the 
potential confounders that must be considered in etiologic research of sperm quality studies 
so that the influences of the exposure(s) of interest can be isolated.  Without adjusting for 
confounders there is a mixing of effects and it is not clear if the putative agent is responsible 
for the observed effect or another factor that was not evaluated.  While most studies 
controlled medical conditions through restriction of study subjects, statistical adjustment for 
other potential confounders was often neglected.  
Use of simple exposure assessment is another area in which there is room for 
improvement.  Exposure assessment was also lacking in the use of time frames that are 
relevant to spermatogenesis, which is approximately three months.  In addition, many 
studies suffer from very small sample sizes, affecting the power of the study to detect 
smaller effect sizes (21, 272). 
Not all of the semen quality literature is flawed, as there are several robust studies 
(196, 249, 252, 279).  These methodologically stronger studies provide a basis from which 
to better gauge the range of exposure/outcome effect estimates.  In a systematic literature 
review of 24 studies conducted from 1966 to 1996 on cigarette smoking and sperm quality, 
Vine et al. (249) reported a mean reduction of 13% in sperm concentration, a mean 
reduction of 13% in motility and a mean reduction of 3% in morphologically normal sperm.  
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In another-well designed study of twenty-five eighteen year old men from the Czech 
Republic, results indicated a range of alterations in sperm count and quality associated with 
smoking status, with a 41% decrease in sperm count, a 54% decrease in sperm 
concentration, and a 69% decrease in total number of motile sperm cells (279).  In another 
small, but well-conducted study of 29 infertility clinic patients, decrements in seminal 
parameters were also associated with smoking status.  Specifically, current smokers had a 
reduction of 20% in total sperm count, 21% in motility and 27% in normal morphology 
compared to smokers (196).  Other strong studies on the effects of smoking and sperm 
quality did not observe differences in standard sperm quality parameters between smokers 
and non-smokers (201).  Data on the sperm quality impacts for the other exposures (alcohol 
consumption, caffeine intake, increased adiposity) are much more limited.   
Additional research is needed to supplement the information provided by these high-
quality studies. The present study incorporates the necessary improvements needed to 
refine and extend our understanding of the etiologic relationship between lifestyle exposures 
and measures of sperm quality.   
 
H.  Conclusions and Significance 
Reproduction is a key biologic event relevant to individuals and populations.  
Evidence of declining sperm quality, a global increase in the incidence of testicular cancer 
and congenital defects of the male reproductive system has prompted etiologic research to 
identify factors that effect male reproductive health.  While decrements in sperm quality may 
in part be the consequence of complex environmental exposures, there is also evidence 
suggesting that other factors may be playing a role as well.  However, the impact of 
prevalent, personal behaviors, such as smoking, alcohol use, caffeine intake and increased 
body fat, on the human male reproductive system is not fully resolved.  What is clear is the 
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particular vulnerability of the male reproductive tract to the damaging effects of toxicants.  In 
addition, the induction of several reproductive pathologies are now recognized as having a 
male-mediated component, including idiopathic infertility and heritable mutations transmitted 
to offspring, which have the potential to cause transgenerational health effects (253, 280).  
These abnormal endpoints are believed to reflect germ cell damage that occurs during 
spermatogenesis.  Given the importance of preserving fertility and protecting DNA integrity 
of spermatozoa to ensure accurate transmission of genetic information, further research 
designed to elucidate the role of lifestyle factors in the perturbation of normal male 
reproduction is essential.  This study, informed largely by the methodological limitations that 
have complicated interpretation of previous work, will improve on exposure assessment, 
statistical analysis and the evaluation and treatment of confounding.  Results of this 
dissertation research can help to clarify the etiologic role of modifiable, personal behaviors 
on clinically relevant markers of the reproductive functioning of men.  Given the relatively 
high prevalence and often concomitant nature of these exposures, the detection of even 
modest effect sizes would represent findings with broad public health significance.   
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I. Figures 
 
Figure 1. Male reproductive anatomy 
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 Figure 1.2.  Spermatogenesis in human males 
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 CHAPTER 2: SPECIFIC RESEARCH AIMS 
The purpose of this dissertation research was to examine the effects of tobacco use, 
alcohol consumption, caffeine intake and body mass index in relation to measures of human 
sperm quantity and quality.  The primary aims were:  
 
1.  Evaluate the relationship between tobacco use and:  
total sperm count,  
sperm concentration,  
sperm morphology,  
sperm DNA integrity and sperm maturity, as measured by the Sperm 
Chromatin Structure Assay. 
 
2.  Evaluate the relationship between alcohol consumption and the sperm 
quantity/quality measures listed in aim 1.  
 
3.  Evaluate the relationship between caffeine intake and the sperm quantity/quality 
measures listed in aim 1.  
 
4.  Evaluate the relationship between body mass index and the sperm quantity/quality 
measures listed in aim 1. 
 CHAPTER 3:  RESEARCH METHODS   
A.  Overview 
To evaluate the effects of tobacco use, alcohol consumption, caffeine intake and BMI 
on measures of human sperm quality, data were analyzed from a prospective cohort study 
of 229 fertile men, ages 18 to 40 years, who resided in Raleigh, North Carolina, Galveston, 
Texas or Memphis, Tennessee between 2000 and 2004.  Subjects were identified through 
their female partners who were participating in a related study of drinking water disinfection 
byproducts (DBPs) and spontaneous abortion risk.  Men who agreed to participate were 
asked to provide a single semen sample, using a specimen kit designed specifically for 
home use.  Samples were packed with dry ice to maintain the specimen temperature 
between five and 10 degrees Celsius during shipping, and delivered overnight to a central 
laboratory for analysis the next morning.  Semen samples were processed at the central 
study laboratory of the Environmental Protection Agency (EPA) where semen volume, total 
sperm count, sperm concentration and sperm morphology were measured.  In addition, 
aliquots of semen were frozen and later analyzed for DNA damage, using the sperm 
chromatin structure assay.  Sperm motility was not evaluated because it declines over time 
and can only be reliably measured in fresh samples less than one to two hours old.  Prior to 
collecting the semen sample, a standardized telephone interview was used to obtain 
information on drinking water consumption, occupation, medical and reproductive history, 
diet, current height and weight, tobacco use, alcohol consumption and caffeine intake.   
Data analysis involved the evaluation of independent and aggregate effects of the 
four selected lifestyle exposures and the five primary sperm quality endpoints.  Tobacco was 
examined as lifetime and recent use, timing of use and dose.  Amount and type of alcohol 
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was also analyzed. Caffeine intake was determined based on algorithms published in the 
literature; source of caffeine intake was also considered as other constituents may impact 
sperm quality parameters.  Body mass index was computed with self-reported height and 
weight.  Separate linear regression models were constructed to generate effect estimates 
for each exposure and each of the sperm quality measures.   
 
B. The female study (“Right from the Start” Study) 
Right from the Start (RFTS) was a community-based, prospective study designed to 
evaluate the effects of DBPs on spontaneous abortion risk.  Pregnant women who were no 
more than 12 weeks gestation were recruited from prenatal clinics and the community in 
three study sites between December 2000 and April 2004 (14).  Eligible women were 18 
years of age or older, literate in either English or Spanish, received city water in their home, 
had not used fertility medication to achieve the study pregnancy, and intended to deliver in 
the study area.  Telephone interviews were conducted at two times during the study period 
to obtain information regarding drinking water habits, medical and reproductive history, 
occupation, physical activity and caffeine, tobacco and alcohol use.  Recruitment for the 
Healthy Men Study (HMS) was initiated during the second interview that included questions 
about the father’s characteristics.  A total of 3,132 women completed the study; 960 were 
eligible to be contacted for the HMS study.   
 
C.  The male study (“Healthy Men Study”)  
1.  Design and conduct  
Potential HMS subjects were identified through women participating in the RFTS 
study (13).   When informed consent was obtained, RFTS women were given information 
about the HMS and told that they would be contacted at a later date to invite their partner to 
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participate in the new study.  Active recruitment for the HMS began during the second RFTS 
interview when women were asked screening questions to determine their partner’s initial 
eligibility to participate.  Figure 3 outlines the recruitment strategy.  There were two phases 
of eligibility screening.  Initial eligibility was determined if a respondent reported that her 
male partner lived with her and she was willing to answer questions about him, that he was 
between the ages of 18 and 40 years, and he did not physically or sexually abuse her.  
RFTS women whose male partners were initially eligible were sent a letter that described 
the HMS, requested permission to contact her partner and provided a toll-free number for 
the women to call if they declined further HMS contact.  Women who did not decline were 
contacted by a HMS staff member to obtain the name, primary telephone number and 
availability of her partner so that he could be contacted directly.  Men were then mailed a 
letter and brochure describing the study. The mailing was followed by a phone call from 
HMS staff in which the second phase of eligibility screening was conducted.   Eligible men 
were between the ages of 18 and 40 years, living with their RFTS study partner, had not 
received a vasectomy or chemotherapeutic agents in the prior three months, had not been 
away from their home more than 30 days in the prior three months and were not planning on 
moving outside of the study area within the subsequent three weeks.  Once eligibility was 
established, men signed and returned consent forms to HMS staff who then scheduled the 
telephone interview.  
Computer-assisted telephone interviews were conducted by Battelle Centers for 
Public Health Research and Evaluation, a research firm in Durham, NC.  Men were asked 
questions covering a wide range of areas that included sources of water exposure, health 
and reproductive history, environmental and occupational exposures, diet, stress, hobbies, 
lifestyle factors and socio-demographic characteristics.  To facilitate the interview, men were 
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sent visual and memory aids such as a diagram to estimate beverage size and a calendar 
prior to the interview.  (Table A.5).  
When the telephone interview was completed, HMS staff contacted the man via 
telephone to arrange for delivery of the specimen collection kit to his home.  The collection 
kits were specifically designed to allow a man to collect a semen specimen in the privacy of 
his home and to do so at a time convenient to him (17).  Prior to sending the kit, staff 
confirmed the participants mailing address and provided verbal instructions on how to use 
the kit, including the instruction to abstain from sexual activity for two to seven days prior to 
obtaining the specimen for the HMS. The specimen collection kit was mailed to the 
participant in the week before the planned collection date and included a set of written and 
pictorial instructions that explained how to properly collect the specimen, package and 
prepare it for shipping, and contact the courier to arrange for pick up of the specimen. 
Instructions for timing the collection were also included and varied by study site because of 
the arrangement made with the local courier contracted to pick up and deliver the specimen 
for the study.   
Collected specimens were prepared for shipping by the study participant who 
packaged the specimen with special ice packs designed to maintain the temperature of the 
specimen at refrigeration levels for at least 24 hours.  Men were instructed to call the courier 
company with whom the HMS had arranged for pick up at the participant’s home on the day 
of collection so that it would arrive at the central laboratory at the EPA the following morning.  
Ten percent of the samples received by EPA were disqualified from analysis because 
specimens had either very low specimen volume (<0.5 ml), the sample had been spilled or 
was otherwise incomplete, shipping was delayed and the specimen was older than 24 
hours, the sample was not packed properly or the interval of sexual abstinence was too far 
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beyond the range of two to seven days.  In these cases, men were asked to provide another 
sample; almost all did so.  
When an adequate sample was received by the EPA lab and the subject’s 
participation in the study was complete, he was sent a thank you letter and a check for $50.  
His partner was also sent a letter and check for $20 for her contribution to the project.   
 
2. Study population  
Response and participation.  A total of 960 women were prospectively selected to be 
contacted about the HMS.  Of those women eligible for HMS recruitment, 305 (31.7%) 
provided the name and contact information of their partner.  For those that did not provide 
contact information, 154 (23.5%) were lost to follow-up, 460 (70.2%) refused to participate 
(due to either the woman or her partner) and 41 (6.3%) reported that her partner did not 
meet the study’s eligibility requirements.  Of the resulting 305 potentially eligible men, 230 
fully participated in the study, completing the telephone interview and submitting an 
adequate semen specimen.  Non-participation of the man or failure to complete the study 
was due to inability to contact/refused to participate (n=46, 15.1%), ineligibility based on 
responses to the second screener (n=52, 17.0%), refusal to answer the screening questions 
(n=12, 3.9%) or inadequate semen sample (n=8, 2.6%).   
Of the 274 men eligible to participate after both screeners were applied, 230 (84%) 
fully completed the study. The response proportion, a more conservative estimate of HMS 
recruitment success, includes in the denominator those men whose eligibility status was not 
able to be determined.  The overall response proportion was 25%, however this probably 
underestimates the true response proportion because it assumes that all men who were not 
able to be contacted were eligible to participate.  For this study, the final sample size was 
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229 because one man who donated an acceptable sample did not provide a written consent. 
For detailed recruitment results see Table A.6. 
 
D.  Exposure assessment  
1.  Overview  
Tobacco use, alcohol consumption, caffeine intake and BMI exposure variables were 
constructed from the data collected in the standardized telephone interview conducted as 
part of the HMS.   Some details in the process of classifying exposure are described more 
fully in the statistical analysis section of this chapter.  All exposure variables were assessed 
in relation to the three months prior to collection of semen specimen, reflecting the amount 
of time required for spermatogenesis to take place.  The exception to this is in the 
assessment of broader time windows such as lifetime exposures and initiation of behaviors 
at other potentially relevant time periods.   
 
2.  Tobacco Use  
Data were available for HMS subject use of five types of tobacco products: cigarettes, 
cigars, pipes, chewing tobacco and snuff.  Tobacco exposure was assessed by examining 
subject’s (1) lifetime and current use, (2) timing and duration of exposure and (3) dose for 
each of the individual tobacco products, where data permitted.   
Lifetime and current use. Evaluation of lifetime tobacco use was the first step in 
assessing tobacco exposure. This involved examining ever/never regular use of any of the 
five tobacco products, with regular use defined as at least once a day for at least a month.  
Men who reported regular use were classified as exposed over their lifetime; all other men 
were classified as unexposed over their lifetime.  Where data permitted, analogous lifetime 
(ever/never) exposure variables were then created for each individual form of tobacco use in 
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which men that reported having engaged in regular use of a particular tobacco product in 
their lifetime were compared to those men who never used that particular form of tobacco.  
Assessment of use at the time of interview (current use) involved classifying subjects as 
current users v. former users v. never users, using the strategy described above for 
classifying lifetime exposure.  
Timing and duration of exposure. Timing of tobacco use, specifically the age at 
initiation, may provide valuable information about susceptible periods of exposure most 
relevant to spermatogenesis.  For each of the five tobacco products, data is available on the 
age at initiation and cessation.  Men who reported that they began using a tobacco product 
during puberty (12 to 15 years of age), the time at which male hormones stimulate primordial 
germ cells to begin the process of mitosis, were classified as exposed.  Duration of 
exposure was estimated based on the question:  ‘how many total years did you use/smoke a 
particular product’.  Time since cessation was examined for men that reported having quit 
smoking. 
Dose.   Dose is a function of the average daily amount consumed of a particular 
tobacco product.  Dose can also incorporate time into the definition.  To estimate dose, men 
were asked questions about the daily frequency of use for each of the tobacco products that 
they reported using or having used.  Data are available for the average daily number 
smoked for cigarettes and cigars, the average daily number of pipefuls for pipe smoking, the 
number of times a man put new chewing tobacco into his mouth for chewing tobacco and 
the number of times per day new snuff was put in the nose or mouth.   In the sperm quality 
studies reported in the literature, dose has generally been calculated based on frequency 
alone (number of cigarettes per day) and smoking status has been categorized as low (1 to 
9 cigarettes per day), medium (10-19 cigarettes per day) and high (20+ cigarettes per day).  
The distribution of smoking behavior among men in the HMS data set was a large 
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determinate of what was possible for classifying exposure. As part of this study, duration 
was incorporated into dose.  For example, cigarette smoking was calculated as pack years, 
a well established method of taking into account both the amount each day and the length of 
time of total exposure.   
 
3.  Alcohol Consumption 
Alcohol consumption was determined from interview questions that asked about the 
average number of 12 oz. beers, 4 oz. glasses of wine, and 1 oz. shots of hard liquor 
consumed daily, weekly or monthly.  Exposure status was based on the total number of 
drink equivalents per week.  Exposure was evaluated on a continuum of alcoholic drinks and 
grouped into categories used in previous studies: 0-7 (low), 7-14 (moderate) and greater 
than 14 (high) drinks per week.  Type of alcohol consumed were examined as well, 
specifically, wine, beer and “hard liquor”.   
 
4.  Caffeine Intake  
Detailed information was collected to estimate caffeine intake among HMS study 
subjects.  Data were collected on daily intake of caffeinated coffee, decaffeinated coffee, hot 
caffeinated tea, iced caffeinated tea, and decaffeinated tea (not including herbal teas).  For 
each of these beverages, men were asked to report the number of daily glasses consumed, 
the average size of the drink (assisted by a diagram to improve accuracy), and whether the 
beverage was instant or brewed.  In addition, men were also asked questions about 
caffeinated sodas (e.g. Pepsi, Mountain Dew) and water products (e.g. Java Water).  For 
each brand of soda or water identified, men were asked about the material of the container, 
the number of containers consumed, and the average size of the container (also using the 
diagram aid).  An algorithm was employed to assign exposure status that was a function of 
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the type of beverages consumed, the cup sizes for each beverage and the number of cups 
drunk daily.  Published parameters of the caffeine content for each kind of beverage was 
applied to obtain the best estimate of individual caffeine exposure.  Total daily caffeine 
(milligrams) intake was computed for each subject.  Caffeine exposure was examined on a 
continuous scale, as well as categorized based on natural discontinuities in the distribution 
of the data.  Type of beverage (e.g. coffee, tea, soda) was also examined.  
 
5.  Body Mass Index  
Men were asked to report their current height and weight.  Height was measured in 
feet and inches, which were converted to meters.  Weight was measured in pounds and was 
divided by 2.2 to covert the metric to kilograms.  BMI was calculated by dividing weight in 
kilograms by meters squared.  The current standards for defining BMI values fall into four 
distinct categories of kg/m2 for adults: <18.5 = underweight, 18.5-24.9 = normal weight, 25-
29.9 = overweight, 30+ = obese.  These cutpoints were used to assign exposure.  Additional 
model, such as splines, were also created to fully explore the shape of the distribution with 
the sperm outcomes.   
 
E.  Outcome Measurements:  Sperm Assays  
1.  Laboratory assay methods  
Semen specimens were collected via masturbation at the home of the HMS 
participant, packed on ice and express shipped for next-day delivery to the central 
laboratory of the EPA for analysis and storage.  Upon receipt, specimens were logged into 
the HMS tracking system, labeled and frozen for storage until the time when the assays 
would be conducted.  Two experienced technicians from the EPA, blinded to the lifestyle 
exposures of HMS participants, performed a standard clinical semen analysis using the 
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WHO criteria (22). The semen analyses included a determination of semen volume, total 
sperm count, sperm density (the number of cells/mL of semen), and a comprehensive 
morphological assessment that included individual categories of defects in the head, tail and 
midpiece sections.  In addition, technicians performed the Sperm Chromatin Structure Assay 
(SCSA) to assess DNA damage and spermatozoal maturity (4).  It was not possible to 
evaluate motility because specimens were shipped and the motility of sperm declines over 
time.  
In preparation for semen analysis, samples were allowed to liquefy at room 
temperature (37 degrees Celsius) for up to 60 minutes, making sure that the sample was 
gently mixed well to reduce potential errors in the assessment of sperm concentration.  
Volume was determined in a graduated conical cylinder.  Sperm concentrations and total 
counts were determined using the Neubauer hemocytometer method on two separate 
preparations of the semen sample, one for each side of the counting chamber. Sperm 
concentration results were confirmed using the CASA (computer-assisted semen analysis) 
method.  Using appropriate dilutions (1:5, 1:10, 1:20, 1:50) based on preliminary 
estimations, slides were prepared with a positive displacement pipette of 10 µl of diluted 
semen transferred to each of the counting chambers of the hemocytometer.  Counts were 
made of complete (head, midpiece and tails) spermatozoa only.  For each specimen, total 
counts were conducted twice to reduce the probability of error.  To calculate the 
concentration (millions of spermatozoa/ml) the average total number of sperm was divided 
by the appropriate conversion factor determined during the preliminary estimation of total 
count.  For example, if the average total sperm count was determined to be 140 with a 
dilution of 1:10 and 10 large squares were counted, then the conversion factor would be 4 
and the concentration would be 35 x 106/ml (Table 3.1).   
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For the morphological assessment, two slides were prepared for duplicate 
evaluation, using the feathering technique and Papanicolaou stain recommended by WHO 
(22).  Kruger’s strict criteria were used to evaluate overall morphology, which specifies that 
each functional region of the spermatozoon (head, neck, midpiece, and tail) must be normal 
to be considered normal (10).  Any borderline forms were classified as abnormal.  Moving 
systematically across pre-selected areas of the slide, technicians examined and scored 200 
spermatozoa and recorded the defects of those abnormal.  Percent morphologically normal 
spermatozoa were recorded. Technicians also evaluated each functional region separately.   
The SCSA was conducted at South Dakota State University, where 229 straws of 
frozen semen from the HMS participants were shipped for analysis.  To conduct the assay, 
semen samples were thawed and diluted in a low pH solution (0.15 M NaCl, 0.01 M Tris 
HCl, 1mM disodium EDTA pH 7.4, 4ºC) to a sperm concentration of 1-2 x 106/ml and 
immediately mixed with 400 µl of 0.08 N HCl, 0.15 M NaCl, 0.1% Triton X 100 pH 1.2, 4ºC.  
Precisely thirty seconds later 1.20 mL of acridine orange (AO) staining solution (0.037 M 
citric acid, 0.126 M Na2HPO4, 0.0011 M disodium EDTA, 0.15 M NaCl pH 6.0, 4ºC) 
containing 6 µg/mL electrophoretically purified AO (Polysciences, Inc, Warrington, PA) was 
added and placed in the flow cytometry chamber whereby the sample flow is initiated.  The 
purpose of the low-ph solution is to potentially denature DNA that is damaged.  If the flow 
rate exceeded 300 spermatozoa per second, a new diluted sample was prepared.  
Structurally normal chromatin is distinguished from abnormal based on the differential 
pattern of AO staining by sperm chromatin: AO stains normal double-stranded DNA green 
and denatured, single-stranded DNA is stained red.  Three minutes after the start of the 
procedure, signal acquisition to a computer list mode is initiated. Raw data generated by the 
flow cytometer were sent to a specialized computer which is used to determine the percent 
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DFI and green fluorescence (HDS), which identifies immature spermatozoa (see Chapter 1 
for assay details).  This procedure was repeated twice for each sample (4).  
 
2.  Laboratory quality assurance and control  
Laboratory quality control and standardization refers to the procedures implemented 
by technicians and supervisors to detect and reduce systematic and random error of test 
results.  At this time, universally accepted definitions, standards and procedures do not exist 
for semen quality analysis and therefore it is not possible to make comparisons across 
laboratories.  Each laboratory must establish its own reference ranges which can be used to 
compare results.   
General control procedures.  The central laboratory of the EPA has adopted and 
implemented the quality control guidelines recommended by the WHO.  General quality 
control procedures are conducted at different time frames and include the routine 
surveillance and correlation of results within samples, analysis of intra and inter-technician 
variability in replicate measures of the main semen variables conducted weekly, analysis of 
mean test results conducted monthly, participation in external quality assurance activities 
and calibration of pipettes conducted quarterly and the yearly calibration of counting 
chambers and other equipment (22).   
Procedures for reducing error of specific assays.   Errors in the measurement of 
sperm count and concentration were reduced in several ways.  First, duplicate counts were 
conducted on each sample.  Differences and sums for the two counts were then calculated.  
Using a graph of expected differences given various sums, the computed difference 
between the two counts is plotted relative to the computed sum.  If the obtained difference is 
less than the expected difference (falls on or below the curve), then the arithmetic mean of 
the two counts is accepted as the total sperm count. Should the difference exceed (falls 
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above curve) what is expected given the sum of the counts, the results are discarded, the 
sample remixed, and the procedure repeated from the beginning.     
 
3. Outcome description  
A total of five outcomes were examined in the proposed study (Table 3.2):  total 
sperm count (million), sperm concentration (million/mL), percent morphologically normal 
sperm cells, percent DFI (%DFI) and percent HDS (%HDS).  A natural log statistical 
transformation was applied to count outcomes and arc sine transformation was applied to 
outcomes measured as proportions.  Both continuous and categorical treatment of the 
outcomes is planned for the statistical analysis, which is described in detail below.   
The sperm count and quality under investigation vary with respect to their sensitivity 
as indicators of reproductive risk following exposure to a potential toxicant and reliability as 
a measure.  The likelihood of observing an effect in an outcome is also a function of the 
exposure under consideration, which may have different mechanisms of toxicity and 
consequent effects relative to other exposures.  While it is difficult to specify with certainty 
the outcomes that are most likely to demonstrate evidence of effect per se, there are 
outcomes that are more reliable and have a better record for being successfully utilized in 
epidemiologic sperm quality studies than others.  Of the five outcomes that will be 
examined, the outcomes likely to be the most sensitive and reliable are sperm concentration 
and percent DFI.  Relative to the other outcomes that will also be examined, sperm 
concentration and percent DFI have a strong biologic basis for observing results given the 
exposures of interest and a well-established record of being successfully incorporated into 
epidemiologic studies.  In addition, they are objective measurements for which alterations 
are believed to be a strong indication of increased reproductive risk.  Morphology has also 
been successfully utilized in sperm quality studies, especially when conducted with strong 
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quality control procedures as with the HMS study.  However, sperm morphology is a 
subjective measure and its clinical relevance is less clear than the other measures. 
 
F.  Potential Confounding Factors  
Numerous factors were potential confounders in the present study.  For a factor to 
confound the exposure-disease relationship in a cohort study, such as this dissertation 
research, it must be related to the exposure and the outcome (among the unexposed).  A 
factor that is independently related to the outcome, but not the exposure (or vice-versa) will 
not distort the estimate of effects between the exposure of interest and the outcome.  The 
extent of confounding is a function of the strength of the association of a factor with the 
exposure and outcome; it is possible for a factor to satisfy the requirements of a confounder 
and not materially influence the exposure-disease association.   
In this study, confounding may come from the presence of well-established 
reproductive toxicants: radiation, DBDP and lead, however, because these factors are either 
banned or regulated they are not expected to exert a significant influence on the sperm 
quality outcomes that were examined in this study.  Confounding is more likely to arise from 
the presence of other factors for which exposure is more prevalent or from host factors that 
are not modifiable. These other factors are discussed in detail in Chapter 1 of this document 
and were measured in the HMS telephone interview.   
Table 3.3 presents potential covariates grouped into three categories:  (1) likely 
confounders, (2) possible confounders and (3) unlikely confounders.  Likely confounders 
were expected to clearly satisfy the requirements of confounding; possible confounders 
were factors associated with the exposure(s), but not likely to be associated with measures 
of sperm count and quality OR its relationship with the outcomes has not been consistent in 
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the literature; and unlikely confounders were not expected to be strongly associated with 
either exposure or outcome.   
Only likely (age and site) and possible confounders (education, income, length of 
sexual abstinence, perceived stress, past medical history, history of infertility and other 
study exposures) were examined in the regression models.  The presence of confounding 
was determined by comparing adjusted and crude effect estimates.  Covariates resulting in 
a change in effect estimate (beta coefficient for linear regression) of 10% or more were 
retained in the final models.  Age, income and length of sexual abstinence were included as 
obligate covariates for purposes of comparison with previous studies.  The variable ‘site’ 
was also retained to address unmeasured confounding and geographic variation reported in 
sperm quality studies.   
 
G.  Data Analysis  
A dataset for the proposed study of the 229 HMS subjects was obtained and created for 
analysis specific to this dissertation research. Data analysis was conducted using the SAS 
software system and began with a comprehensive examination of each variable to (1) 
understand the distribution of individual variables and identify natural breakpoints, which  
informed variable specification in preparation for future analyses and (2) identify and correct 
errors.  Initial description of continuous variables included means, medians, standard 
deviations, skewness and kurtosis. Categorical and dichotomous variables were described 
in terms of frequencies.  Visual inspection was used to aid initial examination of variables 
and included histograms, box and Q-Q plots (1). 
Extreme values and other potential errors identified as part of the univariate analysis 
were compared with information in the electronic interview records for possible coding or 
data entry errors.  If it was not possible to reconcile the data based on review of the 
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interview record, other evidence was used to decide how to treat the value in question.  If it 
was clear that a particular value was erroneous because the variable could not assume 
such a value, it was coded as missing, but this rarely happened.  If the value was possible, it 
was not changed in the data set.  Missing data was also checked against the interview 
record, and when the review did not provide additional information, data were inferred from 
answers to other questions.  Otherwise, missing data points were left as is, for example, the 
three missing cases for household income.  The data checking and cleaning process was 
coordinated with the HMS data manager.   All data cleaning activities were resolved and 
specific actions recorded for future reference before inferential data analysis began.  
To estimate the independent effects of each exposure on the five sperm quality 
outcomes measured on a continuous scale, separate linear models were constructed.  
Statistical transformation of outcomes was conducted to better satisfy the normality 
assumption for straight-line models (linear model assumptions can be found in Kleinbaum et 
al., 1998) (8).  Natural log transformations were applied to the count outcome variables total 
sperm count and sperm concentration.  Arc sine transformations were conducted for 
variables that were measured as proportions, namely, percentage of sperm cells with normal 
morphology and the SCSA parameters %DFI and %HDS.   
The goal of multivariable modeling in this study was to estimate the etiologic effect of 
the four exposures on the five quantitative and qualitative sperm quality outcomes.  For this 
reason, each regression equation was constructed using the process of backward 
elimination whereby “full” models were compared to “reduced” models in which variables 
had been eliminated sequentially to assess confounding and model fit (9).  The basic model 
building strategy involved examining the crude exposure/outcome association, assessing 
confounding and evaluating multicollinearity and model fit.  Several models were 
constructed for each outcome based on parameterization of the exposure.  In the absence 
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of clear biologic, toxicologic or epidemiologic evidence to guide how exposure data should 
be grouped, model choice was largely a data-driven process.  However, parameterization of 
exposures was generally restricted to two or at the most three approaches to reduce the 
potential for over-interpreting random variation.   
Analysis began with examining the crude (unadjusted) exposure/disease 
relationships, using simple regression techniques.  The presence and extent of confounding 
was assessed by comparing crude effect estimate coefficients to coefficients adjusted for 
the potentially confounding variable. Order of variable selection for confounding assessment 
was based on p-value size in the full model, beginning with the largest and working 
backwards to smaller values.  If there was a ten percent change or more in the beta 
coefficient of the exposure variable, the covariate was retained in the model. However, to 
facilitate comparisons with prior sperm quality studies, historically strong confounders (age, 
income, length of abstinence) were retained in the model as obligate covariates even if they 
do not satisfy the 10% change criteria.  The last step involved assessing multicollinearity by 
examining changes in the effect estimate between the crude and full models and examining 
the strength of the relationship between covariates.   
For linear regression equations modeling the influence of tobacco exposures, 
tobacco use was specified in various forms in separate equations, where possible.  Each 
regression equation addressed different questions with respect to lifetime and current use, 
duration and timing of use, and dose.  Alcohol use was examined both as a continuous and 
categorical variable measuring total number of alcoholic drink equivalents consumed in a 
week.  We also explored the relative effects of the various types of alcohol consumed with 
the use of dummy variables.  Total daily caffeine intake, which was constructed as a 
function of drink type, size of beverage and number consumed each day was treated as 
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both a dichotomous and then categorical variable in the caffeine equations. Type of 
beverage was also examined and specified as a dummy variable.   
The effect of BMI, calculated by dividing weight in kilograms by height in meters 
squared, was initially evaluated on a continuous scale, which maximized statistical power 
and reduced the impact of any measurement error arising from the use of self-reported 
height and weight.  However, extreme measurement error related to self-reported height and 
weight was not anticipated given the study population of young men and high sensitivity 
(94%) in classifying overweight and obesity reported in the literature among this cohort (11).  
Therefore, a quantitative sensitivity analysis was not conducted for the present research.  
BMI was also categorized based on the four standard cutpoints defined previously to 
facilitate comparison with published study results.  Dummy variables were created, with 
normal weight (18.5-24.9 mg/kg2) specified as the reference category.  Splines were also 
constructed to determine the approximate shape of the relationship between BMI and the 
sperm outcomes and determine if the standard approach (WHO categories) provided a 
reasonable estimation of the underlying relationship.   
In addition to the primary analytic approach detailed above, supplementary analyses 
were also be conducted.  While linear regression equations provide coefficients for the 
absolute effect (i.e. percentage/percentage point difference in outcomes between those 
exposed and unexposed) for each of the exposures of interest when the transformed sperm 
quality outcomes are measured continuously, relative effects are not estimated with this 
analytic approach.  Therefore, it will also be informative to generate risk estimates of the 
relative effect for each exposure.  This was accomplished by categorizing continuous sperm 
quality outcomes into two groups, using fertility thresholds reported in the literature.  Logistic 
models were constructed to evaluate dichotomized outcomes.  Finally, to derive analytical 
products that are more easily interpreted than standard coefficients obtained from linear 
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regression, we back-transformed predicted quantities obtained by applying the natural log 
transformation to percent difference in outcome between contrasting exposure categories.  
 
H.  Power Calculations 
Sample size (n=229) is fixed for the proposed study, as the HMS data to be analyzed 
have already been collected.  The primary aims of the proposed study were to estimate the 
differences in mean sperm counts and sperm concentrations, and differences in proportions 
for percent morphologically normal sperm, %DFI and %HDS associated with tobacco 
smoke, alcohol consumption, caffeine intake and BMI.  With the sample size already 
established, the purpose of the power calculations was to demonstrate the range of power 
for each exposure/outcome dyad, given varying assumptions of estimated effect sizes 
(small, medium and large), at alpha level set at 0.05 and a non-directional test.  For 
differences in standardized means, small effects equal .20, moderate effects equal .50 and 
large effects equal .80.  Difference of proportions is defined as the raw difference in arcsin 
transformed proportions of sperm endpoints, with small effects equal to a difference 
between five and ten percent, moderate effects equal to a difference between 20 and 25 
percent and large effects equal to a difference between 35 and 39 percent.  Prevalence for 
each of the lifestyle exposures was based on estimates obtained from preliminary analysis 
of HMS data.  Results are presented in Table 3.4.  Estimates are based on dichotomous 
exposure measures, and although it is expected that there will be some loss of power when 
potential confounders are included in multivariable models, power is likely to be gained with 
categorical and continuous treatment of the lifestyle exposures.  Power calculations were 
computed by hand and based on power tables from Cohen, 1988 (2).  See Appendix A.7 for 
formulas and exact computations.   
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Results suggest that given the fixed sample size of 229 and the estimated 
prevalence for each of the lifestyle exposures, the power to detect small effect sizes for any 
of the exposure/outcomes dyads is very low, ranging from 0.19 for current tobacco exposure 
to 0.29 for ever/never tobacco exposure and caffeine exposure (measured as coffee 
consumption for the power analysis).  Power to detect moderate effect sizes for the tobacco 
exposure assessment (smoker v. non-smoker), is better, but still below the standard 0.80.  
However, the power to detect moderate differences in both mean and proportional outcomes 
for each of the other exposures is consistently at or above 0.90.  Considering the excellent 
power to detect moderate effects sizes for all but the smoker v. non-smoker tobacco 
exposure, it is likely to have adequate power to detect small to moderate effects as well 
(~0.80).  Again, it is important to remember that the power calculations are only estimates, 
including those for small effect sizes, and it is likely that the power will improve with more 
refined measurement (ordinal and continuous) of exposure.  Using a one-sided test for 
certain exposures, such as tobacco, may be appropriate and would also improve statistical 
power to detect differences.  Finally, it is also important to consider that the results do not 
reflect within-subject variation in sperm quality and the degree to which this variation is 
observed across sperm parameters.  Morphologic appearance that has relatively low intra-
individual variation will have greater power, as will the parameters generated from the SCSA 
(% DFI and % HDS), while sperm concentration with large intra-individual variation will have 
less power to detect exposure effects.  The power for subgroup analyses is poor. 
 
I.  STRENGTHS AND LIMITATIONS  
There are several limitations of this dissertation research.  Sperm quality studies 
have historically low participation rates.  Although the HMS performed relatively well in level 
of participation compared to that attained by other sperm quality studies, and the calculated 
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rate is likely an under estimation of the actual proportion of eligible men that completed the 
study (13), the 25% rate of participation introduces the possibility of selection bias.  Low 
participation rates do not always result in selection bias, which only occurs if the exposure-
outcome relationship is modified by response status, for example, if smokers with lower 
sperm counts were also more likely to participate in the study.  It is conceivable that a 
determinate of participation, such as SES, could also be related to lifestyle factors that are 
hypothesized to be related to sperm quality.  To address this issue, HMS data have been 
assessed for the presence of bias (comparing data for those that completed the study with 
those that did not), with results indicating that participation was associated with age and 
socio-economic idicators, but not lifestyle exposures, such as cigarette smoking or alcohol 
consumption.   
Although consistent with most other sperm quality studies, the use of a single semen 
sample for computing means for each of the sperm quality assays is another limitation of the 
proposed study.  The problem with basing results on a single sample stems from the large 
intra-individual variation in the quantity and quality of spermatozoa (7).  This issue would be 
more of a concern, however, if the goal of the study were to evaluate and classify fertility 
status for clinical decision making.  While this study evaluated clinically relevant outcomes, 
this was not a fertility study per se, and there was no determination of fertility status or 
clinical decisions made based on these findings.  In addition, motility has the highest within-
subject variation, which this study did not examine.  Morphology, with an intraclass 
correlation (ICC) of 0.50, is the most reliable outcome we studied, having good precision 
and ability to detect differences in populations (18).  However, sperm count and 
concentration have a relatively large ICC and are therefore considered to be low powered 
parameters.  Nonetheless, while the use of single semen specimens may result in 
attenuation of effects due to outcome misclassification and reduction of power, which likely 
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contribute to the variability of results reported by studies, it is still considered satisfactory in 
cross-sectional epidemiologic studies with well-defined study protocols, such as the HMS 
(12).  
Another drawback of the present study was the inability to examine motility.  Sperm 
motility is a time sensitive assay, which was not possible to include in the sperm analyses 
conducted for the HMS because the study used a home collection and mail delivery system 
to obtain the specimen.  Nonetheless, a wide array of sperm quantity and quality indicators 
was measured, and was available to be examined in relation to the exposures of interest in 
this study.   Moreover, incorporating the SCSA measure of DNA damage permitted a more 
complete characterization of reproductive health effects associated with lifestyle behaviors 
not previously described in the literature.   
Use of self-reported information to ascertain exposure may have introduced bias, 
particularly for sensitive question(s) for which there may have been the perception of a 
socially desirable answer.  For the current study, each of the exposures (tobacco use, 
alcohol consumption, caffeine intake, BMI from weight and height) were ascertained using 
self-reported information obtained during the standardized telephone interview.  Fortunately, 
recent data have indicated that seminal cotinine, the main metabolite of nicotine and a 
specific biomarker of exposure to cigarette smoke, is well correlated with self-reported data 
on the number of cigarettes smoked per day (r=0.61 p<.001) (19) and the magnitude of 
correlation coefficients of effect using self-reported data is only slightly lower than when 
exposure is assessed using logged cotinine levels (21).  Use of alcohol and caffeinated 
products, socially accepted behaviors, were not anticipated to be measured with systematic 
error.   
BMI, on the other hand, may have presented a more complicated problem, as some 
data suggest that there may be systematic error in self-reported height and weight.  
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Although men, on average, only slightly over report both measurements, the source of bias 
stems from the distribution of the reporting error in which overweight men under report their 
weight, while underweight men over report their weight and both groups do so to a greater 
degree than men of normal weight (16).  Despite the bias, differences between self-reported 
BMI and measured BMI tend to be small (self-reported BMI (25.8) – measured BMI (26.0) = 
-0.27) (15), particularly for men under 45 years of age and can be used reliably for both 
research and clinical settings (11). In addition, several methods were incorporated into the 
analyses to evaluate and reduce exposure misclassification, including specifying BMI as a 
continuous variable and using splines.  
The validity of BMI as a measure of adiposity has also been questioned, as it is 
possible to be overweight relative to height and not over fat.  This issue continues to be 
debated in the literature (5), but research generally suggests that BMI has as good a 
predictive value of adiposity as other methods (6, 20).   
There were also several strengths of the proposed study.  Limitations of previously 
conducted research on lifestyle factors and sperm quality have compromised the 
interpretation of results.  The proposed study incorporates several basic, but important 
methodological features that have been lacking in much of the previous sperm quality 
research and which are necessary to generate valid results.  Key features of the current  
study include a well-defined community-based group of men; clear study protocols and 
quality assurance/quality control procedures; incorporation of multiple sperm quality assays, 
particularly the inclusion of the SCSA to evaluate sperm maturity and DNA integrity, which 
will provide a more comprehensive characterization of the reproductive effects of lifestyle 
factors than in previous studies; exposure assessment limited to time periods relevant to the 
outcomes under consideration; simultaneous evaluation of several prevalent, often 
concomitant behaviors; and adjustment of potential confounders.   
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The current study also benefitted from the quality of the facilities in which the assays 
were conducted and extensive experience of scientists who performed the assays.  
Standard semen analyses were conducted at the US EPA and the SCSAs were conducted 
at the facility and under the supervision of the scientist, Donald Evensen, who developed 
and tested this measure of DNA damage (3).  Another study strength comes from the 
blinding of laboratory staff and researchers to the exposure status of the study subjects.  
Finally, because all men were fertile, differential reporting of exposures based on fertility 
status was not expected, a likelier scenario in case-control studies or studies that obtained 
subjects from fertility clinics.   
 Human sperm studies are the only way to directly assess the effects of toxicants on 
male germ cells (23).  The present epidemiologic study addresses prevalent, largely 
modifiable factors that may adversely affect sperm parameters associated with fertility, as 
well as the viability and health of a resulting conceptus.  For extensively studied exposures 
like tobacco smoke, and to a lesser extent alcohol consumption, this study has improved 
upon some of the methodological limitations of previous research and consequently may 
help to clarify the nature and extent of their association with sperm quality.  The other 
exposures that we evaluated, caffeine intake and BMI, have been relatively unstudied and 
as such this study helps shape our understanding of how these factors might also effect 
sperm quality and inform the direction of future studies addressing lifestyle exposures.  
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J. Tables 
 
Table 3.1  Dilutions and conversion factors for the improved Naubauer hemocytometer  
                                                                                                                       Conversion factors 
                                                                                                            Number of large squares counted 
                                                                                                     
________________________________ 
 
Spermatozoa per            Dilution   
400 X field                (semen+diluent)                     25                            10                               5 
< 15 1:  5   (1+4) 20 8 4 
15-40 1:  10 (1+9) 10 4 2 
40-200 1:  20 (1+19) 5 2 1 
>200  1:  50 (1+49) 2 0.8 0.4 
 †Adapted from the WHO manual fourth edition (1999) 
 
 
  
97 
 
Table 3.2 Outcome variables and treatment for statistical analysis 
Outcome Measurement Transformation Analytical Treatment 
Quantitative     
      sperm count   million    natural log continuous 
      sperm concentration    million/mL    natural log continuous 
Qualitative     
    sperm morphology             
    normal sperm cells   percent    arc sine continuous & dichotomous 
    SCSA parameters    
            % DFI   percent    arc sine continuous & dichotomous 
            % HDS    percent    arc sine continuous 
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Table 3.3 Covariates by likelihood to confound and variable coding  
Covariates Coding Plans 
  
Likely confounders  
age (years)* ? 19-25 
      26-30 
      31-34 
      35-40 
  
site* ?  raleigh 
      memphis 
      galveston 
Possible confounders  
education ? <high school graduate 
      high school graduate 
      ≥ high school graduate 
  
Income level ($)*  ?  <20,000 
       20,000-39,999 
       40,000-80,000 
       >80,000 
  
length of sexual abstinence (days)* ?  2-3 
      4-5 
      ≥ 6 
  
perceived stress (based on 4-point scale) ? yes/no 
  
past medical history (e.g. cancer, CAD) ? yes.no 
  
history of infertility ? yes/no 
  
other study exposures  
      tobacco use 
      alcohol consumption 
      caffeine intake (daily mgs)   
      BMI (mg/kg2)** 
 
? never use v. ex-user v. current user 
? ≥ 1 drink per day v. < 1 drink per day 
? 0 v. 1-150 v. 151-300 v. >300 
? 18.5-<25 v. 25-<30 v. >30  
Unlikely confounders  
  race and ethnicity  
  fever in past 3 months  
  STD history  
  seasonality  
  environmental/occupational exposures  
    * Denotes obligate covariates.  
 **  There are no underweight men in the HMS sample.  
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Table 3.4  Power Estimates to Detect Lifestyle Exposure Effects on Continuous and Proportional 
Measures of Sperm Quality Parameters Under Small, Medium and Large Effect Size Assumptions 
(n=229) 
Exposure (prevalence estimate) 
and Effect Sizes* 
Power (alpha =.05) 
 Difference in Standardized Means 
(sperm count, concentration) 
Differences in Proportions 
(morphology, CR, %DFI, %HDS) 
  
0.19 0.19 
0.77 0.77 
Tobacco Exposure (15%) 
(smoker v. non-smoker)   
Small  
Medium  
Large 0.99 0.99 
  
0.29 0.29 
0.94 0.94 
Tobacco Exposure (40%) 
(ever v. never smoker) 
Small  
Medium  
Large 100 100 
  
0.25 0.25 
0.90 0.90 
Alcohol past 3 months (76%) 
(yes v. no) 
Small  
Medium  
Large 100 100 
  
0.29 0.29 
0.94 0.94 
Coffee past 3 months (40%) 
(yes v. no) 
Small  
Medium  
Large 100 100 
  
0.26 0.26 
0.91 0.91             
BMI Exposure (26%) 
(obese/v.obese v. nl.and overwt.) 
Small  
Medium  
Large 100 100 
*Effect sizes for differences in standardized means (Ma-Mb/δ) and proportions, with arcsine transformations (Ф1-
Ф1) are small=.20, medium=.50, large=.80; taken from Power of Normal Curve and T-test tables in Cohen, 1988 
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 CHAPTER 4: EFFECTS OF CIGARETTE SMOKING, ALCOHOL CONSUMPTION AND  
CAFFEINE INTAKE ON SPERM QUALITY PARAMETERS OF FERTILE MEN 
 
 
A. Abstract 
BACKGROUND:  Male reproductive health may be declining and lifestyle exposures have 
been implicated. However, the effects of personal behaviors on male reproduction remain 
unclear.   METHODS: We analyzed data from a community study of 229 fertile men aged 18 
to 40 years to evaluate the effects of cigarette smoking, alcohol consumption and caffeine 
intake on sperm quality.  A telephone interview was used to collect data on lifestyle 
exposures and potential confounders.   Sperm count, concentration and morphology, as well 
as DNA damage and spermatozoa maturity were evaluated from a single semen sample 
provided by each participant.  We used linear and logistic regression to assess the 
relationship between lifestyle exposures and sperm outcomes.  RESULTS: Compared to 
non-smokers, neither current nor former cigarette smokers had decrements in the sperm 
outcomes we examined, adjusting for confounders.  However, former smokers had 
significantly lower proportions of immature spermatozoa (p < .01) (-2.80%; 95% CL, -4.69%, 
-0.93%).  Relative to non-drinkers, sperm outcomes were generally more favorable for 
consumers of alcoholic beverages.   Conversely, daily caffeine intake over 300 milligrams 
was associated with a 2.75% reduction in the percentage of morphologically normal sperm 
cells (p < .05) (95% CL, -4.92%, -0.59) compared to non-caffeine drinkers.  Results from 
logistic regression, using fertility-based cutpoints reported in the literature, supported those 
from linear models.  CONCLUSIONS:  Among fertile men, cigarette smoking was not related 
to diminished sperm quality.  Alcohol consumption may protect sperm quality, but caffeine 
intake was significantly associated with altered sperm morphology.  Results suggest 
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variation in reproductive effects of three prevalent lifestyle exposures.  Further confirmation 
among fertile men is required.  
 
B. Introduction 
The reproductive potential of human males depends upon the production of a 
sufficient number of healthy, functional spermatozoa.  Human male reproduction is 
vulnerable to disruption and can occur at any time during the process of sperm production, 
maturation and transit through the male reproductive tract (64).  According to some studies, 
sperm quality and other indicators of male reproductive function appear to be declinding (17, 
50).  In the United States, prevalent lifestyle exposures are potentially important explanators 
of these reported trends, as 23% of adult men currently smoke cigarettes (4) and 70% 
consume alcohol (44). 
Cigarette smoking is the most studied lifestyle exposure reported in the semen 
quality literature, yet decades of research have failed to provide definitive evidence about its 
effects on male reproduction.  Despite inconsistency across study findings due to wide 
variation in the size and composition of study populations (healthy volunteers, infertility 
patients) and methods, there is some indication that the chemicals present in cigarette 
smoke may alter testicular and post-testicular events, although the underlying mechanisms 
of toxicity and the specific sperm parameters affected are still undetermined (22, 32, 40, 47, 
52, 56).  There is also some suggestion that the effects may be small (26, 56) and limited to 
specific subgroups (27).  Epidemiologic data on alcohol consumption are more limited, 
although heavy, long-term drinking has been demonstrated to severely impair testicular 
function and hormonal regulation (9, 28).  However, the impact of moderate alcohol 
consumption, a more prevalent and socially-accepted behavior, has not been established 
(27, 31).  For example, while consuming small amounts of alcohol has been linked with 
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sperm chromosomal abnormalities (38), other studies have found alcohol to be favorably 
associated with certain sperm measures, including count, motility and normal morphologic 
features (10), as well as DNA integrity (11).  Data on the effects of caffeine intake are too 
limited to draw conclusions.    
 Further research designed to elucidate the role of lifestyle exposures in the 
perturbation of normal male reproductive function is warranted.  The aim of the present 
study was to evaluate the independent effects of cigarette smoking, moderate alcohol 
consumption and caffeine intake on standard measures of human sperm quality (sperm 
count, concentration and morphology), as well as a marker of sperm cell DNA integrity and 
maturity among a community-based cohort of healthy, young fertile men.  
 
C. Materials and Methods 
1.Study design and subject recruitment 
To address our study aims we analyzed data collected from 2000 to 2004 as part of 
a prospective study of water disinfection by-products (DBPs) and sperm quality called “The 
Healthy Men Study” (HMS).  The design and conduct of the HMS, including subject 
selection and participation rates have been described previously (24, 30).  Our study 
protocol was approved by the University of North Carolina School of Public Health’s Internal 
Review Board.  Briefly, the HMS identified and recruited male subjects through their 
pregnant partners who participated in a prospective study of drinking-water DBPs and 
spontaneous abortion risk (the “Right from the Start” (RFTS) study) (34).  Men were 
recruited from three study sites: Raleigh, NC; Galveston, TX; and Memphis, TN, which were 
selected to reflect varying exposure levels of chlorinated and brominated water DBPs.  
Eligible men were between the ages of 18 and 40 years, living with their RFTS study 
partner, had never received a vasectomy and had not been treated with chemotherapeutic 
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agents or been away from their home for more than 30 days in the prior three months.  
Once eligibility was established, a signed informed consent was obtained and the telephone 
interview was scheduled.   A total of 229 men completed the study, having provided 
informed consent, completed the interview and provided a satisfactory semen sample.   
 
2. Study questionnaire 
Each study participant completed a computer-assisted telephone interview (CATI) 
that was administered by trained interviewers. The CATI system, with automated error 
detection, allowed responses to be directly entered into a computerized database.  The 
average interview lasted approximately 40 minutes.  Men were asked questions covering a 
broad range of topics that included: health and reproductive history, environmental and 
occupational exposures, diet, stress, hobbies, drinking-water exposures, as well as 
information about tobacco use, alcohol consumption and caffeine intake.   To facilitate the 
interview, men were sent visual aids prior to the interview, including a diagram to estimate 
beverage size and a calendar.   
 
3. Semen collection and analysis 
When the telephone interview was completed, participants were asked to provide a 
single semen specimen.  The details of collection and shipping have been previously 
described (24, 30).  Briefly, HMS staff contacted the man by telephone to arrange for 
delivery of the specimen collection kit to his home.  The collection kits were specifically 
designed to allow a man to collect a semen specimen in the privacy of his home and at a 
convenient time for him (39).  Prior to sending the kit, staff confirmed the participant’s 
mailing address and provided verbal instructions on how to use the kit, including the 
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necessity of abstaining from sexual activity for two to seven days prior to obtaining the 
specimen for the HMS.  
Study participants prepared collected specimens for shipment and packaged the 
specimen with ice packs designed to maintain the temperature of the specimen at 
refrigeration levels for at least 24 hours.  Men were instructed to call the courier company on 
the day of collection so that the sample would arrive at the Environmental Protection Agency 
(EPA) laboratory the following morning.   When an adequate sample was received by the 
EPA lab and the subject’s participation in the study was complete, he was sent a thank you 
letter and a check for $50.  His partner was also sent a letter and check for $20.   
Immediately upon receipt, the sample was processed as described by Luben et al., 
2007 (24).   Briefly, samples were allowed to liquefy at room temperature (37oC) for up to 60 
minutes.  Volume was determined in a graduated conical cylinder.  Sperm concentrations 
and total counts were determined using the automated counting system, IVOS-IDENT 
(Hamilton Thorn Research, Beverly, MA) (66), and with the Neubauer hemocytometer 
method.  For the morphological assessment, duplicate smears were stained with 
Papanicolaou stain (61) and scored based on Kruger’s strict criteria, which specifies that 
each region of the spermatozoon (head, neck, midpiece, and tail) must be normal to be 
scored normal (21).  Percent morphologically normal spermatozoa were recorded.  We did 
not evaluate sperm motility because it could not be reliably measured given the amount of 
time required for shipping.  
 DNA integrity and sperm cell maturity were evaluated, using the sperm chromatin 
structure assay (SCSATM) as described by Evenson et al. (8).  Briefly, sperm DNA was 
treated with acid and stained with acrinidine organge (AO), a metachromic fluorescent stain.  
Damaged DNA is denatured by the acid and stains red whereas intact DNA resists 
denaturation and stains green.  The relative amount of red and green stain are detected and 
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quantified by flow cytometry.  Structurally normal chromatin is distinguished from abnormal 
chromatin based on the differential pattern of AO chromatin staining.  The SCSATM endpoint 
called the DNA fragmentation index or DFI is used to define sperm with DNA damage.  
Although the SCSA is an indirect measure of DNA strand breaks, percentage DFI values 
have been shown to correlate well with direct assessment techniques such as TUNEL and 
comet assays (8).  Sperm with intact DNA that lack the normal amount of protamines absorb 
more stain and exhibit brigher than normal green fluorescence.  This endpoint is called high 
DNA stainability (HDS) and is thought to measure immature (underprotaminated) sperm 
cells with abnormal chromatin packaging (49).   
In this paper, we report on five sperm quality outcomes:  total sperm count (million), 
sperm concentration (million/mL) and percent morphologically normal sperm cells, in 
addition to the two distinct parameters generated from the SCSA: (1) percentage of sperm 
cells with moderate to high degrees of DNA fragmentation (%DFI) and (2) percentage of 
sperm cells with altered chromatin condensation (% HDS), a marker of sperm maturity.   For 
the outcome sperm concentration we present the counts determined by the IVOS-IDENT 
method, which produced exposure/outcome effect estimates generally consistent with those 
obtained with the hemocytometer method.  In our statistical analyses, each of the five 
outcomes was examined as a continuous variable; percent normal morphology and %DFI 
were also examined dichotomously.   
 
4. Exposure Assessment 
Data were available for five tobacco products: pipes, cigars, chew, snuff and 
cigarettes.  However, examination of tobacco use was limited to cigarette smoking because 
the prevalence of use for other tobacco products was low, ranging from 1% for pipe smoking 
to 7% for snuff.  Cigarette smoking status was categorized as current smoker, former (ex-) 
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smoker and never-smoker.  Former smokers had quit at least three months prior to the 
telephone interview.  Number of cigarettes smoked each day was examined as a continuous 
variable and categorized as 0 cigarettes per day, 1-10 cigarettes per day, and greater than 
10 cigarettes per day.  Number of years smoked, not including periods of quitting, was 
examined continuously and categorized as 0 years, 1-5 years, 6-10 and greater than 10 
years.   Pack-years, defined as the number of cigarettes smoked per day divided by 20 and 
multiplied by the total number of years smoked, was also evaluated, using the same 
parameterizations as we used for duration.  At the bivariate level, each measure of cigarette 
use was examined in relation to each outcome.  Evidence for a linear association between 
any of the smoking variables and the outcomes was not strong and the distribution was 
highly skewed, therefore we used categorical parameterization of cigarette smoking in 
regression equations.  
Alcohol consumption was determined from interview questions that asked about the 
average number of 12 oz. beers, 4 oz. glasses of wine, and 1 oz. shots of hard liquor 
consumed daily, weekly or monthly.  Exposure status was assigned based on the total 
number of drink equivalents per week.  Alcohol consumption was evaluated as a continuous 
variable and also categorized into four exposure groups:  no alcohol consumption, greater 
than 0 up to 7 drinks per week (low exposure), more than 7 and less than 15 drinks per 
week (moderate exposure), and greater than 15 drinks per week (high exposure).  The 
categorical parameterization of alcohol consumption was used in the linear regression 
analysis.  We also examined the type of alcohol consumed.  Exposure status was assigned 
as follows:  wine and/or hard liquor, beer alone, beer and wine, beer and hard liquor and all 
three.  Wine and hard liquor were not able to be examined separately because only three 
men exclusively drank wine and three exclusively drank hard liquor.   
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Interview data were also collected on the size and number of cups of coffee and non-
herbal hot and iced tea (caffeinated and decaffeinated) consumed per day, and the brand 
(e.g. diet coke), container type (glass, cans, or bottles), average size and number per day of 
caffeinated waters and sodas.  We calculated total daily consumption based on the type, 
size and number of reported beverages.  We obtained estimates of caffeine content from a 
comprehensive database of published current parameters for most beverages available on 
the market (www.energyfiend.com), and applied the estimates to the beverage brands 
reported by the participant.  Caffeine exposure was initially evaluated as a continuous 
variable of the total number of milligrams (mgs) per day, however, because of its non-linear 
distribution, men were assigned to the following exposure groups: no caffeine intake 
(unexposed), greater than 0 up to 150 mgs (low exposure), great than 150 up to 300 mgs 
(moderate exposure) and over 300 mgs per day (high exposure), which is the approximately 
equivalent to drinking at least 3 cups of coffee.  We also examined the type of caffeinated 
beverages consumed and men were assigned to one of the following categories:  coffee, 
tea, soda, coffee and tea, coffee and soda, tea and soda or all three beverage types.  
 
5. Statistical Analysis 
We performed statistical transformations on sperm outcomes to better approximate 
the normality assumption of the dependent variable in a linear model.  Specifically, the 
natural log transformation was applied to sperm count and sperm concentration, and an arc 
sine transformation was applied to percent morphologically normal sperm cells, %DFI and 
%HDS.  However, we report the results obtained from untransformed proportional outcomes 
because results obtained with arc sine transformed outcomes were not materially different 
and untransformed outcomes are easier to interpret.  
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 Potential confounders were initially identified based on prior knowledge of factors 
related to both sperm quantity/quality and the exposures under consideration.  Geographic 
region (study site), age, total household income, education, length of sexual abstinence, 
history of a chronic or serious illness, body mass index (BMI) and the other study exposures 
(cigarette smoking, alcohol consumption and caffeine intake) were evaluated as potential 
confounders.  We also considered level of perceived stress as a potential confounder, which 
we measured as the sum of response scores (0 to 16) of four stress-related questions in 
which participants ranked perceived stress on a scale from 0 to 4.  It was not necessary to 
consider history of infertility because none of the men reported reproductive problems.  We 
also did not consider environmental and occupational exposures because of their low 
reported prevalence.  Bivariate analyses were conducted for each potential confounder or 
exposure with the five outcomes.  Specification for each of the potential confounders was 
based on the pattern of the bivariate distribution, which varied by outcome for age, income 
and BMI.  Site was also evaluated as a potential modifier of the relationship between each 
of the lifestyle exposures and the sperm outcomes.  
Multiple linear regression was used to estimate the association of each exposure and 
each outcome, adjusting for confounders. A total of fifteen models were constructed, one for 
each exposure and outcome pair, using a backward elimination strategy to determine the 
final model.  Model building involved entering the exposure variable and all covariates into a 
“full” model and sequentially evaluating each covariate, beginning with the variable with the 
largest p-value.  Covariates that changed the parameter estimate of the exposure variable 
by at least 10% were retained in the final model as confounders.   Age, length of sexual 
abstinence, income, and geographic area (study site) were retained in all final models as 
obligate covariates to facilitate comparison across other sperm quality studies; other 
exposures were included in final models only if they met the criteria for confounding.  
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We checked model fit and assumptions by plotting residuals.  Models for percent 
morphologically normal sperm cells and %DFI suggested a lack of variance homogeneity.  
We tested the extent to which moderate heteroskedasticity influenced the results for each of 
the three exposures by conducting the non-parametric Wilcoxon rank-sum test.  Results 
were consistent with those produced from the linear regression models.   
Finally, we fit logistic models for the outcomes percentage of normal forms and 
%DFI.   It was not possible to conduct logistic regression for sperm count or sperm 
concentration due to the low prevalence of men with oligozoospermia in the HMS sample.  
We also did not evaluate %HDS dichotomously because a clinically-significant threshold has 
not yet been established.   We dichotomized percentage of morphologically normal forms 
and %DFI based on fertility thresholds reported in the literature. Specifically, we used 15% 
as the cut point for dichotomizing percent normal forms and 30% for dichotomizing %DFI 
based on data from in vitro and clinical studies, which have indicated significant declines in 
fertility and pregnancy rates when the percentage of sperm cells with normal morphologic 
features (applying strict criteria) falls below 15% (21) or when the percentage of sperm cells 
with moderate to high fragmented DNA (%DFI) is above 30% (7, 42).   We conducted crude 
and adjusted logistic regression, maintaining the same variable specifications for the three 
lifestyle exposures that were used for linear regression.  Adjusted models included the 
confounders identified in linear regression model building.  Men in the “fertile” groups (i.e. ≥ 
15% normal forms; < 30% DFI) were the reference category.   
 
D. Results 
1. Characteristics of study population 
The distribution of socio-demographic characteristics and prevalence of cigarette 
smoking, alcohol consumption and caffeine intake of HMS participants are presented in 
  
112 
 
Table 4.1.  Participants were predominately white, non-Hispanic (84%) and between 25 and 
34 years of age at the time of data collection (70%).  Most men were college-educated and 
reported an annual household income over $40,000.   A majority (80%) reported mild to 
moderate levels of stress.  Few reported having a chronic or serious medical diagnosis 
(8%), although 78% of participants had a BMI that classified them as either overweight or 
obese; none were underweight.  No participant reported a diagnosis of reproductive or 
fertility problems (data not shown).  Additional descriptive information of HMS participants 
can be found in Tables A.8 and A.9.  
 Reported current cigarette smoking was relatively low (16%) among HMS 
participants compared to the national average of 23.4% (4), with an additional 18% of 
participants classified as former smokers.  Of the former and current smokers, 20 (26%) 
smoked for less than 5 years, 32 (42%) smoked 6 to 10 years and 25 (32%) smoked for 
more than a decade (data not shown).  Sixty-seven (29%) of the participants did not 
consume any alcoholic beverages in the prior three months to interview and an additional 
55% averaged less than one alcoholic drink per day.  Only six percent of participants could 
be classified as “heavy” drinkers, consuming more than 14 beverages in a one-week period.   
Most participants (83%) reported daily caffeine intake and over a quarter (26%) ingested 
more than 300 mgs of caffeine per day.  Table A.10 provides distributions of socio-
demographic characteristics by the three study exposures.  
 
2. Sperm quality outcomes 
Unadjusted means (± SD) and medians (range) of each of the five sperm quality 
outcomes untransformed are presented in Table 4.2.  The mean (median) sperm 
concentration for HMS participants was 110.30 (86.15) million/mL and the mean (median) 
total sperm count was 348.17 (252.61) million, which are well above the current World 
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Health Organization (WHO) reference values of ≥ 20 million/mL and ≥ 40 million/specimen 
for these parameters (61).  Given that the partners of the men in the HMS were pregnant at 
the time the sample was collected, it is not surprising that only 5% had sperm 
concentrations and 3% had sperm counts below these WHO reference values.   
 The mean (± SD) percentage of morphologically normal sperm cells was 14% (± 
6%).  Contrary to the distribution for the quantitative sperm parameters, nearly 60% of HMS 
participants had values that fell below the 15% normal morphology threshold reported in the 
literature as necessary for optimal fertility (21).  The mean (± SD) percentage DFI for HMS 
participants was 19% (± 12%.), with approximately 13% of the sample DFIs exceeding the 
30% threshold value.  The mean HDS was 8% (± 5%.).   
 
3. Lifestyle exposures and sperm quality 
Table 4.3 provides descriptive statistics for each sperm outcome relative to cigarette 
smoking, alcohol consumption and caffeine intake.   In general, each of the three lifestyle 
exposures showed differential effects across the sperm outcomes.  With respect to cigarette 
smoking, former smokers demonstrated generally better sperm outcomes than either non- or 
current smokers.  Differences between smoking groups was particularly evident for the 
outcomes sperm count and concentration, in which the means for ex-smokers were 459.18 
million and 132.19 million/mL respectively, compared to 282.16 million and 109.41 
million/mL for current smokers and 339.63 million and 105.33 million/ml for men who never 
smoked (untransformed data not shown).   Ex-smokers also had lower proportions of 
immature sperm cells (6%) and cells with fragmented DNA (17%) than non-smokers and 
current smokers, alike (9%, 20%, respectively).  
Consumption of alcoholic beverages at light, moderate and heavy exposure levels 
was associated with better sperm profiles across all of the outcomes.  In particular, the 
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mean percentage of morphologically normal forms increases proportionally with each level 
of alcohol consumption (13%, 14%, 17%, 18%, respective of exposure level).   However, 
caffeine drinkers, particularly those at the highest level of intake had lower proportions of 
morphologically normal sperm cells (13%) and higher degrees of sperm cell fragmentation 
(21%) compared to men who did not consume caffeinated beverages (16%, 17%, 
respectively).   
 Parameter estimates and 95% confidence limits (95% CL) obtained from unadjusted 
(crude) and adjusted (final) multivariable linear regression models are presented in Table 
4.4.   To enhance interpretability, we back-transformed beta coefficients produced from 
linear regression models of natural log-transformed outcomes by applying the formula (eβ  - 
1) x 100. Parameter estimates for count outcomes reported in Table 4.4 should therefore be 
interpreted as model-estimated percent difference in outcome between contrasting exposure 
categories (6). Confidence limits were obtained by applying the same formula to the 95% 
confidence limits obtained for each β coefficient (14).   It is also important to consider the 
direction of the effect estimate in relation to the sperm outcome.  Specifically, negative 
estimates for sperm count, sperm concentration and percent morphologically normal sperm 
cells indicate an adverse effect, whereas positive estimates indicate adverse effects for the 
outcomes %DFI and %HDS.  Results from logistic regression are presented in Table 4.5.  
Site-stratified linear and logistic regression results are presented in Tables A.12 to A.14. 
In comparison to non-smokers, neither current nor former cigarette smokers had 
significant decrements in any of the five sperm outcomes that we examined, adjusting for 
confounders.  To the contrary, both current and former smokers had better sperm count and 
concentrations than their non-smoking counterparts, although these results were not 
significant after confounder adjustment (p > .05).  Specifically, former smokers had, on 
average, 23% higher sperm counts (95% CL, -10.42%, 68.20%) and 11% higher sperm 
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concentrations (95% CL, -2.92, 25.86) than non-smokers, with similar, though somewhat 
attenuated, results for current smokers.  The differences in the percentage of sperm cells 
with normal morphology, %DFI and %HDS between the three smoking groups were 
negligible, with a notable exception for the outcome %HDS, in which former smokers had a 
significantly lower proportion of immature sperm cells compared to non-smokers (p < .01) (-
2.80%; CL, -4.69%, -0.93%).  This was the only statistically significant result produced from 
multiple regression analysis of cigarette smoking.  Other measurements of cigarette 
smoking (i.e. daily amount, duration, and dose) produced generally similar results across all 
outcomes and are presented in Table A.11.   Logistic regression results were also 
consistent with those from linear regression.  
With respect to alcohol exposure, most of the sperm outcomes we examined were 
more favorable among men that consumed alcoholic beverages than those who did not, 
adjusting for confounders.  Relative to non-drinkers, men who consumed alcohol at any 
level of exposure had, on average, higher sperm counts and concentrations, although 
percentage increases were not  statistically significant at all exposure levels nor was there a 
clear linear dose-response trend despite the highest magnitude of effect occurring among 
men that were the heaviest drinkers in the sample.  Specifically, men who drank more than 
14 alcoholic beverages per week had sperm counts that were, on average, 88% (p-value 
<.05) (95% CL, 13.88%, 209.57%) higher and sperm concentrations 20% (95% CL, -1.98%, 
46.23%) higher than men who did not drink alcohol at all.   
Alcohol consumption also was positively correlated with sperm quality.   In 
comparison to non-drinkers, men who consumed 8 to 14 drinks per week had, on average, a 
2.59% (95% CL, -0.31%, 5.48%) higher proportion of sperm cells with normal morphology, 
and men who consumed more than 14 drinks per week had a 4.33% (p <.05) (95% CL, -
1.04%, 7.62%) higher proportion of sperm cells with normal morphology.  It is notable that 
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the positive association observed at the highest level of alcohol exposure is largely driven by 
men from Raleigh who exhibited, on average, significantly higher percentages of normal 
sperm cells relative to non-drinkers (11%; 95% CL, 5%, 17%), while point estimates of effect 
for men from Memphis (0.00%; 95% CL, -5%, 4%) and Galveston (-1%; 95% CL, -6%, 5%), 
suggested little difference in morphology between those at the heaviest level of alcohol 
exposure and those unexposed.   See Table A.13. 
Finally, multiple linear regression results for the SCSA parameters indicated that 
alcohol consumption was associated, on average, with significantly lower proportions of 
sperm cells exhibiting moderate to high degrees of DNA fragmentation (%DFI) for light 
drinkers (p < .05) (-3.84%; 95% CL, -7.40%, -0.28%) and moderate drinkers (p <.05) (-
6.71%; 95% CL, -12.51, -0.91%) in comparison to non-drinkers.  Percentage of immature 
sperm cells was not significantly correlated with alcohol consumption, except among light 
drinkers for whom we observed a significantly higher percentage of cells with HDS 
compared to non-drinkers (p < .05) (2.00%; 95% CL, 0.44%, 3.56%).   
Logistic regression results supported those generated by the linear models.  In 
addition, after adjustment for the number of weekly alcoholic beverages and confounders, 
our analysis did not reveal a consistent pattern for any type or combination of alcohol with 
respect to the sperm outcomes.  See Table A.13. 
The effects of caffeine intake varied by sperm outcome.   With respect to sperm 
count and concentration, there was no clear pattern of association with level of caffeine 
exposure.   However, caffeine intake was correlated with decrements in normal sperm 
morphology.  In comparison to men that had no daily caffeine intake, men in the lowest 
exposure group (> 0 and ≤ 150 mgs) and those in the highest exposure group (> 300 mgs) 
had, on average, lower proportions of sperm cells with normal morphologic features (p <.05) 
(light: -2.75; 95% CL, -4.92%, -0.59%; heavy: -2.58; 95% CL, -4.88, -0.28).  Similarly, results 
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from logistic regression indicated that men in the highest exposure group had over 3 times 
the odds (p <.05) (OR=3.31; 95% CL, 1.27, 8.61) of falling below the threshold of 15% 
sperm cells with normal morphology compared to men without daily caffeine intake.    
Although point estimates produced from crude linear models suggested a positive 
dose-response relationship (not statistically significant) between level of daily caffeine intake 
and %DFI, this trend did not persist after confounder adjustment.   Logistic regression 
produced similar results, with crude and adjusted odds ratios increasing in magnitude as the 
level of caffeine exposure increased, although results were generally not significant and 
highly imprecise.  Caffeine intake did not appear to affect the percentage of sperm cells with 
immature chromatin (%HDS).   
Based on results of linear regression modeling, no particular source or combination 
of sources was significantly associated with any of the sperm outcomes after confounder 
adjustment.  However, at the bivariate level, results indicated significantly higher, on 
average, sperm counts observed among tea drinkers compared to men who did not drink 
tea (p < .05) (31%; 95% CL, 0%, 70%), and significantly higher %DFI associated with 
drinking soda compared to non-soda drinkers (p < .05) (3%; 95% CL, 0%, 7%).  See table 
A.14 
 
D. Discussion 
The aim of the present study was to examine the etiologic role of three common 
lifestyle exposures on clinically relevant markers of testicular function and germ cell DNA 
integrity and maturity in a cohort of fertile men.  Our results revealed cigarette smoking, 
alcohol consumption and caffeine intake to have differential effects on the five sperm 
outcomes we examined.  We found no evidence to suggest that cigarette smoking (current 
or former) is harmful to testicular functioning among fertile men, and for reasons we do not 
  
118 
 
fully understand, may increase sperm concentration and confer protection from abnormal 
chromatin condensation in former smokers.  These results persisted regardless of how we 
measured smoking exposure (amount, duration, dose).  We also found evidence of 
protective effects associated with alcohol consumption, independent of beverage type.  The 
present study also provided evidence of adverse caffeine effects on sperm cell morphology, 
with some suggestion that the type of caffeinated beverage may also influence sperm 
parameters independent of the milligrams consumed daily.  These results warrant 
confirmation in future research.   
 Cigarette smoke contains approximately 4,000 chemical compounds, including 69 
known carcinogens (62).  Although the exact mechanisms of toxicity are still undetermined, 
data from experimental and animal studies have shown the male reproductive system to be 
a potential target for the toxic constituents of tobacco smoke (19, 33, 36, 63, 65).  However, 
epidemiologic studies have produced widely conflicting evidence of an association between 
cigarette smoking and testicular toxicity in human males as evidenced by alterations in 
conventional sperm parameters and measures of DNA damage.   Moreover, it is challenging 
to directly compare the present study of presumed fertile men with previous epidemiologic 
research in this area because subjects have been selected predominately from infertility 
clinics or andrology laboratories (45), which may introduce selection bias or limit 
generalizability to other populations (3, 26).  The most comparable results to those of the 
present community-based study of fertile men are likely to come from studies of young, 
healthy community volunteers or men with demonstrated fertility who sought vasectomies.  
Interestingly, it is within study samples of ‘healthy’ men (i.e. not infertility patients) for whom 
the relationship between cigarette smoking and sperm quality decrements is reportedly the 
strongest, particularly for sperm count, concentration and motility (55,57), which has been 
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observed in several studies (23, 40, 48, 57, 60), including the most recent and largest to 
date (35).   
However, results of the present work are consistent with those from a collection of 
studies that have not supported the hypothesis of an association between cigarette smoking 
and alterations in sperm quantity or quality (1, 18, 25, 41, 51. 58), with findings from some 
studies limited to alterations in semen volume (5, 32), while others revealed, as did ours, 
statistically non-significant trends toward higher sperm counts and concentrations 
associated with smoking (47, 59).  Although the biologic basis for smokers to have higher 
sperm numbers than non-smokers is unclear, there is some evidence that cigarette smokers 
have higher serum testosterone levels (12, 51), which may indicate a compensatory 
mechanism in response to Leydig cell impairment (35).  However, we cannot rule out the 
possibility that these results are due to chance alone.  In the present study, we also 
observed an inverse correlation between former cigarette smoking and the percentage of 
sperm cells with altered chromatin packaging (%HDS), a relatively novel biomarker of germ 
cell maturity that has rarely been used in epidemiologic studies to characterize the effects of 
cigarette smoking on testicular function.  It is difficult to explain why former smokers would 
produce significantly lower fractions of sperm cells with altered chromatin condensation, 
which may be the result of inadequate exchange of somatic histones for protamines (49).  
Were it not for our observation that current smokers had a non-significant trend in the same 
direction, we might interpret this result as a possible return to normal post-testicular 
functioning, but we speculate that this finding is more likely a manifestation of unmeasured 
confounding than physiologic processes of spermiation.  Interestingly, cigarette smoking 
was not correlated with DNA strand breaks (%DFI), despite strong biological plausibility to 
the contrary (65).  Nevertheless, results of the present study for both SCSA outcomes are in 
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agreement with those from several prior studies of healthy men (40, 41, 49), including 
studies that used different techniques to measure DNA damage (46).  
Animal and epidemiologic studies have described a range of complex reproductive 
pathologies associated with acute and chronic alcohol intoxication that include significant 
hormonal, structural, and cytological alterations of the male reproductive system (13, 20, 28, 
29, 53, 54).  However, comparatively little is known of the reproductive consequences 
associated with more moderate drinking habits, particularly among healthy men.  The 
present study, with only fourteen men classified as relatively “heavy” drinkers (> 14 drinks 
per week), suggests that “social” alcohol consumption may protect sperm count and 
concentration, a finding which was first reported in 1994 in a study of Italian taxi-cab drivers 
(10).  However, subsequent studies have not found significant associations between alcohol 
and quantitative sperm parameters (5, 51), and though there have been reports of 
concurrent increases in free testosterone (51), there is otherwise no clear biological basis 
for observing such an effect.   
The present study also revealed qualitative differences in the sperm of alcohol 
drinkers compared to non-drinkers.  We observed a monotonically increasing trend for the 
percentage of morphologically normal sperm cells with increasing alcohol intake, with a 
threshold effect at less than eight drinks per week.  In a 2001 study of the partners of 
pregnant women, Auger et al. (1) found that moderate drinkers had proportionally fewer 
sperm defects than either heavy or non-drinkers.  This novel finding may be explained by 
antioxidant and anti-inflammatory mechanisms activated by bioflavonoids present in alcohol, 
particularly red wine, as some studies have suggested that moderate alcohol use is 
associated with reductions in biomarkers of systemic inflammation (C-reactive protein, white 
blood cells) and oxidative DNA damage (8-hydroxy-2-deoxyguanosine) (2, 64), but the 
mechanisms have not been confirmed.   Our analyses did not reveal material differences in 
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morphologic benefits by type of alcohol consumed, although the distribution of the data did 
not allow us to evaluate wine separately because only three men drank wine alone and 85 
(41%) drank wine in combination with beer and/or hard liquor. There is also some 
suggestion that anti-inflammatory effects are due to ethanol itself, rather than other 
constituents, such as bioflavinoids (16).  However, it is also been suggested that this finding 
is due to unmeasured confounding, such as diet and exercise (1).  Alcohol consumption also 
appeared to protect chromatin integrity (%DFI), although the relationship was not montonic 
across exposure levels.   
With respect to caffeine exposure, our most important finding was for a weak, but 
significant, decline in the percentage of normal sperm cells associated with caffeine intake, 
particularly at the lowest and highest exposure levels.  These results reinforce earlier, limited 
findings from in vitro and epidemiologic research that caffeine intake may exert modest 
effects on sperm cell morphology (15), including a study from Vine et al. (58) who reported a 
weak association between caffeine intake and morphology in a sample of 86 healthy 
volunteers and a more recent study by Sobriero et al. (47) who observed a statistically non-
significant decrease in the percentage of normal forms associated with increased coffee 
intake among 500 vasectomy candidates.  Our finding of no association between caffeine 
intake and %DFI (after adjustment for confounders), was not consistent with previous 
research, which has implicated caffeine as a potential factor in sperm cell DNA damage (37,  
43), however, this may be a function of different techniques for measuring DNA damage, as  
the SCSA measures single-stranded DNA damage only.   
To the best of our knowledge, this is the first study to examine the independent 
effects of cigarette smoking, alcohol consumption and caffeine intake on standard sperm 
parameters and markers of DNA damage among a cohort of presumed fertile men.  
Simultaneously evaluating all three exposures within a single, well-defined cohort of men is 
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a significant strength of the present study because it allowed us to evaluate and directly 
compare the range of effects associated with each specific behavior within the same group 
of men.  Moreover, the unusually low correlation between exposures allowed us to separate 
the effects of each exposure from that of the other two through statistical adjustment in 
regression models, which was not possible in most prior research in this area (26).    
The present study was also strengthened by several methodological features that 
included consideration of the etiologically relevant time frames with respect to lifestyle 
exposures, adequate adjustment for a range of potential confounders, and access to 
modern semen analysis techniques, including the SCSA, which allowed us to conduct a 
comprehensive assessment of the reproductive effects associated with lifestyle exposures.  
In addition, we were able to conduct a detailed exposure assessment with data collected as 
part of the telephone interview.   
Our cohort of fertile men conferred both strengths and potential limitations to the 
present study.  Fertile study subjects may reduce differential reporting of exposure based on 
fertility status, as well as the potential for selection bias, which is more probable when 
subjects are selected from infertility clinics (3, 26).  However, it could also be argued that the 
distribution of sperm parameters in a cohort of young, fertile men is skewed to the extent 
that we are potentially missing an etiologically relevant portion of the distributions, which 
would obscure our detection of exposure/outcome effects that exist at that lower end of the 
spectrum, particularly effect sizes that are small.  While we cannot completely rule out this 
possibility, we believe that this is not a likely scenario given the fairly representative 
distribution of sperm parameters, especially for the qualitative outcomes.   
There are several additional limitations to the present study.   Although we were able 
to adjust for many of the variables suspected to confound the exposure/outcome 
association, it is likely that our results reflect, at least to some extent, residual confounding 
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attributable to unmeasured variables such as diet and exercise.  The present study is also 
subject to the usual concerns regarding self-reported data, which was used to ascertain 
exposures and confounders.   Interpretation of our effect estimates is also constrained by 
imprecision, and few men were heavy smokers (14 smoked 20+ cigarettes per day) or 
heavy drinkers (14 consumed 14+ drinks per week), which may obscure weak effects.  In 
addition, random error cannot be ruled out as an explanation for our findings.  Finally, we did 
not have an adequate sample size to examine joint effects among exposures.  
 In summary, the results of the present study suggest that lifestyle exposures vary 
considerably with respect to their independent effects on standard sperm parameters and 
markers of germ cell DNA damage and immaturity.  The high prevalence of these personal 
behaviors, coupled with their modifiability suggests a fruitful area for further research.  We 
recommend future studies continue to examine these exposures simultaneously among a 
cohort of men from the general population and of sufficient size to allow the examination of 
joint effects and detection of small effect sizes.  
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F. Tables 
Table 4.1 Demographic characteristics of HMS participants (n=229) 
Covariate          n ( %)  
Study Site   
   Raleigh           92 (40) 
   Memphis         91 (40) 
   Galveston         46 (20) 
Age (years)   
   19 to 24         26 (11) 
   25 to 29         70 (31) 
   30 to 34         89 (39) 
   35 to 40          44 (19) 
Race    
   White, non‐Hispanic        192 (84) 
   Black, non‐Hispanic          17 (7) 
   Hispanic            8 (3) 
   Asian            5 (2) 
   Other, mixed race            7 (3) 
Household Income (US $/year)   
   missing           3  (1) 
   ≤ 40,000         53 (23) 
   40,000 to 80,000       109 (48) 
   80,000         64 (28) 
Education    
   High school         36 (13) 
   Some college        46 (20) 
   Graduated college      147 (64) 
Days of abstinence   
   2 to 3      113 (49) 
   4 to 5        63 (28) 
   ≥ 6        53 (23) 
Perceived stress (stress score)   
   No (0)       30 (13) 
   Low (1‐4)     138 (60) 
   Moderate (5‐7)       45 (20) 
   High (≥ 8)       16 (7) 
Presence of Chronic Illness   
   Yes        18 (8) 
   No      211 (92) 
BMI   
   < 18.5 (underweight)          0 (0) 
   ≥ 18.5 to < 25 (normal)        62 (27) 
   ≥ 25.0 to < 30  (overweight)      109 (48) 
   ≥ 30  (obese)        58 (16) 
Smoking Status   
   Never Smoked       152 (66) 
   Current Smoker        41 (18) 
   Ex‐Smoker        36 (16) 
Alcohol Consumption (drinks/week)   
   Non‐drinker        67 (29) 
   > 0 to ≤ 7       127 (55) 
   > 7 to ≤ 14         21 (9) 
   > 14        14 (6) 
Caffeine Intake (mgs/day)   
   No daily caffeine        40 (17) 
   > 0 to ≤ 150        68 (30) 
   > 150 to ≤ 300        61 (27) 
   > 300        60 (26) 
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Table 4.2.  Descriptive statistics of sperm outcomes for HMS participants  
Outcome                                                                      n                                 Mean ± SD                                         Median (range) 
Sperm concentration (millions/mL)         228  110.30 ± 83.1        86.2  (2.4‐539.15) 
Sperm count (millions/sample)         228   348.17 ± 296.2    252.6  (5.3‐1,706) 
Percent normal forms  229   14 ± 6   13.0  (2.0‐36.0) 
Percent DFI  224    19 ± 12   17.0  (3.0‐72.0) 
Percent HDS  224  8.0 ± 5      7.0  (2.0‐29.0) 
 
 Table 4.3  Summary statistics of  sperm outcomes by lifestyle exposure (SD=standard deviation, P50=median, Min=minimum, Max=maximum) 
 
   Sperm count †     Sperm concentration††      Percent normal forms  Percent DFI  Percent HDS 
Exposure 
 Mean  SD  P50  Min Max  Mean SD  P50  Min Max  Mean SD  P50  Min  Max  Mean SD  P50  Min Max   Mean SD  P50  Min Max 
Smoking status 
   Never smoked  5.46 0.96  5.49  1.66 7.44 1.89 0.37 1.89 0.38 2.73 0.14 0.06 0.13 0.02  0.36 0.20 0.11 0.18 0.03 0.63 0.09 0.05 0.08 0.02 0.29
   Current smoker  5.39 0.74 5.46 3.80 6.82 1.96 0.28 2.01 1.15 2.52 0.14 0.04 0.13 0.05 0.22 0.20 0.13 0.17 0.03 0.55 0.08 0.05 0.07 0.03 0.27
   Ex‐smoker  5.83 0.81 5.84 4.31 7.16 2.03 0.30 2.07 1.48 2.58 0.15 0.06 0.15 0.05 0.29 0.17 0.12 0.15 0.04 0.72 0.06 0.03 0.05 0.03 0.15
Current #  cigs/day  
   1 to 10   5.21 0.66 5.46 3.99 6.22 1.88 0.27 1.94 1.15 2.24 0.12 0.05 0.13 0.05 0.22 0.15 0.10 0.12 0.03 0.50 0.09 0.06 0.08 0.03 0.27
   > 10   5.57 0.77 5.59 3.80 6.83 2.04 0.28 2.06 1.54 2.52 0.15 0.03 0.15 0.11 0.22 0.24 0.14 0.19 0.04 0.55 0.07 0.03 0.06 0.03 0.17
Former #  cigs/day 
   1 to 10   5.91 0.80 5.84 4.38 7.16 2.04 0.29 2.04 1.55 2.58 0.17 0.06 0.16 0.05 0.29 0.18 0.14 0.15 0.05 0.72 0.06 0.03 0.05 0.03 0.15
   > 10   5.70 0.83 5.80  4.31 6.83 1.99 0.33 2.12 1.48 2.36 0.13 0.05 0.13 0.06 0.22 0.15 0.07 0.15 0.04 0.25 0.07 0.03 0.06 0.04 0.13
Current #  yrs smoked  
   > 0 and ≤ 5   5.36 0.51 5.40 4.80 5.93 1.94 0.26 2.03 1.51 2.13 0.13 0.06 0.13 0.08 0.22 0.12 0.05 0.11 0.06 0.19 0.08 0.02 0.07 0.06 0.11
   > 5 to ≤ 10  5.31 0.90 5.46 3.80 6.82 1.90 0.36 1.93 1.15 2.51 0.13 0.05 0.13 0.05 0.22 0.20 0.12 0.18 0.06 0.50 0.09 0.06 0.08 0.03 0.27
   > 10   5.48 0.64 5.50 4.54 6.61 2.02 0.21 2.04 1.63 2.36 0.14 0.03 0.14 0.06 0.21 0.21 0.15 0.17 0.03 0.55 0.07 0.04 0.06 0.03 0.17
Former # yrs smoked 
   > 0 and ≤ 5   5.77 0.75 5.77 4.65 6.99 2.04 0.24 2.04 1.72 2.56 0.16 0.06 0.16 0.06 0.29 0.20 0.17 0.17 0.05 0.72 0.06 0.02 0.05 0.04 0.11
   > 5 to ≤ 10  5.96 0.90 5.90 4.38 7.16 1.98 0.35 2.10 1.48 2.58 0.14 0.05 0.13 0.06 0.24 0.15 0.07 0.12 0.05 0.31 0.07 0.03 0.06 0.04 0.15
   > 10   5.69 0.81 5.72 4.31 6.70 2.09 0.34 2.16 1.49 2.40 0.16 0.07 0.16 0.05 0.25 0.14 0.08 0.15 0.04 0.25 0.05 0.02 0.04 0.03 0.09
Age began smoking 
   > 15 years of age  5.56 0.69 5.55 3.99 6.99 1.97 0.28 2.03 1.15 2.56 0.15 0.05 0.14 0.06 0.29 0.19 0.14 0.13 0.03 0.72 0.07 0.04 0.06 0.03 0.27
   ≤ 15 yrs of age  5.68 0.98 5.85 3.80 7.16 2.04 0.32 2.10 1.49 2.58 0.14 0.06 0.13 0.05 0.24 0.18 0.08 0.18 0.04 0.40 0.07 0.04 0.06 0.03 0.17
Alcohol (drinks/week) 
   Non‐drinker  5.16 1.01  5.32  1.66 6.83 1.83 0.39 1.91 0.38 2.42 0.13 0.05 0.13 0.02  0.34 0.22 0.12 0.18 0.05 0.72 0.08 0.04 0.07 0.03 0.20
   > 0 to ≤ 7   5.65 0.82 5.59 3.50 7.44 1.97 0.32 1.92 1.19 2.73 0.14 0.06 0.13 0.04 0.33 0.19 0.11 0.18 0.03 0.59 0.09 0.05 0.07 0.02 0.29
   > 7 to ≤ 14  5.53 0.76 5.58 3.97 7.08 1.89 0.35 1.92 1.21 2.48 0.17 0.05 0.18 0.05 0.26 0.15 0.10 0.13 0.04 0.43 0.08 0.04 0.06 0.04 0.17
   >14   5.85 1.03 5.96 3.78 7.16 2.03 0.31 2.14 1.28 2.42 0.18 0.09 0.15 0.08 0.36 0.16 0.11 0.13 0.05 0.50 0.07 0.04 0.06 0.03 0.15
Caffeine  (mgs/day) 
   No daily caffeine  5.45 0.82  5.52  3.29 7.08 1.93 0.30 1.92 1.21 2.59 0.16 0.06 0.16 0.08  0.33 0.17 0.11 0.16 0.04 0.55 0.09 0.05 0.07 0.04 0.23
   > 0 to ≤ 150  5.51 0.95 5.56 1.93 7.16 1.90 0.34 1.95 0.89 2.42 0.13 0.05 0.13 0.03 0.25 0.18 0.10 0.15 0.03 0.59 0.08 0.05 0.07 0.02 0.21
   > 150 to ≤ 300  5.45 0.93 5.48 1.66 7.44 1.89 0.39 1.91 0.38 2.58 0.15 0.07 0.13 0.02 0.36 0.21 0.13 0.17 0.04 0.72 0.08 0.04 0.07 0.03 0.21
   > 300  5.59 0.92 5.51 3.75 7.35 1.97 0.34 2.00 1.21 2.73 0.13 0.06 0.13 0.05 0.34 0.21 0.12 0.19 0.03 0.51 0.08 0.06 0.07 0.03 0.29
†log millions/mL         
††log millions/specimen 
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                  Table 4.4. Results of multivariable linear regression (reported as model‐estimated percent difference/percentage point difference) for sperm outcomes by lifestyle exposure  
 
 
 
Lifestyle Exposure 
 
Difference in sperm 
count (%) 
  (95% CL) 
 
Difference in sperm 
concentration (%) 
(95% CL) 
Difference in percentage of 
morphologically normal 
sperm cells  
(percentage points) 
(95% CL) 
Difference in percentage of 
sperm cells with 
 DNA damage (%DFI) 
(percentage points) 
(95% CL) 
Difference in percentage of 
sperm cells with HDS 
(percentage points) 
(95% CL) 
Cigarette smoking status           
Crude Model           
    Never smoked  referent  referent  referent  referent  referent 
    Ex‐smoker  46.23 (5.13, 103.40)*  15.03 (1.01, 31.00) *   1.33 (‐0.81, 3.47)  ‐2.77 (‐7.03, 1.49)         ‐2.46 (‐4.22, ‐0.69)** 
    Current smoker  ‐5.82 (‐30.93, 28.40)   7.25 (‐4.88, 20.92)  ‐0.41 (‐2.44, 1.62)  ‐0.52 (‐4.57, 3.52)  ‐0.70 (‐2.37, 0.98) 
Final Model           
    Never smoked  referent  Referent  Referent  Referent  Referent 
    Ex‐smoker   23.37 (‐10.42, 68.20)a  10.52 (‐2.96, 25.86)b  ‐0.22 (‐3.79, 3.36)c  ‐0.41 (‐4.72, 3.91)c      ‐2.80 (‐4.69, ‐0.93)d** 
    Current smoker  8.32 (‐22.89, 50.68)a  10.52 (‐2.96, 27.12)b  ‐0.61 (‐3.38, 2.16)c  ‐0.16 (‐4.60, 4.28)c      ‐0.82 (‐2.75, 1.11)d 
Alcohol consumption/week           
Crude Model           
    No alcohol   Referent  Referent  Referent  Referent  Referent 
    > 0 to ≤ 7 drinks  63.23 (25.86, 111.7)**  15.03 (4.08, 27.12)**  0.20 (‐1.50, 1.89)  ‐2.60 (‐6.04, 0.83)          0.78 (‐0.68, 2.24) 
    > 7 to ≤ 14 drinks    46.23 (‐5.82, 124.79)        6.18 (‐10.42, 25.86)    3.75 (0.95, 6.56) **      ‐6.51 (‐12.26, ‐0.76)*  0.09 (‐2.35, 2.56) 
    > 14 drinks  99.38 (19.72, 232.01) **  22.14 (0.00, 49.18) *    4.83 (1.53, 8.13) **   ‐5.79 (‐12.42, 0.83)  ‐0.89 (‐3.70, 1.92) 
Final Model           
     No alcohol   referent  Referent  Referent  Referent  Referent 
     > 0 to ≤ 7 drinks  52.20 (17.35, 99.37)e**  13.88 (2.02, 25.86)f*  ‐0.17 (‐1.96, 1.62)g       ‐3.84 (‐7.40, ‐0.28)e*  2.00 (0.44, 3.56)e* 
     > 7 to ≤ 14 drinks   43.33 (‐6.76, 122.55)e  7.25 (‐9.52, 28.40)f  2.59 (‐0.31, 5.48)g     ‐6.71 (‐12.51, ‐0.91)e*  2.12 (‐0.42, 4.66)e 
     > 14 drinks  87.76 (13.88, 209.57)e*  19.72 (‐1.98, 46.23)f  4.33 (1.04, 7.62)g*       ‐5.27 (‐11.74,  1.12)e  0.84 (‐2.00, 3.67)e 
Caffeine intake (mgs/day)           
 Crude Model           
     No caffeine  referent  Referent  Referent  referent  Referent 
     > 0 to le 150 mgs  6.18 (‐25.17, 52.20)  ‐3.92 (‐15.63, 10.52)     ‐2.57 (‐4.85, ‐0.29)*  0.53 (‐4.04, 5.10)         ‐0.20 (‐2.13, 1.74) 
     > 150 to le 300 mgs      0.00 (‐30.93, 43.33)       ‐3.92 (‐16.47, 10.52)  ‐1.35 (‐3.68, 0.97)   3.14 (‐1.52, 7.79)  ‐0.61 (‐2.58, 1.36) 
     > 300 mgs   15.03 (‐20.55, 64.87)    4.08  (‐9.52, 19.72)     ‐2.76 (‐5.09, ‐0.43) *  3.66 (‐1.01, 8.33)  ‐0.07 (‐2.05, 1.90) 
  Final  Model           
     No caffeine  Referent  Referent  Referent  referent  Referent 
     > 0 to le 150 mgs  ‐3.92 (‐32.29, 34.99)h      ‐7.69 (‐19.75, 5.13)i     ‐2.75 (‐4.92, ‐0.59)j*  ‐0.29 (‐4.90, 4.33) k  0.48 (‐1.53, 2.49) h 
     > 150 to le 300 mgs     ‐4.88 (‐33.64, 34.99)h  6.76 (‐18.94, 7.25)i  ‐0.89 (‐3.12, 1.33)j  0.40 (‐4.33, 5.13)k  ‐0.15 (‐2.25, 1.94)h 
     > 300 mgs  5.13 (‐26.66, 52.20)h  ‐1.98 (‐14.79, 13.88)i    ‐2.58 (‐4.88, ‐0.28)j*         0.52 (‐4.34,  5.39)k  0.77 (‐1.38, 2.92)h 
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a Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education,  BMI, chronic  illness, and stress. 
b Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education and BMI.  
c Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI, chronic illness, stress and caffeine intake. 
d Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, and chronic illness.  
e Adjusted for geographic region, age, length of sexual abstinence, income, and smoking status. 
f Adjusted for geographic region, age, length of sexual abstinence, income, smoking status and stress. 
g Adjusted for geographic region, age, length of sexual abstinence, income, smoking status and education. 
hAdjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI, chronic illness, stress and smoking status. 
i Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI,  and stress. 
j Adjusted for geographic region, age, length of sexual abstinence, income, and weekly alcohol intake. 
k Adjusted for geographic region, age, length of sexual abstinence, income,  education, BMI, and chronic illness 
l Adjusted for geographic region, age, length of sexual abstinence, income,  education, BMI, chronic illness, stress and smoking status. 
 
 
   *p<.05 
**p<.01 
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       Table 4.5.  Results of multivariable logistic regression by lifestyle exposure  
 
 
    Lifestyle Exposure 
 Percent normal forms 
OR (95% CL) 
Percent DFI 
OR (95% CL) 
Cigarette smoking status      
Crude Model     
    Never smoked  referent  referent 
    Ex‐smoker  0.77 (0.37, 1.60)  0.49 (0.14, 1.72) 
    Current smoker  1.19 (0.59, 2.44)  1.11 (0.44, 2.80) 
Final Model     
    Never smoked  referent  referent 
    Ex‐smoker  0.82 (0.34, 1.96)a  0.76 (0.19, 3.12)a 
    Current smoker  1.04 (0.41, 2.64)a  1.15 (0.35, 3.75)a 
Alcohol consumption/week     
Crude Model     
    No alcohol   referent  referent 
    > 0 to ≤ 7   0.92 (0.50, 1.70)   0.79 (0.36, 1.75) 
    > 7 to ≤ 14         0.22 (0.08, 0.65)    0.49 (0.10, 2.41)  
    > 14   0.56 (0.18, 1.78)   0.34 (0.04, 2.85) 
Final Model     
     No alcohol   referent  referent 
     > 0 to ≤ 7   0.99 (0.50, 1.99)  0.63 (0.24, 1.64) 
     > 7 to ≤ 14    0.26 (0.08, 0.82)b   0.47 (0.08, 2.82) c 
     > 14   0.63 (0.18, 2.27)b   0.35 (0.04, 3.37)c 
Caffeine intake (mgs/day)     
 Crude Model     
     No caffeine  referent  referent 
     > 0 to le 150 mgs   1.75 (0.79, 3.80)   2.20 (0.43, 11.14) 
     > 150 to le 300 mgs   1.65 (0.74, 3.70)    4.20 (0.87, 19.89)  
     > 300 mgs     2.85 (1.24, 6.60)*     5.60 (1.22, 26.96)* 
  Final  Model     
     No caffeine  referent  referent 
     > 0 to le 150 mgs  2.04 (0.84, 4.93)d   1.92 (0.33, 11.20)e 
     > 150 to le 300 mgs  1.69 (0.69, 4.17)d   2.82 (0.52, 15.38) e 
     > 300 mgs    3.31 (1.27, 8.61)d*   3.35 (0.61, 18.41)e 
a Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI, chronic illness, stress 
and caffeine intake. 
b Adjusted for geographic region, age, length of sexual abstinence, income, smoking status and education 
c Adjusted for geographic region, age, length of sexual abstinence, income, and smoking status 
d Adjusted for geographic region, age, length of sexual abstinence, income, and alcohol intake 
e Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI, and chronic illness 
 
*p<.05 
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 CHAPTER 5: BODY MASS INDEX AND SPERM QUALITY OF FERTILE MEN 
 
A. Abstract 
Objective:  To examine the association between overweight, obesity and sperm quality of 
fertile men. 
Design: Community-based cohort study  
Setting: Participants were male partners of pregnant women, participating in a prospective 
cohort study of drinking-water disinfection byproducts and pregnancy outcomes.  
Patient(s):  From 2000-2004, 229 fertile men aged 18 to 40 years.  
Interventions: A standardized telephone interview was used to collect data on reproductive 
and health history, including height and weight, and potential confounders.  Participants 
provided a single semen sample. 
Main Outcome Measure(s): Sperm count, concentration and percent morphologically 
normal sperm cells, as well as a marker of DNA damage (%DFI) and chromatin maturity 
(%HDS) from the sperm chromatin structure assay (SCSATM). 
Results: As measured by body mass index (BMI), neither obesity nor overweight were 
associated with significant decrements in any of the sperm outcomes we examined.  To the 
contrary, obese men (BMI ≥ 30) had significantly higher sperm concentrations (16%; 95% 
CL: 2%, 32%), relative to men with a normal BMIs (18.5-24.9).  After confounder adjustment, 
BMI was not significantly associated with DNA damage (%DFI). 
Conclusions: Among fertile men, overweight and obesity were not associated with reduced 
sperm quality or DNA damage.  Confirmation of these findings is required. 
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B. Introduction 
In epidemiologic studies, body fat is most commonly estimated by calculating body 
mass index (BMI), a measure of weight in kilograms (kg) adjusted for height in meters 
squared (m2) (5).  The underlying assumption of the BMI formula is that fat mass accounts 
for most of the variation seen in weight for persons of the same height, and empirical 
evidence has supported this assumption (44) (r=0.96, P<0.001).  Overweight and obesity 
have been defined in a variety of ways using BMI (21), however, the World Health 
Organization (WHO) currently classifies BMI values as underweight (<18.5), healthy weight 
(18.5-24.9), overweight (25-29.9) and obese (≥ 30 obese) (15).   
In the past three decades, the prevalence of overweight and obesity, as defined by 
BMI, has increased dramatically in the United States (21), with the most recent data from the 
National Health and Nutrition Examination Survey (NHANES, 2004) indicating that 34% of 
adults are overweight and 32% are obese (20).  Excess body fat is a well-established risk 
factor for numerous serious health conditions, including coronary artery disease, 
hypertension, type II diabetes and several cancers (5, 19).   As such, current prevalence 
estimates demonstrate the extent to which overweight and obesity represent a serious 
public health problem among adults in this country, as the burden of weight-related illness is 
expected to rise accordingly (23).   
Although the magnitude of overweight and obesity is increasingly clear, the full 
spectrum of health consequences associated with increased adiposity has yet to be 
delineated.   For example, it is only recently that the relationship between excess body fat 
and reproductive outcomes has been studied.   Among women, several adverse conditions 
and events have been linked with overweight and obesity, including anovulation, infertility, 
miscarriage and pregnancy complications (16, 26, 41), however, much less is known about 
the impact of increased body adiposity on male reproductive functioning.   
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To date, a limited number of epidemiologic studies have examined the relationship 
between BMI and indicators of male reproductive health, including serum hormone levels, 
sperm quality parameters and fecundity (28, 29).   Although several studies have reported 
alterations in hormonal levels (8, 38, 40) and fecundity (24, 32, 36) associated with 
increased accumulation of adipose tissue, sperm quality studies have been less numerous 
and inconsistent, with several studies reporting significant reductions in sperm numbers (9-
11) and other studies reporting no effect (1) or proportional sperm increases associated with 
higher body fat (39).   The aim of the present study was to evaluate the independent effect 
of BMI on standard measures of human sperm quality (sperm count, concentration and 
morphology) and sperm cell DNA integrity and maturity among a community-based cohort of 
young, fertile men.   
 
C. Materials and Methods 
1. Study design and subject recruitment 
To address our study aims we analyzed data collected from 2000 to 2004 as part of 
a prospective study of water disinfection by-products (DBPs) and sperm quality called “The 
Healthy Men Study” (HMS).  The design and conduct of the HMS, including subject 
selection and participation rates have been described previously (17, 22).  Our study 
protocol was approved by the University of North Carolina School of Public Health’s 
Institutional Review Board.  Briefly, the HMS identified and recruited male subjects through 
their pregnant partners who participated in a prospective study of drinking-water DBPs and 
spontaneous abortion risk (the “Right from the Start” (RFTS) study) (31).  Men were 
recruited from three study sites: Raleigh, NC; Galveston, TX; and Memphis, TN, which were 
selected to reflect varying exposure levels of chlorinated and brominated water DBPs.  
Eligible men were between the ages of 18 and 40 years, living with their RFTS study 
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partner, had never received a vasectomy and had not received chemotherapeutic agents or 
been away from their home for more than 30 days in the prior three months.  Once eligibility 
was established, a signed informed consent was obtained and the telephone interview was 
scheduled.    
Of the 274 eligible men, 229 (84%) fully participated in the study, having provided 
informed consent, completed the interview and provided a satisfactory semen sample.  The 
overall response proportion, defined as the number of men in the final HMS sample (229) 
divided by the total number of men we attempted to recruit for the study (908) was 25% (22).  
Although the final HMS sample was more likely to be white, with more education and higher 
household incomes than the study base, there were few differences with respect to age and 
lifestyle factors such as cigarette smoking and alcohol consumption (22).  
 
2. Study questionnaire 
Each study participant completed a computer-assisted telephone interview (CATI) 
that was administered by trained interviewers. The CATI system, with automated error 
detection, allowed responses to be directly entered into a computerized database.  The 
average interview lasted approximately 40 minutes.  Men were asked questions covering a 
broad range of topics that included environmental and occupational exposures, stress, 
lifestyle exposures (tobacco, alcohol, caffeine), as well as reproductive and medical history, 
including current height and weight.  To facilitate the interview, men were sent visual aids 
prior to the interview, including a diagram to estimate beverage size and a calendar.   
 
3. Semen collection and analysis 
When the telephone interview was completed, participants were asked to provide a 
single semen specimen.  HMS staff contacted the man by telephone to arrange for delivery 
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of the specimen collection kit to his home.  The collection kits were specifically designed to 
allow a man to collect a semen specimen in the privacy of his home and at a convenient 
time for him (33).  Prior to sending the kit, staff confirmed the participant’s mailing address 
and provided verbal instructions on how to use the kit, including the necessity of abstaining 
from sexual activity for two to seven days prior to obtaining the specimen for the HMS. The 
specimen collection kit was mailed to the participant in the week before the planned 
collection date and included a set of written and pictorial instructions that explained how to 
properly collect, package and prepare the specimen for shipping, and to contact the courier 
to arrange for pick up. Instructions for timing the collection were also included and varied by 
study site because local courier companies were contracted to pick up and deliver the 
specimens at specific times to ensure proper delivery timing to the main laboratory of the 
U.S. Environmental Protection Agency (EPA). 
Study participants prepared collected specimens for shipment and packaged the 
specimen with ice packs designed to maintain the temperature of the specimen at 
refrigeration levels for at least 24 hours.  Men were instructed to call the courier company on 
the day of collection so that it would arrive at the central laboratory of the EPA the following 
morning.  Ten percent of the samples received by EPA were disqualified from analysis 
because they had either very low specimen volume (<0.5 ml), the sample had been spilled 
or was otherwise incomplete, shipping was delayed and the specimen was older than 24 
hours, the sample had not been packed properly or the interval of sexual abstinence well-
exceeded the range of two to seven days.  In these cases, men were asked to provide 
another sample.  When an adequate sample was received by the EPA lab and the subject’s 
participation in the study was complete, he was sent a thank you letter and a check for $50.  
His partner was also sent a letter and check for $20.   
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In preparation for semen analysis, samples were allowed to liquefy at room 
temperature (37oC) for up to 60 minutes.  Volume was determined in a graduated conical 
cylinder.  Sperm concentrations and total counts were determined by IVOS-IDENT 
(Hamilton Thorn Research, Beverly, MA) (43).  Counts were made of complete (head and 
tails) spermatozoa only.  Total counts were conducted twice for each specimen to reduce 
the probability of error.  For the morphological assessment, two slides were prepared for 
duplicate evaluation, using the feathering technique and Papanicolaou stain recommended 
by the WHO (42).  Kruger’s strict criteria were used to evaluate overall morphology, which 
specifies that each functional region of the spermatozoon (head, neck, midpiece, and tail) 
must be normal to be scored normal (13).  Any borderline forms were classified as 
abnormal.  Percent morphologically normal spermatozoa were recorded.  We did not 
evaluate sperm motility because it could not be reliably measured given the amount of time 
required for shipping.  
 The Sperm Chromatin Structure Assay (SCSA), a method for evaluating single-
stranded DNA breaks and chromatin maturity, was conducted at South Dakota State 
University, where 229 straws of frozen semen from the HMS participants were shipped for 
analysis.  To conduct the assay, semen samples were thawed and diluted in a low pH 
solution (0.15 M NaCl, 0.01 M Tris HCl, 1mM disodium EDTA pH 7.4, 4ºC) to a sperm 
concentration of 1-2 x 106/ml and immediately mixed with 400 µl of 0.08 N HCl, 0.15 M 
NaCl, 0.1% Triton X 100 pH 1.2, 4ºC.  After thirty seconds, 1.20 mL of acridine orange (AO) 
staining solution (0.037 M citric acid, 0.126 M Na2HPO4, 0.0011 M disodium EDTA, 0.15 M 
NaCl pH 6.0, 4ºC) containing 6 µg/mL electrophoretically purified AO (Polysciences, Inc, 
Warrington, PA) was added and placed in the flow cytometry chamber whereby the sample 
flow was initiated.  The purpose of the low-ph solution is to potentially denature DNA that is 
damaged.  Structurally normal chromatin is distinguished from abnormal based on the 
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differential pattern of AO staining by sperm chromatin: AO stains normal double-stranded 
DNA green and denatured, single-stranded DNA is stained red (4).  Three minutes after the 
start of the procedure, signal acquisition to a computer list mode is initiated.  Raw data 
generated by the flow cytometer were sent to a specialized computer to calculate the 
percentage of sperm cells with moderate to high degrees of DNA fragmentation and green 
fluorescence, which identifies immature spermatozoa with normal chromatin.  This 
procedure was repeated twice for each sample.  Although the SCSA is an indirect measure 
of DNA strand breaks, percentage DFI values have been shown to correlate well with direct 
assessment techniques such as TUNEL and comet assays (4).  
In this paper, we report on five sperm quality outcomes:  total sperm count (million), 
sperm concentration (million/mL) and percentage of morphologically normal sperm cells, in 
addition to the two distinct parameters generated from the SCSA: (1) percentage of sperm 
cells with moderate to high degrees of DNA fragmentation (%DFI) and (2) percentage of 
sperm cells with altered chromatin condensation (% HDS).    In our statistical analyses, each 
of the five outcomes was examined as a continuous variable; percentage of morphologically 
normal sperm cells and %DFI were also examined dichotomously.   
 
4. Statistical Analysis 
To examine the shape of the association between BMI and each of the five sperm 
outcomes, four models were applied: linear (BMI continuously), indicator (BMI categorized), 
quadratic (BMI squared) and quadratic spline.  When modeled with indicator terms, BMI was 
categorized according to the current adult WHO standards for defining BMI values; normal 
weight men were the reference category.  Model fit was evaluated based on plots of 
observed and predicted values, pattern of residuals and Akaike's Information Criterion (AIC) 
values.  There was no clear “shape” of the relationship between BMI and any of the sperm 
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outcomes and, in general, all four models (linear, indicator, parabola, and spline) fit equally 
well.  Therefore, we chose to examine the relationship between BMI and the sperm 
outcomes in regression analyses, using the WHO BMI categories specified as indicator 
terms in the equations.  There are several advantages to modeling BMI categorically.  WHO 
BMI standard categories have well-established clinical relevance and research applications, 
as standard BMI categories are correlated with other health outcomes.  In addition, using 
BMI categories will improve comparability with previous studies of weight status and sperm 
quality.   
Potential confounders were initially identified based on prior knowledge of factors 
related to both BMI and sperm quantity/quality.  Geographic region (study site), age, total 
household income, education, length of sexual abstinence, history of a chronic or serious 
illness, and lifestyle exposures (cigarette smoking, alcohol consumption and caffeine intake) 
were evaluated as potential confounders.  We also considered level of perceived stress as a 
potential confounder, which we measured as the sum of the response scores (0 to 16) of 
four stress-related questions in which participants ranked perceived stress on a scale from 0 
to 4.  It was not necessary to consider history of infertility because none of the men reported 
reproductive problems.  We also did not consider environmental and occupational 
exposures because of their low reported prevalence.   
Multiple linear regression analysis was used to estimate the association between 
BMI and each sperm outcome, adjusting for confounders.   Using a backward elimination 
strategy, we constructed a separate model for each sperm outcome, which included 
confounders that changed the parameter estimate for BMI by at least 10%.  In each final 
model, age, geographic region, length of sexual abstinence and education were retained as 
obligate confounders to adjust for residual confounding and facilitate comparison across 
other sperm quality studies.  Model fit was evaluated by plotting residuals, which did not 
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suggest a great departure from assumptions of linear regression.  Non-parametric analysis. 
using a Wilcoxon rank-sum test confirmed model fit and robustness of results.  
Finally, we fit logistic models for the outcomes percentage of normal forms and 
%DFI, which were dichotomize at the following cutpoints: <15% morphologically normal 
sperm cells v. ≥15% morphologically normal sperm cells, and ≤30% DFI v. >30% DFI, which 
represent thresholds of fertility reported in the literature for each outcome, respectively (3, 
13, 35).  We conducted crude and adjusted logistic regression, maintaining the same 
variable specification for BMI and including the confounders identified in linear regression 
model building.  Men in the “fertile” groups (i.e. ≥ 15% normal forms; < 30% DFI) were the 
reference category.  It was not possible to conduct logistic regression for sperm count or 
sperm concentration due to the low prevalence of men with oligozoospermia in the HMS 
sample.  We also did not evaluate %HDS dichotomously because a clinically-significant 
threshold is not well-established.    
We transformed the outcomes sperm count and concentration, using the natural 
logarithm to better approximate the normality assumption of the dependent variable in linear 
models.  We used the arc sine transformation to obtain normality for percentage of 
morphologically normal sperm cells, %DFI, and %HDS, however, we report the results for 
the three proportional outcomes untransformed as they were not substantively different from 
transformed estimates.  
 
D. RESULTS  
Demographic characteristics and potential confounders are presented in Table 5.1.  
Participants were predominately white, non-Hispanic (84%) and between 25 and 34 years of 
age at the time of data collection (70%).  Most men were college-educated and reported an 
annual household income over $40,000.    
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Nearly half of the participants (48%) were classified as overweight, 25% were obese 
and 27% had a healthy BMI; no men were classified as underweight.  BMI was not strongly 
correlated with age or income, but it was significantly related to education, with 34% of 
obese men having a college degree compared to 74% of normal weight and 75% of 
overweight men. Obese men were also more likely than men in the other BMI categories to 
report moderate to high levels of stress (21% v. 12% and 8%, respectively) or a history of 
serious illness.  With respect to lifestyle behaviors, alcohol consumption and BMI were not 
strongly associated, however, heavy caffeine intake (> 300 mgs/day) was more likely to be 
reported among both overweight and obese men (31%) compared to normal weight men 
(13%), and current cigarette smoking was more prevalent among obese men (28%) than 
either overweight (12%) or normal-weight men (15%).   
Unadjusted means (± SD) and medians (range) of each of the five sperm outcomes 
untransformed are presented in Table 5.2.  The mean (median) sperm concentration for 
HMS participants was 110.30 (86.15) million/mL and the mean (median) total sperm count 
was 348.17 (252.61) million, which are well above the current WHO reference values of ≥ 20 
million/mL and ≥ 40 million/specimen for these parameters (42).  Given that the partners of 
the men in the HMS were pregnant at the time the sample was collected, it is not surprising 
that only 5% had sperm concentrations and 3% had sperm counts below these WHO 
reference values.   
 The mean (± SD) percentage of morphologically normal sperm cells was 14% (± 
6%).  Contrary to the distribution for the quantitative sperm parameters, nearly 60% of HMS 
participants had values that fell below the 15% normal morphology threshold reported in the 
literature as necessary for optimal fertility.  The mean (± SD) %DFI for HMS participants was 
19% (± 12%.), with approximately 13% of the sample DFIs exceeding the 30% threshold 
value.  The mean HDS was 8% (± 5%.).   
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Parameter estimates and 95% confidence limits (95% CL) obtained from unadjusted 
(crude) and adjusted (final) multivariable linear and logistic regression models are presented 
in Table 5.3.   To enhance interpretability, we back-transformed beta coefficients produced 
from linear regression models of natural log-transformed outcomes by applying the formula 
(eβ  - 1) x 100.  Parameter estimates for sperm count and concentration reported in Table 5.3 
should therefore be interpreted as model-estimated percent difference in outcomes between 
contrasting exposure categories. Confidence limits were obtained by applying the same 
formula to the 95% confidence limits obtained for each β coefficient (7).   It is also important 
to consider the direction of the estimate in relation to the sperm outcome.  Specifically, 
negative estimates for sperm count, sperm concentration and percent morphologically 
normal sperm cells indicate poorer sperm quality, whereas positive estimates indicate 
greater chromatin alterations, as measured by %DFI and %HDS.   
In general, linear regression results did not indicate an association between BMI and 
decrements in the sperm outcomes we examined.  To the contrary, results revealed that 
obese men (BMI ≥ 30) had, on average, 16% higher sperm concentrations than men of 
normal weight, which persisted after confounder adjustment (95% Confidence Limits (CL): 
2.02%, 32.31%; P-value <.05).  A similar, although non-significant trend, was observed for 
overweight men (BMI ≥ 25 to <30) (11.63%; 95% CL: -0.00%, 23.37%; P-value = 0.05).  
Multiple regression results did not reveal any further differences in sperm outcomes 
associated with contrasting BMI categories.  Although sperm cell DNA damage (%DFI) was 
significantly more prevalent among overweight men than men with normal BMIs in the crude 
linear model (4.22%, 95% CL:0.58%, 7.86%), this relationship did not persist after 
confounder adjustment.  Logistic regression results were generally consistent with those 
from linear models, with estimates similarly imprecise.  Site-stratified results are presented 
in Table A.15. 
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D. DISCUSSION  
In the present study we examined the relationship between elevated BMI and 
measures of testicular function and sperm cell DNA integrity in a cohort of fertile men.  We 
did not find overweight or obesity to be associated with decrements in any of the sperm 
outcomes we examined, after confounder adjustment.  To the contrary, our most striking 
finding was of significantly higher sperm concentrations among obese men, and to a lesser 
extent among overweight men, relative to those with a BMI currently defined as normal.    
 Excess adipose tissue exerts a deleterious effect on most functional systems of the 
body (23).  Obesity is hypothesized to impair normal male reproductive functions by exerting 
a profound effect on the production, metabolism, transportation and target-tissue action of 
sex and non-sex hormones and enzymes (27).  A range of complex abnormalities in serum 
hormone levels has been described in the literature, with the typical hormonal profile of 
obese men characterized by reductions in serum testosterone, sex-hormone binding 
globulin and inhibin-B, and an increase in estrogens (10, 38, 40, 44), which suggest direct 
action on testicular structures (i.e. Leydig cells) and/or disruption of the hypothalamic-
pituitary/hypothalamic-pituitary gonadal axis.  In spite of these hormonal alterations, obese 
men generally exhibit only mild symptoms of hypogonadotropic hypogonadism (38).  
Nonetheless, an expected consequence of extreme disruption in steroidogenesis and 
hormonal regulation is impaired spermatogenesis.  
 Among the limited epidemiologic studies that have examined the relationship 
between increased body adiposity and sperm quality, several have reported significantly 
lower total sperm counts and concentrations of obese men relative to those with normal 
BMIs (10, 12), with one study reporting similar decrements, but only among 
normozoospermic men (18).   In addition to reductions in sperm quantity parameters, Kort et 
al. (11) observed higher sperm cell DNA damage as measured by the SCSA (%DFI) among 
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overweight and obese men compared to those with normal BMIs and Hammoud et al. (9) 
reported significantly higher proportions of low-motile sperm cells with corresponding 
increases in BMI group.   
Other studies, including the present work, found no evidence of a relationship 
between increased BMI and alterations in sperm quality.  In a study by Aggerholm et al. (1), 
researchers found no correlation between BMI and sperm count and concentration, and a 
trend toward higher proportions of normal motile forms with increasing BMI (P-value =0.06), 
despite significantly abnormal serum hormone levels.  Qin et al. (39) observed that although 
underweight men were at risk for sperm count and concentration decrements, those with 
BMIs above normal had higher sperm numbers relative to men with weights in the healthy 
range.   
There does not appear to be one salient design feature that can easily explain the 
differences observed in previous studies.  It is possible that study population (e.g. fertile 
men, men of unknown fertility status, infertility patients) may explain some of the observed 
variation, particularly for studies in which height and weight are self-reported, as this may 
increase the likelihood of exposure misclassification. However, there is no clear pattern of 
results associated with either study population or BMI exposure assessment. Unadjusted 
confounding may also play a role.  For example, Kort et al. (11) reported significantly higher 
proportions of DNA damage (%DFI) associated with elevated BMI, but they did not adjust for 
potential confounders in their analysis, which we found to materially change our 
interpretation of the relationship.   
The present study was strengthened by several methodological features that 
included adequate adjustment for a range of potential confounders and access to modern 
semen analysis techniques, including the SCSA, which allowed us to conduct a 
comprehensive assessment of the reproductive effects associated with BMI.  Our cohort of 
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presumptively fertile men conferred both strengths and potential limitations to the present 
study.  Fertile study subjects may reduce differential reporting of exposure based on fertility 
status, as well as minimize the potential for selection bias, which is more probable when 
subjects are selected from infertility clinics (2).  However, it could also be argued that the 
distribution of sperm parameters in a cohort of young, presumably fertile men is sufficiently 
shifted that we are potentially missing an etiologically relevant portion of the population 
distributions for sperm parameters, which would obscure our detection of exposure/outcome 
effects that exist at that sub-fertile ends of the spectrum, particularly for small effect sizes.  
Although we cannot rule out this possibility, our data revealed sufficient contrasts in 
outcomes across BMI categories for the quantitative parameters (sperm count and 
concentration), and the distribution of qualitative outcomes (morphology, %DFI, %HDS) 
adequately represents areas of the curve that would be classified as sub-fertile.  
There are several additional limitations to the present study.  The bias associated 
with the use of self-reported height and weight compared to measured values for calculating 
BMI has been debated in the literature (25, 34).   However, data suggest that differences 
between self-reported BMI and measured BMI tend to be very small for most men (self-
reported BMI (25.8) – measured BMI (26.0) = -0.27 (30), and among those ages 20 to 39 
years of age, such as the men in the HMS cohort, the probability of correctly classifying 
overweight and obesity is 94% (14).  The validity of BMI as a measure of adiposity has also 
been questioned, as it is possible to be overweight relative to height and not over fat.  
Research generally suggests that BMI is well correlated with adiposity (44) and has a 
predictive value equal to other more direct measurements of body fat (6, 37).   Although we 
were able to adjust for many of the variables suspected to confound the exposure/outcome 
association, it is likely that our results reflect, at least to some extent, residual confounding 
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attributable to unmeasured variables.  Finally, interpretation of our effect estimates is 
constrained by imprecision.   
In the United States, overweight and obesity are prevalent, largely modifiable risk 
factors for many adverse health outcomes.  However, excess adiposity has only recently 
been explored in relation to male reproductive functioning.  The present study adds to the 
relatively limited epidemiologic evidence and extends our understanding of the relationship 
between excess body fat and testicular functioning with respect to fertile men. 
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F. Tables  
 
Table 5.1. Demographic characteristics [no. (%)] of HMS participants overall and by BMI status 
 
 
 
Covariate 
 
 
Overall  
(n=229) 
                                 BMI Status  
        
         Normal             Overweight                   Obese 
         (n=62)                  (n=109)                      (n=58) 
Study Site         
   Raleigh           92 (40)        29 (47)       48 (44)       15 (26) 
   Memphis         91 (40)        23 (37)       41 (38)       27 (47) 
   Galveston         46 (20)        10 (16)       20 (18)       16 (28) 
Age (years)         
   19 to 24         26 (11)        9 (15)        7 (6)       10 (17) 
   25 to 29         70 (31)       20 (32)       34 (31)       16 (28) 
   30 to 34         89 (39)       23 (37)       40 (37)       26 (45) 
   35 to 40          44 (19)       10 (16)       28 (26)         6 (10) 
Race          
   White, non‐Hispanic       192 (84)       54 (87)       96 (88)       42 (72) 
   Black, non‐Hispanic         17 (7)         4 (6)         4 (4)         9 (16) 
   Hispanic            8 (3)         0 (0)         4 (4)         4 (7) 
   Asian            5 (2)         3 (5)         2 (2)         0 (0) 
   Other, mixed            7 (3)         1 (2)         3 (3)         3 (5) 
Household Income (US $/year)         
   missing           3  (1)         0 (0)         2 (2)         1 (2) 
   ≤ 40,000         53 (23)       17 (27)       18 (17)       18 (31) 
   40,000 to 80,000       109 (48)       28 (45)       55 (50)       26 (45) 
   80,000         64 (28)       17 (27)       34 (31)       13 (22) 
Education          
   High school         36 (13)          4 (6)       16 (15)       16 (28) 
   Some college        46 (20)       13 (21)       11 (10)       22 (38) 
   Graduated college      147 (64)       45 (73)       82 (75)       20 (34) 
Days of abstinence         
   2 to 3      113 (49)       33 (53)       54 (50)       26 (45) 
   4 to 5       63 (28)       17 (27)       28 (26)       18 (31) 
   ≥ 6       53 (23)       12 (19)       27 (25)       14 (24) 
Perceived stress (stress score)         
   No (0)       30 (13)       11 (18)       13 (12)         6 (10) 
   Low (1‐4)     138 (60)       41 (66)       65 (60)       32 (55) 
   Moderate (5‐7)       45 (20)         8 (13)       24 (22)       13 (22) 
   High (≥ 8)       16 (7)         2 (3)         7 (6)         7 (12) 
Presence of Chronic Illness         
   Yes        18 (8)          2 (3)         6 (6)        10 (17) 
   No      211 (92)       60 (97)     103 (94)       48 (83) 
Caffeine Intake (mgs/day)         
   No daily caffeine       40 (17)       18 (29)         9 (8)       13 (22) 
   > 0 to ≤ 150       68 (30)       18 (29)       34 (31)       16 (28) 
   150 to ≤ 300       61 (27)       18 (29)       32 (29)       11 (19) 
   > 300       60 (26)         8 (13)       34 (31)       18 (31) 
Alcohol Consumption (drinks/wk)         
   Non‐drinker       67 (29)       18 (29)       25 (23)       24 (41) 
   > 0 to ≤ 7      127 (55)       33 (53)       69 (63)       25 (43) 
   > 7 to ≤ 14        21 (9)         6 (10)       10 (9)         5 (9) 
   ≥ 14       14 (6)         5 (8)         5 (5)         4 (7) 
Smoking Status         
   Never Smoked       152 (66)       47 (76)       77 (71)       28 (48) 
   Current Smoker        41 (18)         6 (10)       19 (17)       16 (28) 
   Ex‐Smoker        36 (16)         9 (15)       13 (12)       14 (24) 
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Table 5.2.  Descriptive statistics of sperm outcomes for HMS participants  
Outcome                                                                   n                                       Mean ± SD                                      Median (range) 
Sperm concentration (millions/mL)           228  110.30 ± 83.1        86.2  (2.4‐539.15) 
Sperm count (millions/sample)  228   348.17 ± 296.2    252.6  (5.3‐1,706) 
Percent normal forms  229                       14.0 ± 6   13.0  (2.0‐36.0) 
Percent DFI  224  19.0 ± 12   17.0  (3.0‐72.0) 
Percent HDS  224  8.0 ± 5      7.0  (2.0‐29.0) 
 
 Table 5.3.  Results of multivariable linear regression (reported as model‐estimated percent difference/percentage point difference) and logistic regression by sperm outcome  
 
 
Body Mass Index 
 
Difference in sperm 
count (%) 
(95% CL) 
 
Difference in sperm 
concentration (%) 
 (95% CL) 
Difference in percentage  
 of morphologically   
normal sperm cells 
(percentage points)  
(95% CL) 
Difference in percentage of 
sperm cells with DNA 
damage (% DFI) 
(percentage points) 
 (95% CL) 
Difference in percentage 
Of sperm cells with HDS 
(percentage points) 
 (95% CL) 
          kg/m2           
  Crude Linear Model           
    18.5‐24.9                        referent  referent  referent  referent  referent 
    25.0‐29.9   8.33 (‐18.13, 44.77)   11.62 (‐0.00, 23.37)   ‐1.53 (‐3.36, 0.30)   4.22 (0.58, 7.86)f*  ‐0.15 (‐1.69, 1.40) 
    ≥ 30.0     7.25 (‐22.12, 49.18)    16.18 (3.05, 31.00)f*  ‐1.57 (‐3.37, 0.54)            1.58 (‐2.60, 5.75)  ‐0.82 (‐2.59, 0.95) 
 Final Linear Model           
    18.5‐24.9                        referent  referent  referent  referent  referent 
    25.0‐29.9   6.18 (‐19.75, 40.49)a   11.63 (‐0.00, 23.37)b  ‐0.58 (‐2.40, 1.27)c  2.52 (‐0.99, 6.04)d  ‐0.00 (‐1.88, 1.42)e 
    ≥ 30.0  12.75 (‐19.75, 56.83)a   16.18 (2.02, 32.31)b g*  ‐0.50 (‐2.67, 1.67)c  0.32 (‐3.99, 4.64)d  ‐0.68 (‐2.63, 1.27)e 
Crude Logistic model           
    18.5‐24.9                        Not done  Not done  referent  referent  Not done  
    25.0‐29.9      1.26 (0.67, 2.38)  2.26 (0.86, 5.93)   
    ≥ 30.0      1.25 (0.61, 2.59)  1.04 (0.32, 3.43)   
Final Logistic model            
    18.5‐24.9                        Not done  Not done  referent  referent  Not done 
    25.0‐29.9      0.94 (0.44, 2.01)c  1.88 (0.62, 5.69)d   
    ≥ 30.0      0.88 (0.36, 2.17)c  0.72 (0.18, 2.83)d   
a Adjusted for geographic region, age, length of sexual abstinence, education, stress, chronic illness, income, alcohol consumption, caffeine intake, smoking status. 
b Adjusted for geographic region, age, length of sexual abstinence, education, and stress. 
c Adjusted for geographic region, age, length of sexual abstinence, education, stress, alcohol consumption, caffeine  intake, and smoking status.   
d Adjusted for geographic region, age, length of sexual abstinence, education, stress, chronic illness, income, and alcohol consumption. 
e Adjusted for geographic region, age, length of sexual abstinence, education, chronic illness,  income,  alcohol consumption, caffeine intake, and smoking status. 
f Tested by simple linear regression 
g Tested by multiple linear regression  
 
*p<.05 
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 CHAPTER 6:   CONCLUSIONS 
A.  Summary of findings  
The results of this dissertation research suggest that lifestyle exposures (cigarette 
smoking, alcohol consumption and caffeine intake) and BMI vary considerably with respect 
to their independent effects on clinically relevant makers of testicular function and germ cell 
integrity and maturity of fertile men.  We found no evidence to suggest that current or former 
cigarette smoking harms sperm quantity (count or concentration), germ cell morphology or 
DNA integrity and, for reasons we cannot fully explain, may protect chromatin packaging 
during sperm cell maturation.   Normal chromatin condensation, as measured by the sperm 
chromatin structure assay (SCSA), has not been previously explored in relation to cigarette 
smoking, and as such, represents a novel finding.   
Despite the strong biological basis for cigarette smoke exposure to disrupt normal 
testicular and post-testicular events in human males, epidemiologic studies have not 
consistently supported this hypothesis.  Discrepant study results may be due in part to 
heterogeneity in the country of study and source population, with over thirty countries 
represented in the literature and men recruited from a wide variety of sites, including the 
general community, andrology laboratories and infertility clinics.  We choose to evaluate 
smoking exposure based on status (current, former, never smoker) because more 
quantitative methods of exposure assessment produced a similar pattern of results, which 
may be due in part to the low number of current smokers (41) who smoked heavily (10).  
Interestingly, our qualitative exposure assessment identified former smokers as having the 
best overall profile across the sperm outcomes we examined in comparison to men that 
never smoked or current smokers.  There is no clear rationale for the observed association, 
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which may be idiosyncratic to the present study, but further investigation of former cigarette 
smokers may provide valuable etiologic insight, if only to identify important confounders. 
 Increased adiposity is another well-established risk factor for numerous serious 
health conditions, which unlike cigarette smoking, has been relatively unexplored in relation 
to male reproductive health.   Excess body fat has been shown to impair Leydig and Sertoli 
cell function and disrupt the negative feedback loop of the hypothalamic-pituitary-gonadal 
axis necessary for normal testicular functioning.  Despite putative mechanistic pathways, the 
causes and consequences of being overweight or obese are complex and uncertain with 
respect to male reproduction.  Limited epidemiologic evidence of alterations in 
spermatogenesis has not been consistent, even in the presence of altered serum sex 
hormone levels.  The findings of the present study do not support an association between 
increased adiposity, as measured by BMI, and decrements in sperm parameters.  However, 
we should not fully discount the weak evidence of a relatively higher prevalence of sperm 
cell DNA damage associated with overweight, and to a lesser extent obesity, revealed by 
the present study.   In addition, we also found evidence of proportionally higher sperm 
numbers in obese men relative to men with healthy weight, which is in agreement with prior 
reports (1,2) 
  The present study also provided evidence of generally favorable sperm outcomes 
associated with moderate alcohol consumption.  The health benefits of moderate drinking 
have been debated in the literature, and our results are in agreement with unexpected 
findings from earlier sperm quality studies, particularly with respect to sperm cell 
morphology, which was reportedly higher among moderate drinkers.  Constituents of various 
alcohol products, particularly the bioflavonoids present in red wine and dark beer, have been 
hypothesized to confer reductions in measures of systemic inflammation and oxidative 
stress, however, ethanol itself is also thought to exert a protective effect, but these results 
are not confirmed.   However, the benefits suggested by these findings must be weighed in 
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relation to risks that may not be evident from or limited to the outcomes evaluated in the 
present study, such as germ cell aneuploidy.  
 Perhaps the most intriguing finding from the present study was of significant 
reductions in the relative proportions of sperm cells with normal morphology associated with 
caffeine intake, particularly at the highest level of consumption (>300 milligrams per day).   
Our results reinforce earlier, limited findings from in vitro and epidemiologic studies, 
however, this relatively novel association has not been consistently observed in all prior 
work (3), and as such, this finding is tentative.  
 
B. Public health significance 
Human reproduction is a key biologic event relevant to individuals and populations.   
Male reproduction is vulnerable to disruption, which can occur at any time during the 
process of spermatogenesis.  Some reports suggest that male reproductive health may be 
declining and lifestyle exposures and increased adiposity have been implicated.  However, 
human sperm studies are the only means to directly assess the effects of potential toxicants 
on sperm cells (4).  As such, the present study contributes important information to our 
overall understanding of the nature and extent of potential factors that may influence the 
quality of human sperm in general, and in specific has provided useful insights about the 
etiologic role of three prevalent lifestyle behaviors and increased adiposity on markers of 
male reproductive fitness among fertile US men.  
 The harm or benefit conferred by any single exogenous agent, including lifestyle 
exposures, is likely to be small within the highly complex, multifactorial process of human 
spermatogenesis.  Nonetheless, it is important to evaluate and understand the impact of 
these personal exposures, however small their relative influence on normal testicular 
functioning may be, not only because the number and quality of sperm are correlated with 
fertility, but because personal behaviors are largely modifiable and therefore amenable to 
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intervention.  This leads to the question of what behavior(s) to modify and why?  The 
independent effects of cigarette smoking, alcohol consumption and caffeine intake have 
been difficult to tease out in most previous research because they are often so highly 
correlated, making it difficult to interpret findings with respect to individual exposures.   In the 
present study we were able to refine etiologic statements with respect to specific behaviors 
because our estimates do not reflect a mixing of exposure effects to the extent that they 
were in much of the earlier work in this area.  These types of incremental methodological 
improvements are critical to our evolving understanding of how individual lifestyle exposures 
may influence the quality and quantity of human spermatozoa.  The present study is also 
significant for its application of our study methods and the resulting insights gained to fertile 
men, a relatively understudied population of males.      
 It would be premature, however, to suggest that the results of the present study be 
used as the basis to initiate immediate change in clinical practice or personal behavior, as 
such decisions should generally not be made on the basis of a single study.  Rather the 
findings of the present study are intended to provide incremental knowledge and should be 
viewed collectively with prior, comparable work, particularly for well-studied exposures like 
cigarette smoking, in order to evaluate the weight of the evidence regarding male 
reproductive health effects.   Moreover, given the wide variability in the magnitude and 
direction of sperm effects that we observed across the different exposures, confirmation is 
required so that relative benefits and risks may be a fully assessed across a spectrum of 
potential sperm outcomes, many of which were not examined in the present study.  
Nonetheless, the high prevalence of each lifestyle exposure, including overweight and 
obesity, suggest that even modest adverse effects, such as what we observed regarding 
caffeine intake and alterations in sperm cell morphology, could have measurable impacts on 
this parameter at the population level among fertile men in the United States.    
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C. Future research directions  
Sperm quality studies of potential male reproductive toxicants have focused on two 
primary lines of investigation:  (1) occupational and environmental exposures and (2) 
lifestyle behaviors.  However important may be the role of complex environmental exposures 
(e.g. bisphenol-A and phthalates) in the balance between health and impairment of male 
reproduction, personal habits should also remain an essential area of epidemiologic inquiry 
in the foreseeable future because the agents to which men are voluntarily exposed are more 
easily modified, and likely present at higher doses than exposures generally encountered in 
the environment.  This poses the dual possibility of greater reproductive health risk, but with 
the potential for more immediate public health action.   
First and foremost, future research should be designed to test specific hypotheses 
regarding lifestyle exposures and sperm quality, with sample sizes sufficient to detect small 
effects and examine the potential for heterogeneity of effect across strata of other lifestyle 
exposures, for example, joint effects of cigarette smoking and caffeine intake.  Ideally, the 
study subjects should be recruited from the general population of men of reproductive age to 
capture the full population distributions of sperm parameters, and rely less on segments of 
the population, such as men seeking infertility evaluation, which may increase the probability 
of selection bias.  Future research would also benefit from exposure refinement, for 
example, incorporating prenatal cigarette exposure and type of alcoholic and caffeinated 
beverages consumed.  Regarding body adiposity, it would be important to incorporate men 
that were underweight to fully characterize the association between body fat and testicular 
function measures.  Exploration of body fat distribution may also be informative.  Finally, 
consideration of potentially health-promoting factors, such as diet and exercise, may also 
prove a fruitful area of investigation, especially if the research objective is to further 
characterize the influence of lifestyle choices on male reproductive fitness.  
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The present study evaluated the effects of highly prevalent, largely modifiable 
personal habits and conditions on a range of sperm outcomes that reflect testicular 
functioning and correlate with fertility.  It is important to continue this line of scientific 
investigation in an effort to provide men of reproductive age with clear, accurate information 
they can use to protect their reproductive health.  
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APPENDIX
  
    
  Table A.1.  Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study 
 Population 
Effect estimates and Standard Deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motility) 
DNA  damage, 
aneuploidy. Other 
measures 
Campbell & 
Harrison, 1979 
Australia  Cross‐
sectional 
253 male partners of 
infertility  
patients  
‐‐  Smokers: 41% reduction 
in concentration; non‐
smokers 26% reduction 
‐‐  ‐‐  Smokers: 35% reduction; 
non‐smokers 26% 
reduction 
‐‐ 
Evans et al., 1981  England  Cross‐
sectional 
43 smokers; 
43 non‐smokers from 
infertility clinic 
‐‐  ‐‐  Smokers: 52.9% ± 1.47 
nl. sperm 
Non‐smokers: 57.7% ± 1.18 
nl. sperm 
p‐value <.01 
% abnormal sperm gen. 
increase with # cigarettes 
smoked, but not 
consistently 
‐‐  ‐‐ 
Godfrey, 1981  Australia  Cross‐
sectional 
40 <21cig /d smoke; 
35 >20 cig /d; 
74 non‐smokers 
From infertility clinic 
‐‐  ‐‐   no   % normal sperm 
<21:65.4% ± 1.8 
>20:64.2% ± 3.7 
0: 65.4% ± 1.8 
p‐value N.S. 
‐‐  ‐‐ 
Shaarawy & 
Mahmoud, 1982 
Egypt   Cross‐
sectional 
25 > 20 cig/d 
20 non‐smokers 
Presumed fertile 
men 25‐35 yrs old 
volunteers 
‐‐  ‐‐  Smokers: 
74.8 ± 42.2; 
Non‐smokers: 
80.8 ± 32.4; 
p‐value N.S. 
% abnormal 
Smokers: 
48 ± 12;  
Non‐smokers 
25 ± 10 
p‐value < .001 
Smokers: 
52 ± 8; 
Non‐smokers 
78 ± 6; 
p‐value <.001 
↑Serum T:  
p‐value<.05; 
Serum LH: 
p‐value<.001; 
Serum FSH: 
p‐value <.01 
Rodriguez‐Rigau, 
et al., 1982 
USA  Cross‐
sectional 
58 smokers: 
24 <20 cig/d; 
34 >20 cig/d; 
101 non‐smokers 
from infertility clinic 
‐‐  <20 cig/d: 
54.4 ± 15.3 
>20 cig/d: 
51.8 ± 7.1  
non‐smokers: 
55.5 ± 7.5  
p‐value N.S. 
‐‐ 
 
% normal: 
<20 cig/d: 
57.7 ± 4.8 
>20 cig/d: 
59.1 ± 3.0 
Non‐smokers: 
44.7 ± 1.3 
p‐value N.S. 
<20 cig/d: 
45.1 ± 2.8; 
>20 cig/d: 
44.6 ± 2.7; 
Non‐smokers 
58.4 ± 2.0 
p‐value N.S. 
‐‐ 
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   Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Andersen et al., 
1984 
Denmark  Cross‐
sectional 
93 ≥ 10 cig/d 
44 < 10 cig/d 
86 non‐smokers 
from infertility clinic 
 
≥ 10 cig/d: 
3.4ml ± 1.4 
< 10 cig/d: 
3.4ml ± 1.3 
Non‐smokers: 
3.84 
p‐value <.05 
≥ 10 cig/d: 
42.1 ± 34.3; 
< 10 cig/d: 
31.0 ± 43.4; 
38.7  
Non‐smokers: 
38.9 
p‐value N.S. 
‐‐  % abnormal 
≥ 10 cig/d: 
46.7 ± 16.6; 
< 10 cig/d: 
53.5 ± 18.8; 
Non‐smokers: 
51.5  ± 20.0 
p‐value N.S.  
Avg. Rating  
≥ 10 cig/d: 
1.9 ± .65; 
< 10 cig/d: 
2.1 ± .07; 
Non‐smokers: 
1.81  ± .57 
p‐value <.05 
 Smokers: 
21.3 nmol/L serum 
T; 
Non‐smokers: 
18.9 nmol/L 
Serum T 
p‐value </05; 
LH, FSH N.S.  
Handelsman et al., 
1984 
Austrailia  Cross‐
sectional 
119 potential sperm 
donors 
Smokers: 
2.6ml ± .3 
Non‐smokers: 
3.4 ± .2 
p‐value N.S. 
Smokers: 
64.1 ± 9.2 
non‐smokers: 
95.5 ± 8.0  
p‐value N.S.  
‐‐  Smokers: 
26.6% ± 1.5 atypical forms; 
Non‐smokers: 
25.5 ± 0.6  
p‐value N.S.  
Smokers: 
67% ± 2 
Non‐smokers: 
72% ± 2  
p‐value < .01 
Plasma LH, FSH, 
prolactin and T 
were N.S.  
Kulikauskas et al., 
1984 
USA   Cross‐
sectional 
95 > 4 cig/day 
127 non‐smokers 
from fertility clinic 
‐‐  Smokers: 
25.3 ± 27.3 
non‐smokers: 
63.6 ± 36.9  
p‐value <.01. 
‐‐  Smokers: 
27.0% ± 7.9 atypical forms; 
Non‐smokers: 
27.1 ± 6.9  
p‐value N.S 
Smokers: 
49% ± 14.8 
Non‐smokers: 
63% ± 10.0 
p‐value < .01 
‐‐ 
Vogt et al., 1984  Germany  Cross‐
sectional 
98 smokers; 
82 non‐smokers; 
healthy student 
volunteers 
Smokers: 
3.9ml ± .2.1 
Non‐smokers: 
4.1 ± 1.9 
p‐value N.S. 
Smokers: 
62.0 ± 56.9 
non‐smokers: 
70.6 ± 66.6  
p‐value N.S. 
‐‐  Smokers: 
67.7% ± 13.1 
Normal forms; 
Non‐smokers: 
67.1 ± 16.9  
p‐value N.S 
Smokers: 
72.3% ± 15.6 
Non‐smokers: 
71.3% ± 17.4 
p‐value N.S.  
Cytophotom‐etry, 
revealed no 
anomalies in the 
DNA content. 
 
Smokers had 
significantly higher 
serum T, but no 
differences in LH 
and FSH of smokers 
v. non‐smokers 
Buiatti, et al., 1984  Italy  Case‐control  112 infertile cases 
(62 smokers; 
127 “healthy” 
controls (72 
smokers) 
          Smoking OR=1.0, 
not able to 
compute 95% CI 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy, other 
measures 
Hoidas, et al., 
1985 
Scotland  Cross‐sectional  11 smokers; 
15 non‐smokers; 
Infertility clinic  
‐‐  ‐‐  ‐‐  No difference in the 
percentage of normal 
forms  
‐‐  ‐‐ 
Kulikauskas et al., 
1985 
USA  Cross‐sectional  103 ≥ 4 cig/d x 5 
years; 
135 non‐smokers; 
(19‐32 yrs old) 
Fertility clinic 
‐‐  Smokers: 
27.3 ± 27.9 
non‐smokers: 
64.2 ± 36.8  
p‐value <.001 
‐‐  % abnormal 
Smokers: 
27.0% ± 8.1; 
Non‐smokers: 
26.7 ± 7.0  
p‐value N.S 
Smokers: 
49.2% ± 15.3 
Non‐smokers: 
63.2% ± 9.8 
p‐value < .001 
‐‐ 
Karagounis, et al., 
1985 
USA  Cross‐sectional  60 1‐15 cig/d; 
340 16‐30 cig/d; 
126 >30 cig/d; 
478 non‐smokers; 
andrology lab 
‐‐  Smokers: 
58.0 ± 7.2 
non‐smokers: 
52.0 ± 9.6  
p‐value N.S. 
‐‐  1‐15 cig/day: 
83.4%  ± 3.3; 
16‐30 cig/day: 
58.5% ± 1.5; 
> 30 cig/day: 
68.5% ± 4.0; 
p‐value <.05 
‐‐  Viability: Smokers: 
61.0 ± 2.9 
non‐smokers: 
56.0 ± 5.1  
p‐value N.S. 
Vogt et al., , 1986  Germany  Cross‐sectional  150 smokers; 
36 ex‐smokers 
52 never smokers; 
from volunteer 
students 
Smokers: 
3.9ml ± .17 
ex‐smokers: 
3.8 ± .29; 
Never: 
4.2 ± .27 
p‐value N.S. 
Smokers: 
50.0 ± 4.4; 
ex‐smokers: 
63.3 ± 10.0; 
Never: 
72.9 ± 8.6; 
p‐value N.S. 
 ‐‐  % normal 
Smokers: 
68.8% ± 1.1; 
Ex‐smokers: 
65.9 ± 2.9; 
Never: 
68% ± 2.3; 
p‐value N.S 
Smokers: 
73% ± 1.3 
ex‐smokers: 
69% ± 3.0; 
Never: 
74% ± 2.3.; 
p‐value N.S. 
Smokers had 
significantly higher 
serum T than non 
smokers; no 
differences for LH 
and FSH serum levels 
Rantala & 
Koskimies, 1986 
Finland  Cross‐sectional  14 1‐10 cig/d; 
32 11‐20 cig/d 
14 >20 cig/d; 50 
non‐smokers; 
from infertility 
clinic 
‐‐  1‐10 cig/d: 
74.4 ± 51.8; 
11‐20 cig/d: 
69.5 ± 51.8; 
>20 cig/d: 
53.2 ± 42.2; 
Non‐smokers: 
74.3 ± 42.2 
p‐value N.S.  
*1‐10 cig/d: 
333.6 ± 235.4; 
11‐20 cig/d: 
262.0 ± 167.9; 
*>20 cig/d: 
166.6 ± 111.4; 
Non‐smokers: 
285.1 ± 188.6; 
*p‐value<.05 
% abnormal; 
1‐10 cig/d: 
32.2% ± 10.2; 
11‐20 cig/d: 
27.4 ± 10.7; 
>20 cig/d: 
27.7 ± 10.5; 
Non‐smokers: 
27.4% ± 10.7; 
p‐value N.S.  
1‐10 cig/d: 
63.2% ± 8.9; 
11‐20 cig/d: 
61.7% ± 13.6; 
*>20 cig/d: 
61.1% ± 10.2; 
Non‐smokers: 
64.9% ± 12.7; 
*p‐value<.01 
‐‐ 
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   Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Lahdetie, 1986  Finland  Cross‐sectional  68 infertility 
clinic, 6 fertile 
volunteers; 
20 smokers, 
subfertile, 34 
non‐smokers, 
subfertile, 5 
fertile non‐
smokers  
*Subfertile 
smokers: 
3.9 ± 1.5 
Subfertile non‐
smokers: 
4.8 ± 2.5; 
*Fertile 
nonsmoker 
3.1 ± 1.4 
p‐value <.05  
Subfertile smokers: 
87.8 ± 85.3 Subfertile 
non‐smokers: 
65.8 ± 59.1; 
Fertile nonsmoker 
98.4 ± 61.2 
p‐value N.S.  
Subfertile smokers: 
347.6 ± 469.8 Subfertile 
non‐smokers: 
295.5 ± 268.4; 
Fertile nonsmoker 
317.7 ± 221.4 
p‐value N.S 
% abnormal: 
 Subfertile smokers: 
63.5% ± 17.3 Subfertile 
non‐smokers: 
63.2% ± 16.9; 
Fertile nonsmoker 
*42.4% ± 10.0 
p‐value <.01 fertile v. sub 
‐‐  No differences in 
Micro‐ 
Nucleated  
Spermatids across 
study groups fertile 
v. infertile, smoker 
v. nonsmoker 
 
Ablin, 1986  USA  Cross‐sectional  103 smokers; 
135 non‐smokers 
‐‐  Lower for smokers v. 
non p<.01 
‐‐  No significant difference  Lower for smokers v. non 
p<.01 
‐‐ 
Effendy & 
Krause, 1987 
Denmark  Cross‐sectional  31 smokers 
62 non‐smokers 
from infertility 
clinic 
Smokers: 
3.0ml ± 2.2 
Non‐smokers: 
3.1 ± 1.8 
p‐value N.S. 
Smokers: 
26.8 ± 22.2 
non‐smokers: 
23.8 ± 28.3  
p‐value N.S.  
‐‐  % normal: 
Smokers: 
52.8% ± 15.3 ; 
Non‐smokers: 
49.5 ± 16.5  
p‐value N.S.  
% abnormal 
Smokers: 
66% ± 16 
Non‐smokers: 
59% ± 19  
p‐value N.S. 
‐‐ Ng/ml T:  
Smokers: 
6.8 ± 2.4 
non‐smokers: 
7.3 ± 9.3  
Mu/ml LH: 
Smokers: 
4.6 ± 3.7 
Nonsmokers: 
5.4 ± 3.9 
Mu/ml FSH: 
Smokers: 
5.5 ± 3.8 
Non‐smokers 
6.1 ± 5.4 
p‐values N.S 
Dikshit et al., 
1987 
India  Cross‐sectional  219 >10 cigs/d 
119 chewers 
288 nonusers 
From infertility 
clinic 
All Users: 
2.71 ± 0.06 
non‐users: 
2.82 ± 0.07  
p‐value N.S. 
All Users: 
49.8 ± 2.46 
non‐users: 
53.12 ± 2.76  
p‐value N.S. 
‐‐  % normal forms 
All Users: 
80.06% ± 0.61 
non‐users: 
80.65% ± 0.57  
p‐value N.S.  
All Users: 
60.78% ± 0.85 
non‐users: 
60.02% ± 0.95  
p‐value N.S. 
‐‐ 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and Standard Deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Klaiber et al., 
1987 
USA   Cross‐sectional  Sample 1: 
140 healthy 
volunteers; 
61 smokers , 79 non‐
smokers; 
Sample 2: 
65 infertility pts: 30 
smokers , 35 non‐
smokers 
‐‐  Sample 1: 
 smokers: 
115.8 ± 68.5 non‐
smokers: 
132.6 ± 97.1 
p‐value N.S 
Sample 2: 
Smokers: 
77.2 ± 65.4 
Non‐smokers: 
140.4 ± 114.1 
p‐value <.01 
‐‐  Sample 1 %ab: 
 smokers: 
21.6 ± 8.7 
non‐smokers: 
20.8 ± 7.5 
p‐value N.S 
Sample 2 %ab: 
Smokers: 
25.1 ± 15.9 
Non‐smokers: 
22.6 ± 8.4 
p‐value <.01 
Sample 1: 
 smokers: 
62.2% ± 17.3 non‐
smokers: 
67.3% ± 15.5 
p‐value N.S 
Sample 2: 
Smokers: 
53.0% ± 22.4 
Non‐smokers: 
65.7% ± 14.0 
p‐value <.01 
‐‐ 
Saaranen et al., 
1987 
Finland  Cross‐sectional  Community‐based 
volunteers: 
26 occasional 
smokers; 
24 regular (≤16 
cig/d); 
30  heavy (>16 cig/d); 
110 non‐smokers 
occasional: 
3.4 ± 1.7; 
regular: 
3.4 ± 1.6; 
heavy: 
2.8 ± 1.2; 
Non‐smokers: 
3.3 ± 1.7; 
p‐value <.05 for 
heavy v. regular 
only 
occasional: 
108.2 ± 85.2; 
regular: 
156.9 ± 142.3; 
heavy: 
111.7 ± 92.0; 
Non‐smokers: 
153.4 ± 133.9; 
p‐value N.S 
‐‐  % normal: 
57.9% ± 12.1; 
regular: 
54.3% ± 11.5; 
heavy: 
56.3% ± 12.3; 
Non‐smokers: 
56.2% ± 13.1; 
p‐value N.S 
Occasional: 
49.9% ± 14.1; 
regular: 
50% ± 15.4; 
heavy: 
52.5% ± 13.8; 
Non‐smokers: 
52.4% ± 12.7; 
p‐value <.01for heavy v. 
non – started out better 
and decrease more 
rapidly.  
‐‐ 
Klaiber & 
Broverman, 1988 
USA  Cross‐sectional  22 smokers; 
21 non‐smokers; 
Volunteer subjects 
‐‐  Smokers: 
110.6 ± 118.6; 
118.3 ± 75.5; 
p‐value N.S. 
‐‐  % abnormal: 
Smokers: 
20.5 ± 8.9; 
Non‐smokers 
21.9 ± 7.0; 
p‐value N.S. 
Smokers: 
63.7 ± 19.1; 
Non‐smokers: 
65.7 ± 14.0 
Estradiol higher v. 
non‐smokers; 
serum T levels not 
different 
Stachel et al., 
1989 
Germany  Cross‐sectional  51 smokers; 
29 non‐smk 
volunteers 
‐‐  No significant 
relationship  
‐‐  ‐‐  ‐‐  ‐‐ 
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Saaranen et al., 
1989 
Finland  Cross‐
sectional 
28 smokers; 
32 non‐smokers; 
From infertility 
clinic and partners 
of pregnant 
women 
smokers:  
3.1 ± 1.5 
Non‐smokers: 
3.1 ± 1.6 
p‐value N.S. 
smokers:  
101.2  ± 85.3 
Non‐smokers: 
127.7 ± 129.9 
p‐value N.S. 
‐‐  % normal: 
Smokers: 
52.6%  ± 14.4 
Non‐smokers: 
49.8% ± 15.8 
p‐value N.S. 
smokers:  
44.6  ± 16.4 
Non‐smokers: 
44.2 ± 16.3 
p‐value N.S. 
‐‐ 
Attia et al., 1989  Egypt  Cross‐
sectional 
50 heavy smokers; 
35 never smk; 
(18‐40 yrs); 
Recruited from 
dental clinics 
‐‐  ‐‐   ‐‐  ‐‐  ‐‐  Smokers: 
Estradiol pcg/ml: 
59.8 ± 10.1; 
Non‐smokers: 
48.6 ± 4.8; no 
differences in 
serum T levels 
Marshburn et al., 
1989 
USA   Cross‐
sectional 
44 >20 cig/d; 
108 ≤ 20 cig/d; 
294 non‐smokers; 
From infertility 
clinic 
>20 cig/d: 
3.0.2 ± 0.2; 
≤ 20 cig/d; 
2.6 ± 0.1; 
Non‐smokers: 
3.1 ± 0.1; 
p‐value <.01 
>20 cig/d: 
76.0 ± 8.1; 
≤ 20 cig/d; 
79.7 ± 4.9; 
Non‐smokers: 
85.4 ± 3.0; 
p‐value N.S.  
‐‐  % abnormal: 
>20 cig/d: 
30% ± 1.7; 
≤ 20 cig/d; 
29% ± 1.2; 
Non‐smokers: 
28% ± 0.6; 
p‐value N.S. 
>20 cig/d: 
56% ± 3.8; 
≤ 20 cig/d; 
58% ± 1.8; 
Non‐smokers: 
61% ± 1.0; 
p‐value N.S 
Significant joint 
effect of heavy 
smoking and 
drinking >4 cups of 
coffee per day (p‐
value <.001) 
Oldereid et al., 
1989 
Norway  Cross‐
sectional 
68 1‐14 cig/d; 
79 >14 cig/d; 
203 non‐smokers; 
From infertility 
clinic 
>14 cig/d: 
4.0 (1.1‐9.2); 
1‐14 cig/d: 
4 (1‐8.7); 
Non‐smokers: 
4 (.5‐9.5); 
p‐value N.S. 
>14 cig/d: 
63 (1‐300); 
1‐14 cig/d: 
61 (1‐352); 
Non‐smokers: 
53 (2‐430); 
p‐value N.S. 
>14 cig/d: 
225 (4‐2145); 
1‐14 cig/d: 
212 (3‐1265); 
Non‐smokers: 
231 (2‐2695); 
p‐value N.S. 
% abnormal: 
>14 cig/d: 
61% (15‐83); 
1‐14 cig/d: 
56% (17‐95); 
Non‐smokers: 
61% (18‐97); 
p‐value N.S. 
 >14 cig/d: 
51% (5‐96); 
1‐14 cig/d: 
52% (8‐92); 
Non‐smokers: 
53% (4‐99); 
p‐value N.S. 
Flow cytometry did 
not reveal 
differences in DNA 
condensa‐ 
tion in smokers v. 
non‐smoker 
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy, other 
measures 
Close, et al., 
1990 
USA  Cross‐sectional  22 smokers; 
142 non‐smokers; 
Infertility clinic  
‐‐  Smokers: 
66.7 ± 53.0 
non‐smokers: 
68.1 ± 68.4  
p‐value N.S.  
‐‐  ‐‐  Smokers: 
45.6% ± 22.2 
Non‐smokers: 
44.6% ± 24.7 
p‐value N.S.  
 Median # 
leukocytes: 
Smokers: 
6 (0‐20) 
Non‐smokers: 
3 (0‐52) 
p‐value <.05; 
Sperm penetration 
assays were 
abnormal for all 
smokers 
Holzki et al., 
1991 
Germany  Cross‐sectional  40 smokers; 
22 non‐smokers; 
Infertility clinic 
Smokers: 
3.1 ± 1.3 
non‐smokers: 
3.7 ± 1.4  
pvalue=.05 
Smokers: 
82.7 ± 54.7 
non‐smokers: 
73.3 ± 53.4  
p‐value N.S. 
Smokers: 
255.1 ± 176.5 
non‐smokers: 
272.6 ± 253.5  
p‐value N.S. 
% normal: 
Smokers: 
64.2% ± 11.0;; 
Non‐smokers: 
61.1 ± 13.7  
p‐value N.S 
Smokers: 
38.8% ± 14.8 
Non‐smokers: 
37.6% ± 14.6 
p‐value N.S.  
‐‐ 
Dunphy, et al., 
1991 
UK  Cross‐sectional  330 couples: 
25 > 20 cigs/d; 
53 11‐20 cig/d 
58 ≤ 10 cig/d; 
194 non‐smokers 
from infertility 
clinic 
no  no  no  no  no  ‐‐ 
Lewin et al.,  
1991 
Israel  Cross‐sectional  40 40+ cigs/d; 
38 30‐39cig/d; 
157 20‐29 c/d; 
57 10‐19 c/d; 
382 0 cig/d; 
infertility clinic, 
w/infertile men 
removed from 
study 
‐‐  40+ cig/d: 
48 ± 5.1; 
30‐39 cig/d: 
50 ± 5.6; 
20‐29 cig/d: 
43 ± 2.2; 
10‐19 cig/d: 
53 ± 4.0; 
Non‐smokers: 
55 ± 1.7; 
p‐value N.S. 
 ‐‐  ‐‐  40+ cig/d: 
51 ± 2.3; 
30‐39 cig/d: 
44 ± 2.1; 
20‐29 cig/d: 
45 ± 1.1; 
10‐19 cig/d: 
47 ± 2.1; 
Non‐smokers: 
46 ± 0.7; 
p‐value N.S. 
Sperm penetration 
assay (%): 
40+ cig/d: 
30 ± 5.6; 
Nonsmokers: 
33 ± 1.8; 
p‐value N.S. 
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Gerhard, et al., 
1992 
Germany  Cross‐
sectional 
 
 
212 men seeking 
infertility treatment 
whose wives 
ovulated and did 
not have a tubal 
blockage  
 no  no  no  no  no  Serum T (pg/ml): 
Smokers: 
127.22 
Non‐smoke: 
98.72 
(p<.01) 
LH mU/ml: 
Smokers: 
126.61 
Non‐smoke: 
105.13  
(p<.01) 
Prolactin (ng/ml): 
Smokers: 
90.23 
Non‐smoke: 
123.83 
(p<.001) 
Estradiol (pg/ml): 
Smokers: 
129.79 
Non‐smoke: 
102.71 
(p<.01) 
Oldereid, et al., 
1992 
Norway  Cross‐
sectional 
252 men attending 
infertility clinic: 
49 ≥ 15 cig/d 
46 <15 cig/d 
145 non‐smokers 
‐‐  ≥ 15 cig/d: 
74.9 ± 10.6; 
<15 cig/d: 
76.5 ± 9.1; 
Non‐smoker:    
87.5 ± 6.9 
p‐value N.S.  
 
‐‐  % abnormal: 
≥ 15 cig/d: 
56.4 ± 2.7; 
<15 cig/d: 
56.9 ± 2.9; 
Non‐smoker:    
55.0 ± 1.8 
p‐value N.S.  
≥ 15 cig/d: 
22.4 ± 1.9; 
<15 cig/d: 
21.1 ± 2.0; 
Non‐smoker:    
22.2 ± 1.4 
p‐value N.S.  
‐‐ 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Osser et al., 1992  Sweden  Cross‐sectional  75 >19 cigs/d: 
84 10‐19 cig/d 
27 1‐9 cig/d; 
164 non‐smokers 
From infertility clinic 
 
>19 cig/d: 
3.2 ± 0.2; 
10‐19 cig/d: 
3.5 ± 0.2; 
1‐9 cig/d: 
3.7 ± 0.3; 
Non‐smokers: 
3.7 ± 0.1; 
P<.05 for heavy v. 
nonsmoker 
>19 cig/d: 
66.6 ± 6.1; 
10‐19 cig/d: 
74.5 ± 6.5; 
1‐9 cig/d: 
87.8 ± 11; 
Non‐smokers: 
74.9 ± 4.3; 
P<.01 for heavy v. 
nonsmoker 
>19 cig/d: 
213 ± 21; 
10‐19 cig/d: 
261 ± 24; 
1‐9 cig/d: 
325 ± 30; 
Non‐smokers: 
277 ± 25; 
p‐value N.S.  
% abnormal: 
>19 cig/d: 
51.8 ± 1.6; 
10‐19 cig/d: 
47.9 ± 1.6; 
1‐9 cig/d: 
48.9 ± 2.9; 
Non‐smokers: 
49.9 ± 1.2; 
p‐value N.S. 
>19 cig/d: 
46.0 ± 2.2; 
10‐19 cig/d: 
47.3 ± 1.8; 
1‐9 cig/d: 
46.9 ± 2.8; 
Non‐smokers: 
49.6 ± 2.3; 
p‐value N.S. 
‐‐ 
Parazzini et al., 
1993 
Italy  Case‐ 
control 
97 cases were 
infertile men from 
infertility clinic; 
Two ctrl grps: 
1. 121 men from 
infertile couple 
w/normal sperm 
studies; 2. 105 
partners with recent 
delivery 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐Ctrl grp 1: 
< 15 cig/d v. never 
smoke: 
OR=0.7 (95% 
CI:.0.3‐1.6) 
≥15 cig/d v. never 
smoke: 
OR=3.2(95% CI:1.4‐
7.2) 
p‐value=.05 
Ctrl grp 2: 
< 15 cig/d v. never 
smoke: 
OR=1.3 (95% 
CI:.0.5‐3.5) 
≥15 cig/d v. never 
smoke: 
OR=2.2(95% CI:0.6‐
5.2) 
p‐value <.05 
Controlled for age, 
ed, coffee and 
etoh 
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Pacifici et al., 1993  Italy  Cross‐
sectional 
44 smokers ages 18‐
50 yrs; 
50 non‐smokers ages 
18‐45 yrs from 
infertility  clinic  
Smokers: 
4.1ml ± 1.6 
Non‐smokers: 
4.1 ± 1.7 
p‐value N.S. 
Smokers: 
40.1 ± 29.0 
non‐smokers: 
38.2 ± 31.8  
p‐value N.S. 
‐‐  % abnormal: 
Smokers: 
45.5% ± 16.2; 
Non‐smokers: 
47.5 ± 18.8  
p‐value N.S. 
Smokers: 
38.2% ± 19.5 
Non‐smokers: 
47.0% ± 19.6  
p‐value < .01 
‐‐ 
Banerjee, et al., 1993  India  Cross‐
sectional 
40 smokers; 
29 chewers; 
8 multiple; 
21 neither from 
infertility clinic pts. 
Smokers: 
3.3ml ± .2 
Chewers: 
3.3 ± .1; 
Multiple: 
3.1 ± .10; 
Neither: 
3.1 ± .08 
p‐value N.S. 
 Smokers: 
46.1ml ± 2.3 
Chewers: 
41.2 ± 4.3; 
Multiple: 
40.2 ± 6.6; 
Neither: 
48.4 ± 3.5 
P<.05 for all three 
groups v. neither 
Smokers: 
125.4ml ± 18.65; 
Chewers: 
105 ± 14.20; 
Multiple: 
121.83 ± 6; 
Neither: 
155 ± 11.12; 
p‐value <.05 for all three 
groups v. neither 
% abnormal 
Smokers: 
7.03% ± 0.18; 
Chewers: 
4.35% ± 0.42; 
Multiple: 
9.62% ± 0.18; 
Neither: 
2.57% ± 0.12; 
p‐value <.05 for all three 
groups v. neither  
Smokers: 
61.3% ± 1.96; 
Chewers: 
40.6% ± 5.46; 
Multiple: 
63.4% ± 2.6; 
Neither: 
62.36% ± 2.0 
p‐value <.05 for chewers 
v. neither 
 
‐‐ 
Hughes et al., 1994  Canada  Cross‐
sectional 
316 couples 
attempting IVF 
‐‐  Prewash sperm 
concentration: 
Smokers: 
108; non‐smokers: 130 
Postwash sperm 
concentrations 
Smokers: 
17.1; non‐smokers: 21.6 
p‐value <.01 
‐‐  no  no  ‐‐ Fertility rates for 
smokers and non‐
smokers did not 
differ 
Vine et al., 1994  USA  Meta‐ 
analysis 
20 studies published 
from 1966 to 
October, 1992 
‐‐  Smokers 13‐17% lower 
(95% CI: 8.9‐21.5) 
‐‐  ‐‐  ‐‐  ‐‐ 
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or 
 % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Chia, et al., 
1994 
Singapore  Cross‐sectional  137 smokers; 
473 non‐smokers; 
Infertility clinic  
Age 22‐55 yrs 
Smokers: 
2.7; 
Non‐smokers: 
2.6  
p‐value N.S. 
Smokers: 
15.8; 
Non‐smokers: 
20.2; 
p‐value<.05 
‐‐  % normal 
Smokers: 
12.3%; 
Non‐smokers: 
15.5%; 
p‐value <.001 
 
Smokers: 
39.6; 
Non‐smokers: 
39.2; 
P‐value N.S.  
‐‐ 
Wyrobek et al., 
1995 
Czech  
Republic 
Cross‐sectional  15 >20 cig/d & 
>1000ng>mL 
nicotine; 
15 non‐smokers; 
(19‐32 yrs old) 
Volunteer from army 
enlistment 
registration 
no  no  no  no  no  Smokers produce 
more aneuploid 
sperm than non‐
smokers: 
YY8 (p<.05), 8‐8, X 
or Y, (p<.05) and 
total hyper‐ 
Haploid freqs 
(p<.05) 
Mulla, et al., 
1995 
Not reported  Cross‐sectional  30 infertile pts 
w/varicocele; 
30 infertile pts 
smoking >10 cig/day; 
20 healthy, fertile 
non‐smoking 
volunteers with 
normal 
spermiograms 
Varicocele: 
4.0ml ± 1.6; 
Smokers: 
4.0ml ± 1.9; 
Fertile: 
4.0ml ± 1.6; p‐
value N.S. 
Varicocele: 
33.0 ± 35.9; 
Smokers: 
46.7 ± 40.0; 
Fertile: 
96.0 ± 62.1  
p‐value <.001. 
‐‐  % normal 
Varicocele: 
18.8%  ± 14.3; 
smokers: 
27.2% ± 11.6; 
Fertile: 
37.5% ± 9.5; 
p‐value <.05 
Varicocele: 
40.9%  ± 16.7; 
smokers: 
49.5% ± 15.5; 
Fertile: 
59.9% ± 16.5; 
p‐value <.05 (only for 
fertile v. varicocele) 
Acrosine activity 
Varicocele: 
53.5%  ± 20.0; 
smokers: 
68.1% ± 14.3; 
Fertile: 
76.6% ± 13.6; 
p‐value <.05 
Goverde, et al., 
1995 
Netherlands  Case‐ 
control 
47 defined as 
infertile by WHO; 68 
ctrls with nl. WHO 
spermiograms 
‐‐   ‐‐   ‐‐     ‐‐    ‐‐   Light smk: 
OR=1.22; 
Heavy smk: 
OR=2.19 
(hand calcs) 
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   Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study 
 Design 
Study 
Population 
Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy 
Pakrashi &  
Chatterjee, 1995 
India  Cross‐sectional  29 smokers;  
25 chewers; 
30 non‐
smokers; 
From andrology 
lab  
 
 
* Note: 
All values 
reported in last 
column are 
statistically 
significant 
(p<.0001) for 
smokers v. non‐
smokers; the 
only significant 
difference 
between 
chewers and 
non‐users was 
in epididymal 
function  
‐‐   ‐‐   ‐‐   ‐‐  ‐‐   ‐‐ S. Vesicles 
1. A. Sugar :  
Smokers: 
2.4 ± 0.1 
Chewers: 
4.1 ± 0.2; 
Nonsmokers: 
4.0 ± 0.3 
2. Phosphate 
Smokers: 
59 ± 3 
Nonsmokers: 
119 ± 5 
Prostate 
1.Acid Phos:  
Smokers: 
1428 ± 120; 
Nonsmokers: 
3450 ± 157 
2. Zinc 
Smokers: 
7.0 ± 0.4; 
Nonsmokers: 
12.5 ±0. 5 
Epidiymis 
Smokers: 
10.6 ± 0.3; 
Nonsmokers: 
12.5 ± 0.6 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study  
Design 
Study 
Population 
Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy 
Sofikitis et al., 1995  USA   Cross‐sectional  Sample 1: 
49 21‐38 yrs, 
Smoked >20 
cig/d x ≥ 3yrs; 
Sample 2: 
28 18‐44 yrs, 
non‐smokers; 
One‐month 
prior to hernia 
repair 
operation 
Sample 1: 
2.6 ± 0.7; 
Sample 2: 
2.5 ± 0.6; 
p‐value N.S. 
 
Sample 1: 
33 ± 14  
Sample 2: 
38 ± 12 
p‐value N.S. 
‐‐  %  normal 
Sample 1: 
 38% ± 11; 
Sample 2: 
65%  ± 9 
p‐value <.05 
Sample 1: 
42% ± 11  
Sample 2: 
69% ± 10 
p‐value <.05 
‐‐ Testicular 
Testosterone 
(ng/ml) 
Sample 1: 
402 ± 124  
Sample 2: 
693 ± 201 
Hypoosmotic 
swelling test 
Sample 1: 
48% ± 12  
Sample 2: 
73& ± 10 
Sperm 
Penetration: 
Sample 1: 
36 ± 15  
Sample 2: 
65 ± 9 
Acrosine activity: 
Sample 1: 
12 ± 5  
Sample 2: 
31 ± 8 
All comparisons p‐
value <.05 
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  Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy 
Keck et al., 1995 
 
Germany  Cross‐
sectional  
44 infertility pts. 
w/normal semen 
analysis; 
118 infertility pts 
w/variable semen 
quality 
Smokers: 
4.0 ± 1.6; 
Non‐smk: 
4.3 ± 1.7; 
p‐value N.S. 
 
Smokers: 
60.0 ± 1.6; 
Non‐smokers: 
42.8 ± 42.6; 
p‐value N.S. 
 
Smokers: 
60.0 ± 1.6; 
Non‐smokers: 
42.8 ± 42.6; 
p‐value N.S. 
 
% normal 
Smokers: 
26.7 ± 14.4; 
Non‐smokers: 
24.4 ± 14.9; 
p‐value N.S. 
 
no  ‐‐ 
Omu et al., 1995  Kuwait  Cross‐
sectional 
50 males attending 
infertility clinic 
Smokers: 
2.6 ± 0.5; 
Non‐smk: 
2.5 ± 0.5; 
p‐value N.S. 
Smokers: 
49.2 ± 18.4; 
Non‐smk: 
44.9 ± 19.2; 
p‐value N.S. 
 
‐‐  % abnormal 
Smokers: 
33.8 ± 9.4; 
Non‐smk: 
31.4 ± 7.6; 
p‐value N.S. 
Smokers: 
54.3 ± 17.7; 
Non‐smk: 
55.4 ± 21.7; 
p‐value N.S. 
 
‐‐ 
Hossain et.al, 
1997 
USA   Cross‐
sectional 
107 semen 
samples from  
IVF center 
‐‐  ‐‐  ‐  % normal 
Smokers: 
34%; 
Non‐smk: 
34%; 
p‐value N.S. 
‐‐  ‐‐ 
Telisman et al., 
2000 
Croatia  Cross‐
sectional 
149 healthy male 
industrial workers 
r=0.018 
p‐value N.S. 
r=‐0.058 
p‐value N.S.  
r=‐0.047 
p‐value N.S. 
r=0.028 
p‐value N.S. 
‐‐  ‐‐ 
Gaspari et al., 
2003 
Italy   Cross‐ 
sectional 
182 men from 
infertility clinic 
88 never smk 
69 smoker 
22 ex‐smoke 
‐‐  ‐‐  ‐‐‐  ‐‐‐  ‐‐  PAH‐DNA adducts 
Smoker: 
1.6 ± 0.8; 
Nev smoke 
1.6 ± 0.7; 
Ex‐smoke 
1.7 ± 0.6 
p‐value N.S. 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and 95% confidence intervals or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Fraga et al., 1996  USA/ 
Argentina 
Cross‐sectional  22 smokers (>10 
cig/d); 
29 non‐smokers; 
Multiple sources 
‐‐  ‐‐  Smokers: 
279 ± 68; 
Non‐smokers: 
358 ± 68 
p‐value N.S.  
‐‐  ‐‐  ‐‐Oxo8dG 
(FMOL/MG DNA) 
Smokers: 
22 ± 1.8; 
Non‐smokers: 
6.7 ± 0.5; 
p‐value <.01 
Alpha‐toco 
Smokers: 
0.26 ± 0.02; 
Non‐smokers: 
0.38 ± 0.05; 
p‐value <.05 
Ascorbic Acid 
(µM) 
Smokers: 
246 ± 40; 
Non‐smokers: 
296 ± 24; 
p‐value N.S 
Vine et al., 1996  USA  Cross‐sectional  25 heavy smokers (≥ 
20 cigs/day) ; 
23 light smokers (1‐
19/day) x 1 year; 
40 non‐smokers; 
(18‐40 yrs); 
Community 
volunteers  
aged matched 
Heavy: 
2.9 ± 1.3; 
Light: 
2.5 ± 1.0 
Non: 
3.1 ± 1.8; 
P‐value N.S.  
Heavy: 
71.6 ± 59.7; 
Light: 
73.5 ± 55.3; 
Non: 
93.9 ± 70.2; 
p‐value N.S.  
************** 
# cig/d, semen cotinine, 
# yrs smoked p<.05 
Heavy: 
189.7 ± 157.5; 
Light: 
165.4 ± 126.0; 
Non: 
276.2 ± 246.2; 
p‐value N.S. 
***************** 
semen cotinine, # yrs 
smoked p<.05 
% abnormal: 
Heavy: 
24.2 ± 10.9; 
Light: 
22.4 ± 8.8; 
Non: 
22.3 ± 9.9 
p‐value N.S.  
************** 
# yrs smoked p<.05 
Heavy: 
54.0 ± 16.3; 
Light: 
48.9 ± 14.8; 
Non: 
52.8 ± 17.2; 
p‐value N.S. 
*************** 
semen cotinine, # yrs 
smoked p<.05 
‐‐ 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or   
 % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy 
Shen, et al., 1997  China  Cross‐sectional  28 smokers; 
32 non‐smokers; 
volunteers 
Smokers: 
2.6 ± 1.50 
non‐smokers: 
2.9 ± 1.52  
p‐value N.S. 
Smokers: 
70.5 ± 2.39 
non‐smokers: 
70.2 ± 2.19  
p‐value N.S.  
Smokers: 
182.2 ± 2.52 
non‐smokers: 
202.9 ± 2.2  
p‐value N.S. 
% normal head: 
Smokers: 
26.5% ± 1.5; 
Non‐smokers: 
23.4 ± 1.5  
p‐value N.S 
Smokers: 
41.3% ± 1.9 
Non‐smokers: 
50.7% ± 1.3 
p‐value N.S.  
8‐OHdG/105 dG 
Smokers: 
6.2 ± 1.7 
non‐smokers: 
3.9 ± 1.3  
p <.001 
Vine et al., 1997  USA  Cross‐sectional  40 ≥ 20 cigs/d  
23 1‐19 cig/d;  
40 non‐smokers; 
18‐35  yr old 
volunteers 
‐‐  ‐‐  ‐‐  No association between 
smoking and means, SD or 
skewness of any of 9 
morphometric indices  
‐‐  ‐‐ 
Robbins, et al., 
1997 
USA  Cross‐sectional  10 heavy 
smokers (≥ 20 
cigs/day) ; 
7 light smokers 
(1‐19/day) x 1 
year; 
28 non‐smokers; 
(18‐40 yrs); 
Community 
volunteers  
‐‐  no  ‐‐  no  no  XY18 
Heavy: 
12.0 ± 8.1; 
Light: 
8.0 ± 4.4; 
Non: 
10.4 ± 7.8; 
p‐value=.07 
YY18 
Heavy: 
1.1 ± 1.3; 
Light: 
1.0 ± 1.1; 
Non: 
1.7 ± 2.9 
p‐value N.S. 
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study  
Design 
Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Zavos, et al., 1998   Greece  Cross‐sectional 
 
 
20 men 25‐35 yrs 
old, smoked >30 
cig/d x 3 yrs; 
20 men 23‐36 yrs 
old, 
Never smoked 
From infertility 
clinic 
Smokers: 
2.8 ± 0.4; 
non‐smokers: 
3.1 ± 0.5  
p‐value N.S. 
Smokers: 
54.3 ± 5.7; 
non‐smokers: 
65.6 ± 6.1  
p‐value N.S. 
‐‐  ‐‐  Smokers: 
58.7% ± 8.1 
Non‐smokers: 
72.3% ± 8.3 
p‐value N.S. 
‐‐ Progressive 
motility (grade 0‐4) 
at 0, 12 & 48 hrs. 
Smokers (0) : 
2.9 ± 0.4; 
smokers (12): 
2.2 ± 0.4; 
smokers (48): 
0.5 ± 0.2; 
Non (0) : 
3.4 ± 0.3; 
Non (12): 
3.3 ± 0.3; 
Non (48): 
2.0 ± 0.1 
Rubes, et al., 
1998 
Czech  
Republic 
Cross‐sectional  10 men smoked 
20+  cig/d; 15 non‐
smokers 18 yrs old, 
living in Teplice, CR 
and reporting for 
military 
registration 
Smokers: 
1.3 ± 0.2; 
non‐smokers: 
1.9 ± 0.2  
p‐value N.S. 
smokers: 
53.1 ± 11.6; 
non‐smokers: 
90.2 ± 24.7  
p‐value N.S.  
‐‐  % normal 
Smokers: 
15.8 ± 15; 
non‐smokers: 
16.9 ± 1.5  
p‐value N.S. 
smokers: 
29.1 ± 7.0; 
non‐smokers: 
32.3 ± 4.6  
p‐value N.S. 
Disomy X 
smokers: 
5.9 ± 0.8; 
non‐smokers: 
5.8 ± 0.6 
Disomy Y 
smokers: 
4.5 ± 0.6; 
non‐smokers: 
2.2 ± 0.3 p<.05 
% COMP smokers: 
11.1 ± 2.2; 
non‐smokers: 
14.1 ± 1.6 p‐value 
N.S 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Zavos, et al., 
1998 (b) 
Greece  Cross‐sectional  29 smokers (> 20 
cigs/d 
x 10+ years); 
15 non‐smokers 
from infertility 
clinic 
Smokers: 
3.8 ± 0.2; 
non‐smokers: 
3.8 ± 0.5  
p‐value N.S. 
‐‐  Smokers: 
187.4 ± 4.0 
non‐smokers: 
235.5 ± 36.2  
P<.05 
% normal head: 
Smokers: 
59.2% ± 2.3; 
Non‐smokers: 
81.6 ± 2.5  
P<.05 
Smokers: 
56.4% ± 3.0 
Non‐smokers: 
71.0% ± 5.6 
P<.05 
Axonemal 
assessment 
Intact components: 
Smokers: 
1%; 
Non‐smokers: 
73.4% 
Ultrastructure 
abnormality: 
Smokers: 99%; 
Non‐smokers: 
26% 
P<.05 
Chia et al., 
1998 
Singapore  Cross‐sectional  91 smokers; 
152 non‐smokers 
w/pregnant 
female partner 
Community 
volunteers 
Smokers: 
1.9± 1.0; 
non‐smokers: 
2.6 ± 1.4  
P<.001 
Smokers: 
40.7± 3.1; 
non‐smokers: 
47.3 ± 2.6  
p‐value N.S. 
‐‐  % normal  
Smokers: 
18.7± 9.5; 
non‐smokers: 
20.9 ± 11.1  
p‐value N.S. 
‐‐  % Viabile 
Smokers: 
73.6 ± 14.0; 
non‐smokers: 
73.6 ± 1336  
p‐value N.S. 
Omu et al., 
1998 
Kuwait  Cross‐sectional  17 ≥20 cig/d; 
23< 20 cig/d; 
40 non‐smokers 
all age matched 
from infertility 
clinic 
 ≥20 cig/d: 
2.7± 0.6; 
< 20 cig/d 
2.9 ± 0.4 ; 
Non‐smokers: 
2.9 ± 1.2  
p‐value N.S. 
 
 
≥20 cig/d: 
49.1± 45.2; 
< 20 cig/d 
59.6 ± 47.3 ; 
Non‐smokers: 
61.0 ± 42.7  
p‐value N.S.,  
 
 ‐‐  % abnormal: 
≥20 cig/d: 
31.4± 8.9; 
< 20 cig/d 
26.6 ± 10.4 ; 
Non‐smokers: 
25.6 ± 6.9  
p‐value N.S. but <.05 for 
smokers v. non‐smokers & 
heavy v. light 
no  Serum T 
(pmol/L): 
Smokers: 
14.3± 2.1; 
Non‐smokers: 
18.4± 2.5 
P<.05 
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   Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study 
 Design 
Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Merino et al., 
1998 
Mexico  Cross‐sectional  (A)57 1‐ 10 cig/d; 
(B)115 ≤ 20 cig/d; 
(C)25 <20 cig/d; 
161 non‐smokers 
from infertility 
clinic 
 
Grp A: 
2.8 ml; 
Grp B: 
2.5; 
Grp C: 
3.0 
Non‐smokers: 
2.0 
p‐value N.S. 
Grp A: 
116 ± 61; 
Grp B: 
155 ± 71; 
Grp C: 
164 ± 71; 
non‐smokers: 
146 ± 68 
p‐value <.05 for A v. 
Non‐smokers  
‐‐  % normal  
Grp A: 
39% (25‐78); 
Grp B: 
43% (16‐68); 
Grp C: 
36% (25‐74); 
non‐smokers: 
46% ± 68 
p‐value <.01 
 
Grp A: 
42 ± 11; 
Grp B: 
45 ± 13; 
Grp C: 
37 ± 15; 
non‐smokers: 
47 % ± 13 
p‐value <.05  
‐‐ 
Potts et al., 1999  UK  Cross‐sectional  >10 cigs/day = 
smokers (n not 
reported); 
No cigarettes= 
non‐smokers (n 
not reported) total 
sample size 35.  
from fertility clinic 
– nl. Sperm only 
‐‐  . ‐‐  ‐‐  ‐‐  ‐‐  % difference of 
DNA strand breaks 
Smokers: 
11.9 ± 3.68; 
Non‐smokers: 
19.32 ± 7.68; 
p< .05 
Zenes et al., 
1999 
Canada  Cross‐sectional  11 > 20 cig/day; 
12 non‐smokers 
for IVF with female 
factor infertility 
no  no  no  no  no 
 
Staining intensity 
score 
Smokers: 
1.73 ± 0.09 
Non‐smkers: 
0.93 ± 0.10 
p‐<.0001 
Al‐Bader et al., 
1999 
Kuwait  Cross‐ 
sectional 
47 heavy smk; 
40 light smk; 
38 no smk; 
16 fertile 
“controls” w/ 
pregnant wives 
‐‐  H: 49 ± 44; 
L: 59 ± 45; 
NS: 61 ± 43; 
C: 63 ± 46; 
p‐value=.05 
‐‐  % normal 
H: 55% ± 11; 
L: 69% ± 10; 
NS: 72% ± 9; 
C: 76% ± 7; 
p‐value=.05 
H: 35% ± 23; 
L: 39% ± 14; 
NS: 40% ± 14; 
C: 40% ± 13; 
p‐value=.05 
Sperm antibodies 
H: 17; 
L: 8; 
NS: 5; 
C: 7; 
p‐value <.05 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or 
 % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Harkonen et al., 
1999 
Denmark  Cross‐sectional  9 smokers; 
2 ex‐smokers; 
19 non‐smokers 
Health Danish farmer 
vol. 
ages 29‐49 
‐‐  Smoker: 
48.9± 25.9; 
Ex‐smoker: 
90.0; 
Non‐smoker: 
91.6± 49.6; 
P<.02 
‐‐  ‐‐  ‐‐  Aneuploid  
1‐1‐7 Smoker: 
13.3± 9.5; 
Ex/non: 
10.5± 3.2 
P=.02 
Chia et al., 2000  Singapore  Case‐control  Cases: 218  men 
w/initial screening 
for infertility (138 
smokers, 80 non‐
smokers) 
Controls: 240 fertile 
men (91 smokers, 
149 non‐smokers) 
‐‐     ‐‐   ‐‐   ‐‐  ‐‐ OR smoking v. 
non‐smoking = 2.96 
(95% CI=1.98, 
4.42), controlling 
fro age, etoh 
status, and 
occupation 
Sergerie, et al., 
2000 
Canada  Cross‐sectional  11 heavy; 
17 light; 
69 non‐smoking 
volunteers from 
sperm donor bank 
Heavy: 
2.0(.9‐5.0); 
Light: 
2.2 (1.1‐3.7); 
Non: 
2.5 (.4‐8.0) 
p‐value N.S. 
Heavy: 
82.0(13.5‐311.0); 
Light: 
86 (3.5‐274); 
Non: 
57 (1‐412) 
p‐value N.S. 
‐‐  % normal 
Heavy: 
76.0%(610‐91.0); 
Light: 
77% (56‐91); 
Non: 
7% 79 (55‐90) 
p‐value N.S. 
Heavy: 
55.0%(11‐80); 
Light: 
60% (20‐78); 
Non: 
55% (6‐845 
p‐value N.S. 
DNA fragment 
measured by 
modified TUNEL  
Heavy: 
12.11(95% CI:3.67‐
17.87); 
Light: 
11.66% (95% CI: 
7.64‐28.64); 
Non: 20.41% (95% 
CI: 14.86‐24.92 
p‐value N.S. 
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   Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Wong, et al., 2000  Nether‐ 
lands 
Case‐control  107 fertile men from 
midwifery practices; 
103 subfertile men 
with documented 
sperm count <20 
million/mL  
‐‐   Seminal cotinine r: 
‐0.06 (N.S.) 
‐‐  Seminal cotinine r: 0.02 
 p‐value NS 
Seminal cotinine r: 
0.19 p<.01 
OR for smoking v. 
non‐smoking = 1.7 
(95% CI: 0.9 – 3.6) 
p‐value N.S. 
Mak, et al., 2000  Canada  Cross‐sectional  87 non‐azoospermic 
infertile men: 
18 regular smokers 
(6‐40 cig/day); 
69 non‐smokers; 
20 fertile “controls” 
‐‐  Smokers: 
20.8 ± 3.3; 
Non‐smokers: 
31.9 ± 6.1; 
Fertile Controls:  
61.4 ± 3.2 
P<.001 
 
‐‐  % normal: 
Smokers: 
44.3 ± 1.9; 
Non‐smokers: 
48.2 ± 2.1; 
Fertile Controls:  
56.5 ± 2.9 
P<.05 
 
Smokers: 
34.0 ± 4.5; 
Non‐smokers: 
29.8 ± 2.2; 
Fertile Controls:  
61.4 ± 3.2 
P<.001 
 
% retained 
cytoplasm 
Smokers: 
12.9 ± 1.7; 
Non‐smokers: 
8.1 ± 0.9; 
Fertile Controls:  
3.2 ± 0.4 
P<.001 
 
Zhang, et al., 
2000 
China  Cross‐sectional  65 >20 cig/d; 
68 11‐20 cig/d 
58 1‐10 cig/d; 
110 non‐smokers 
From infertility clinic 
ages 25‐43 years 
 
  
*>20 cig/d: 
2.1± 0.11; 
11‐20 cig/d 
2.5 ± 0.1 ; 
1‐10 cig/d: 
2.6 ± 0.1 
Non‐smokers: 
2.7 ± 0.1  
* p‐value 
<.05 v. non‐
smokers 
 *>20 cig/d: 
42.9± 2.9; 
11‐20 cig/d 
43.2 ± 1.9 ; 
1‐10 cig/d: 
47.1 ± 2.2 
Non‐smokers: 
52.1 ± 2.5  
* p‐value 
<.05 v. non‐smokers 
‐‐  ‐‐   Forward progression 
grade: 
*>20 cig/d: 
2.4± .04; 
11‐20 cig/d 
2.5 ± .03 ; 
1‐10 cig/d: 
2.6 ± .05 
Non‐smokers: 
2.7 ± .07  
* p‐value 
<.05 v. non‐smokers 
‐‐ 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Wallock et al., 
2001 
USA   Cross‐sectional  24 smokers (12‐26 
cig/d); 
24 non‐smokers  
Volunteers from 
20‐50 years of age 
Smokers: 
3.7 ± 1.9; 
Non‐smokers: 
3.3 ± 1.1 
p‐value N.S.  
 
 
Smokers: 
89 ± 99; 
Non‐smokers: 
73 ± 67; 
p‐value N.S.  
 
 
Smokers: 
308 ± 341; 
Non‐smokers: 
230 ± 199; 
p‐value N.S.  
 
 
‐‐  ‐‐  ‐‐ 
Shi et al., 2001  China  Cross‐sectional  11 ≥ 20 cig/d; 
10 <20 cig/d; 
10 non‐smokers  
volunteers 
 
≥ 20 cig/d: 
2.5 ± 1.4; 
<20 cig/d: 
2.8 ± 1.3; 
non‐smokers: 
2.9 ± 1.4 
 
 
 ≥ 20 cig/d: 
60.7 ± 39.5; 
<20 cig/d: 
64.8 ± 38.3; 
non‐smokers: 
75.2 ± 50.8 
 
 
 
‐‐  % normal 
 ≥ 20 cig/d: 
62.0 ± 18.3; 
<20 cig/d: 
64.3 ± 10.5; 
non‐smokers: 
70.1 ± 6.5 
 
 
‐‐  % Chromo‐some 
13 disomy 
≥ 20 cig/d: 
0.19 v.  
Non‐smokers: 
0.07 
P<.01 
Auger et al., 
2001 
Turku,  
Coppen‐ 
Hagen, 
Edinbergh, 
Paris 
Cohort  1001 male 
volunteers: 
partners of 
pregnant women  
‐‐  ‐‐  ‐‐  No relationship observed 
between smoking status, # 
of cigs/day or passive 
smoking & any sperm 
defects 
‐‐  ‐‐ 
Wang et al.,  
2001 
China  Cross‐sectional  45 petrochem exp. 
& smk; 
23 petrol, no 
smoke; 
81 no petrol, 
smoker; 
49 neither 
petrochem 
exposure or smoker 
E/S: 
2.9 ± 1.2; 
E/NS: 
2.9 ± 1.8; 
NE/S: 
2.9 ± 1.4; 
NE/SS: 
2.68± 1.3 
p‐value N.S.  
E/S: 
41.5 ± 1.9*; 
E/NS: 
52.5 ± 2.1; 
NE/S: 
55.3 ± 1.7; 
NE/SS: 
60.1± 1.8 
*p<.05 v. NE/S grp 
E/S: 
108.5 ± 2.1*; 
E/NS: 
127.0 ± 2.1; 
NE/S: 
141.9 ± 1.9; 
NE/SS: 
152.1± 1.9 
*p<.05   
‐‐  ‐‐  ‐‐ Years of 
cigarette smoking  
(correlation) 
‐0.241  
P<.05 
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Saleh et al., 2002  USA  Cross‐sectional  Grp 1: 12 smokers ≥ 
20 cig/day x 1yr & nl. 
PE; 
Grp 2: 21 no smoke, 
nl. PE; 
Grp 3: 8 smkers 
w/varicocele; 
Grp 4: 11 non 
smoker, no 
varicocele from 
infertility clinic 
Grp 5: hlthy, fertile 
sperm donors 
‐‐  Group 1:  
35 (17, 106); 
Group 2: 
27 (18, 66); 
Group 3: 
13 (12, 34); 
Group 4: 
16 (10, 26); 
Group 5: 
58 (40, 101) 
P<.001 Grp 3 v. group 5 
‐‐  % normal: 
Group 1:  
7 (3, 8); 
Group 2: 
7 (5, 10); 
Group 3: 
5 (2, 9); 
Group 4: 
7 (3.5, 7.5); 
Group 5: 
10 (8, 14) 
P<.05 group 3 v. group 5 & 
group 1 v. group 5  
Group 1:  
43 (29, 56); 
Group 2: 
50 (38, 62); 
Group 3: 
38 (33, 54); 
Group 4: 
33 (29, 57); 
Group 5: 
67 (58, 75) 
P<.001 group 3 v. group 5 
& group 1 v. group 5 
SCSA % DFI  
Group 1:  
26 (17, 28); 
Group 2: 
19 (13, 28); 
Group 5: 
14 (10, 22) 
 p<.05 grp 1 v. grp 5 
ROS (x 106 cpm) 
Group 1:  
63 (6.1, 451); 
Group 2: 
3.2 (0.7, 13); 
Group 5: 
0.1 (0.09, 0.65) 
P<.05 for all 
comparisons 
Trummer et al., 
2002 
Austria  Cross‐sectional  478 smokers; 
109 ex‐smokers; 
517 non‐smokers 
from infertility clinic 
Smokers: 
3.7 ± 1.8; 
Ex‐smoke: 
3.7 ± 1.7; 
Non‐smoke: 
3.6 ± 1.8; 
p‐value N.S.  
Smokers: 
58.8 ± 63.9; 
Ex‐smoke: 
59.1 ± 67.2; 
Non‐smoke: 
57.9 ± 70.8; 
p‐value N.S.  
‐‐  % abnormal: 
Smokers: 
56.1 ± 17.9; 
Ex‐smoke: 
57.6 ± 17.6; 
Non‐smoke: 
57.8 ± 17.6; 
p‐value N.S.  
Grade a only 
Smokers: 
24.8 ± 8.6; 
Ex‐smoke: 
23.4 ± 10.7; 
Non‐smoke: 
24.4 ± 9.4; 
p‐value N.S.  
Round cells 
Smokers: 
3.5 ± 5.3; 
Ex‐smoke: 
2.6 ± 3.4; 
Non‐smoke: 
2.7 ± 3.4; 
p‐value <.05 
Wong et al., 2003  Nether‐ 
lands 
Case‐ 
Control  
73 subfertile cases; 
92 fertile controls  
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  OR smoking v. non‐
smoking: 1.8 (95% 
CI:0.9‐3.6)  N.S.  
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 Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study 
 Design 
Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or 
 % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Horak, et al., 
2003 
Poland  Cross‐sectional  179 volunteers 
20 healthy donor 
volunteers 
w/proven fertility; 
159 from infertility 
clinic 
‐‐  ‐‐.   ‐‐  ‐‐  ‐‐   Bulky DNA adducts 
Smokers:   
2 (1‐12); 
Ex‐smokers: 
2 (1‐5); 
Never: 
1.5 (.5‐8) 
P<.05 w/in healthy 
men  
Kunzle et al., 
2003 
Switzerland  Cross‐sectional  655 smokers (>1 
cig/d); 
1131 non‐smokers; 
Infertility clinic 
Smokers: 
3.6 ± 1.7 
non‐smokers: 
3.7 ± 1.4  
pvalue N.S. 
Smokers: 
67.7 ± 65.9 
non‐smokers: 
79.9 ± 75.0  
P<.001 
Smokers: 
229.4 ± 251.5 
non‐smokers: 
278.1 ± 264.2  
p <.001 
% normal: 
Smokers: 
21.2% ± 14.6;; 
Non‐smokers: 
23.7 ± 15.5  
P<.001 
Smokers: 
37.1% ± 18.6 
Non‐smokers: 
38.7% ± 17.7 
p‐value N.S.  
‐‐ Citrate (µmol/L) 
Smokers: 
86.7 ± 57.3; 
non‐smokers: 
111.7 ± 303.1  
P<.01 
Ozgur, et al., 
2003 
Turkey  Cross‐sectional  116 ≥ 20 cigs/d; 
82 1‐19 cig/d; 
98 non‐smokers 
from infertility 
clinic 
Heavy: 
3.5 ± 2.1; 
Light: 
3.9 ± 2.0 
non‐smkr: 
3.6 ± 1.6  
p‐value N.S. 
Heavy: 
54.5 ± 57.9; 
Light: 
55.4 ± 60.4; 
non‐smokers: 
68.3 ± 65.8;  
p‐value 
N.S. 
‐‐  % Tail defects 
Heavy: 
15.7 ± 9.4; 
Light: 
18.7 ± 10.4; 
non‐smokers: 
19.2 ± 9.8;  
P<.05 
Heavy: 
49.6 ± 19.3; 
Light: 
44.6 ± 19.8 
non‐smokers: 
45.7 ± 20.6  
p‐value 
N.S. 
‐‐ 
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   Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Belcheva et al., 
2004 
Bulgaria  Cross‐sectional 
 
 
25 men ≥ 20 
cigarettes/day x 1 
year; 20 non‐
smokers 22 to 35 
yrs of age  
aandrology clinic 
 no  no  no  no  no  % DNA damage 
Smokers: 
7.3 ± 2.6; 
Non‐smokers: 
5.9 ± 1.3 
p‐value N.S.  
Stutz, et al., 2004  Argentina  Cross‐sectional  18 men w/no 
smoking or etoh 
drinking; 
16 men smoking or 
drinking. Ages 20‐
30 yrs and 
volunteers 
‐‐  Neither: 
88.0; 
Either: 
73.0; 
p‐value N.S.  
 
‐‐  % abnormal: 
Neither: 
42.0; 
Either: 
33.0;  
p‐value N.S.  
Neither: 
65.0; 
Either: 
62.0; 
p‐value N.S.  
‐‐ 
Chen et al., 2004  USA  Cross‐sectional  306 infertility 
patients:  22 
current smokers; 
57 ex‐smokers 
No, controlling for 
age and time 
abstinent 
No, controlling for age 
and time abstinent 
‐‐  No, controlling for age and 
time abstinent 
No, controlling for age 
and time abstinent 
‐‐ 
Okonofua et al., 
2005 
 
Nigeria  Case‐control  150 cases w/ abnl. 
semen parameters; 
150 fertile controls 
w/nl. Sperm  
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  Smoking (duration, 
type of tobacco) 
not significant  
risk factor  
Pasqualotto et al., 
2005 
Brazil  Cross‐sectional 
 
H:70 >20 cig/d; 
M: 154 11‐20 cig 
day 
L:143 <10 cig/d; 
N:522 no from 
vasectomy clinic 
Heavy: 
2.1 ± 0.8; 
Moderate: 
2.3 ± 1.2; 
Mild: 
2.4 ± 1.4; 
non‐smkr: 
3.8 ± 1.4  
P<.01 
Heavy: 
118 ± 85; 
Moderate: 
125 ± 87; 
Mild: 
107 ± 87; 
non‐smkr: 
109 ± 76  
p‐value N.S.  
‐‐  Heavy: 
118 ± 85; 
Moderate: 
125 ± 87; 
Mild: 
107 ± 87; 
non‐smkr: 
109 ± 76  
p‐value N.S. 
Heavy: 
54 ± 13; 
Moderate: 
61 ± 14; 
Mild: 
60 ± 16; 
non‐smkr: 
60 ± 16  
p‐value N.S. 
FSH, LH and 
Testosterone were 
N.S.  
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Table A.1.  (cont.) Previous epidemiologic studies of cigarette smoking and sperm quality parameters 
Reference  Country  Study Design  Study 
Population 
Effect estimates and 95% confidence intervals or p‐values (where reported)  for relationship between smoking and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility  DNA  damage, 
aneuploidy, other 
measures 
Sobreiro et al., 
2005 
Brazil  Cross‐sectional  30 Heavy: 
> 20 cigs/day; 
66 Moderate: 
11‐20 cig/day; 
80 Light: 
1‐10 cig/day; 
324 non‐
smokers 
From 
volunteers of 
vasectomy 
clinic  
Heavy: 
2.1 ± 0.8; 
Moderate: 
2.3 ± 1.2; 
Mild: 
2.3 ± 1.2; 
non‐smkr: 
2.8 ± 1.5  
p‐value N.S.  
Heavy: 
130.6 ± 74.9; 
Moderate: 
127.9 ± 99.2; 
Mild: 
106.6 ± 79.3; 
non‐smkr: 
107 9± 74.6  
p‐value N.S. 
‐‐   % normal: 
Heavy: 
15.7 ± 13.8; 
Moderate: 
16.8 ± 10.2; 
Mild: 
14.5 ± 7.7; 
non‐smkr: 
18.1 ± 9.0  
p‐value N.S 
Heavy: 
55.6 ± 13.2; 
Moderate: 
61.8 ± 15.8; 
Mild: 
58.9 ± 16.7; 
non‐smkr: 
59.6 9± 15.3  
p‐value N.S 
‐‐ 
Arabi & 
Moshtaghi, 2005 
Iran  Cross‐sectional  18 volunteers: 
9 heavy 
smokers 
(>20/day) x 4‐5 
years; 
9 healthy non‐
smokers with 
normal semen 
parameters 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐ Exposure of non‐
smking sperm to 
seminal plasma 
smokers ? 
Sig. ↓ motility, 
acrosome rxn 
Sepaniak et al., 
2006 
France  Cross‐sectional  180 ART 
patients: 
57 non 
smokers; 
51 smokers 
‐‐  smokers: 
60.0; 
Non‐smokers: 
50.0 
p‐value N.S.  
 
‐‐  Typical forms 
smokers: 
29.98; 
Non‐smokers: 
31.09; 
p‐value N.S.  
smokers: 
52.78; 
Non‐smokers: 
51.45; 
p‐value N.S.  
 
DNA Fragment % 
smokers: 
32 (5‐55) ; 
Non‐smokers: 
25.9 (10‐68) 
P<.001  
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   Table A.2.  Previous epidemiologic studies of alcohol consumption and sperm quality parameters  
Reference  Country  Study Design  Study Population  Effect estimates and Standard Deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motility) 
DNA  damage, 
aneuploidy, other 
measures 
Buiatti, et al., 
1984 
Italy  Case‐control  112 infertile cases 
(93 drinkers; 
127 “healthy” 
controls (111 
drinkers); heavy 
drinkers excluded 
           
Marshburn et 
al., 1989 
USA   Cross‐sectional  108 drinkers; 
338 non‐drinkers; 
From infertility clinic 
drinkers: 
2.9 ± 0.1; 
Non‐drinkers: 
3.0 ± 0.1; 
p‐value N.S. 
drinkers: 
83.5 ± 4.9; 
Non‐drinkers: 
83.0 ± 2.8; 
p‐value N.S.  
‐‐  % abnormal: 
drinkers: 
28.0 ± 1.0; 
Non‐drinkers: 
29.0 ± 0.6; 
p‐value N.S. 
drinkers: 
62.0 ± 1.8; 
Non‐drinkers: 
59.0 ± 1.0; 
p‐value N.S 
 
‐‐ 
Close, et al., 
1990 
USA  Cross‐sectional  8 > 30 oz./wk; 
46 3 to 30 oz./wk; 
82 < 2 oz./wk alcohol 
consumed 
From  
Infertility clinic  
‐‐   >30 oz./wk: 
69.0 ± 50.0; 
3‐30 oz./wk.: 
63.8 ± 73.3;  
< 2 oz./wk: 
75.3 ± 68.5 ; 
p‐value N.S. 
‐‐  ‐‐   >30 oz./wk: 
45.6 ± 31.2; 
3‐30 oz./wk.: 
51.2 ± 24.9 ; 
< 2 oz./wk: 
41.6 ± 22.4 ; 
p‐value N.S 
 Median # 
leukocytes: 
>30 oz./wk: 
10 (2‐18)*; 
3‐30 oz./wk.: 
3 (0‐52) ; 
< 2 oz./wk: 
3 (0‐16) ; p<.05 
Dunphy, et al., 
1991 
UK  Cross‐sectional  258 couples 
attending an 
infertility clinic: 
54 men‐ 0 units/wk; 
26 men 1‐5 units/wk; 
60 men 6‐10 
units/wk; 
70 men 11‐20 
units/wk; 
48 men >20 units/wk 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  There was no 
significant 
association 
between male 
alcohol intake and 
any semen 
parameter 
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   Table A.2.  (cont.) Previous epidemiologic studies of alcohol consumption and sperm quality parameters  
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Gerhard, et al., 
1992 
Germany  Cross‐sectional 
 
 
71 men >20 grams 
etoh/day; 
56 men ≤20 grams 
etoh/day; 
101 no etoh  
 From men seeking 
infertility 
treatment whose 
wives ovulated and 
did not have a 
tubal blockage  
 no  no  no  no  no  Estradiol (pg/ml): 
>20 grams/d:  
126.27; 
 ≤20 grams/d:  
99.46; 
No etho: 
103.13; 
p<.05 
Alcohol consumers 
had fewer round 
cells (p<.01) and 
post coital test 
results (p<.01) 
Oldereid, et al., 
1992 
Norway  Cross‐sectional  252 men attending 
infertility clinic: 
106 >200 
mg/month; 
77 5‐200 
mg/month; 
56 <5 g/month  
‐‐  >200 mg/mo.: 
93.8 ± 8.4; 
5‐200 mg/mo.: 
82.8 ± 8.9; 
<5 mg/mo.: 
62.9 ± 7.2 
p‐value N.S. 
‐‐  % abnormal: 
 >200 mg/mo.: 
54.2 ± 2.1; 
5‐200 mg/mo.: 
54.4 ± 2.4; 
<5 mg/mo.: 
59.4 ± 2.4  p‐value N.S.  
 >200 mg/mo.: 
24.3 ± 1.6; 
5‐200 mg/mo.: 
21.3 ± 1.8; 
<5 mg/mo.: 
18.7 ± 1.7; 
p‐value N.S. 
‐‐ 
Goverde, et al., 
1995 
Nether‐lands  Case‐ 
control 
47 infertile cases 
by WHO; 
68 ctrls with nl. 
WHO 
spermiograms 
 
‐‐   ‐‐   ‐‐     ‐‐    ‐‐  Never drink:  
8 cases,11 controls; 
Occasional: 
23 cases, 38 
controls; 
Weekend: 
4 cases 6 controls; 
Daily: 8 cases, 12 
ctrl 
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Table A.2.  (cont.) Previous epidemiologic studies of alcohol consumption and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy, other 
outcomes 
Parazzini et al., 
1993 
Italy  Case‐ 
control 
97 cases were 
infertile men from 
infertility clinic; 
Two ctrl grps: 
1. 121 men from 
infertile couple 
w/normal sperm 
studies; 2. 105 
partners with 
recent delivery 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐Ctrl grp 1: 
1 drink/d v. none: 
OR=1.2(95% 
CI:.0.3‐5.4) 
2‐3 drink/d v. none: 
OR=0.6(95% CI:0.7‐
2.2); 
≥4 drinks/d v. 
none: 
1.2 (95% CI:0.4‐4.0 
p‐value=NS 
Ctrl grp 2: 
1 drink/d v. none: 
OR=1.3(95% 
CI:.0.3‐5.6) 
2‐3 drink/d v. none: 
OR=1.9(95% CI:0.5‐
9.0); 
≥4 drinks/d v. 
none: 
4.1 (95% CI:1.2‐1.4) 
p‐value <.01 
Controlled for age, 
ed, coffee and 
smoking 
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   Table A.2.  (cont.) Previous epidemiologic studies of alcohol consumption and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Figa‐Talamanca  
et al., 1996 
Italy  Cross‐sectional  72 taxi‐drivers; 
50 controls from 
routine pre‐marital 
examination: 
32 no alcohol; 
27 1‐3 drinks/day;  
13 ≥3 drinks/day 
‐‐  % < 40 million 
None: 
25.1%; 
1‐3 drinks/d: 
18.5%; 
≥3 drinks/d: 
7.7%*  * p<.05  
‐‐  > 40% abnormal 
None: 
62.5%; 
1‐3 drinks/d: 
37.0%*; 
≥3 drinks/d: 
69.2% * p<.05 
<40% motile 
None: 
21.9%; 
1‐3 drinks/d: 
14.8%; 
≥3 drinks/d: 
 p<.05 
‐‐ 
Robbins, et al., 
1997 
USA  Cross‐sectional  Group 1 (<6 
drinks/wk.) 
Group 2 (6‐14 
drinks/wk. 
Group 3 
(14+ drinks/wk) 
Community 
volunteers 18‐40 
years of age 
‐‐  no  ‐‐  no  no  Scored sperm cells 
YY18 
Group 1: 
1.1 ± 1.3; 
Group 2: 
0.9 ± 1.2; 
Group 3: 
1.8 ± 2.7; 
p‐value<.05 
XY18 
Group 1: 
12.3 ± 8.1; 
Group 2: 
8.5 ± 7.0*; 
Group 3: 
11.3 ± 7.3*; 
p‐value<.05 
18‐18 
Group 1: 
3.8 ± 3.3; 
Group 2: 
2.9 ± 1.9*; 
Group 3: 
5.3 ± 3.1*;  N.S. 
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Table A.2.  (cont.) Previous epidemiologic studies of alcohol consumption and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and Standard Deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy, other 
measures 
Harkonen et 
al., 1999 
Denmark  Cross‐
sectional 
30 healthy  Danish 
farmer volunteers 
ages 29‐49  exposed 
to fungicides 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  Aneuploidy 
1‐1‐7  
p=.05 for drinkers 
v. non‐drinkers 
1‐7‐7  
p<.01 for drinkers 
v. non‐drinkers, 
controlling for age, 
sperm count, 
smoking 
Chia et al., 
2000 
Singapore  Case‐control  Cases: 218  men 
w/initial screening 
for infertility (92 
social drinkers  126 
non‐drinkers) 
Controls: 240 fertile 
men (90 social 
drinkers, 150 non‐
drinkers) 
‐‐     ‐‐   ‐‐   ‐‐  ‐‐ OR drinking v. 
non‐drinkiing = 
1.33 (95% CI=0.89, 
2.00), controlling 
fro age, smoking 
status, and 
occupation 
p‐value NS 
Auger et al., 
2001 
Turku,  
Coppen‐ 
Hagen, 
Edinbergh, 
Paris 
Cohort  1001 male 
volunteers 20 to 45 
years: partners of 
pregnant women  
‐‐  ‐‐  ‐‐  Men drinking ~ 3.6 units 
per week had less defects 
v. those drinking 16 units 
per week and those who 
drank none 
‐‐  ‐‐ 
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Table A.2.  (cont.) Previous epidemiologic studies of alcohol consumption and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy 
Wong et al., 
2003 
Nether‐ 
lands 
Case‐ 
Control  
73 subfertile cases; 
92 fertile controls 
with preg partner 
w/in last year & nl. 
sperm 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐ 
Gaspari et al., 
2003 
Italy  Cross‐sectional  139 never or 
occasional 
drinkers; 
40 daily drinkers 
From infertility 
clinic 
 
‐‐  ‐‐   ‐‐  ‐‐  ‐‐  DNA adducts (mean 
relative staining 
intensity) 
Never/occ.: 
1.68 ± 0.7; 
Daily drink: 
1.40 ± 0.6 
p<.01 
Stutz, et al., 
2004 
Argentina  Cross‐sectional  18 men w/no 
smoking or etoh 
drinking; 
16 men smoking or 
drinking. 
volunteers 
‐‐  Median 
Neither: 
88.0; 
Either: 
73.0; 
p‐value N.S.  
‐‐  % abnormal: 
Neither: 
42.0; 
Either: 
33.0;  
p‐value N.S.  
Neither: 
65.0; 
Either: 
62.0; 
p‐value N.S.  
‐‐ 
Martini et al.,  
2004 
Argentina  Cross‐sectional  372 smokers ; 
236 etoh drinkers; 
174 both; 
3,194 neither from 
andrology lab 
Smkers: 
2.9 ± 0.1 
Drinkers: 
2.9 ± 0.1; 
*Both: 
2.7 ± 0.1; 
Neither: 
3.0 ± 0.0; 
*p<.05 for both v. 
neither only 
Smkers: 
48.1 ± 2.4 
Drinkers: 
52.5 ± 3.5; 
*Both: 
45.3 ± 3.6; 
Neither: 
50.9 ± 0.9; 
*p<.05 for both v. 
neither only 
 ‐‐  % normal 
Smkers: 
11.9 ± 0.4 
Drinkers: 
11.7 ± 0.4; 
*Both: 
11.7 ± 0.6; 
Neither: 
11.0 ± 0.1; 
*p<.05 for both v. neither 
Smkers: 
45.7 ± 1.2; 
Drinkers: 
43.5 ± 1.4; 
*Both: 
39.6 ± 1.6; 
Neither: 
44.0 ± 0.4; 
*p<.05 for both v. neither 
only 
‐‐ 
    
196 
  
Table A.2.  (cont.) Previous epidemiologic studies of alcohol consumption and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between alcohol consumption and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy, other 
measures 
Okonofua et 
al., 2005 
 
Nigeria  Case‐control  150 cases w/ abnl. 
semen parameters; 
150 fertile controls 
w/nl. Semen quality 
75 occasional or non‐
drinking controls, 37 
cases; 12 1‐2 
glasses/month 
controls, 6 cases; 14 
1‐2 glasses/week 
controls, 24 cases; 15 
1‐2 glasses/day  
controls, 49 cases 
 
 
 
 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐>1‐2 glasses/day 
v. occasional 
drinkers OR 7.14 
(95% CI: 2.3‐22.4) 
>1‐2 glasses/week 
v. occasional 
drinkers OR 3.33 
(95% CI:1.2‐9.4) 
>1‐2 glasses  
per month OR 0.47 
(95% OR 0.0‐4.7 
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   Table A.3.  Previous epidemiologic studies of caffeine intake and sperm quality parameters  
Reference  Country  Study Design  Study Population  Effect estimates and Standard Deviations or p‐values (where reported)  for relationship between caffeine  
intake  and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motility) 
DNA  damage, 
aneuploidy 
Marshburn et 
al., 1989 
USA   Cross‐
sectional 
166 no coffee; 
198 1‐2 cups 
coffee/day; 
82 ≥4 cups coffee/day 
From infertility clinic 
≥4 cups 
coffee/day: 
2.7 ± 0.8; 
1‐2 cups 
coffee/day 
3.1 ± 0.1; 
No coffee: 
3.0 ± 0.1 
p‐value N.S. 
 ≥4 cups coffee/day: 
81.4 ± 5.8; 
1‐2 cups coffee/day 
89.1 ± 3.8; 
No coffee: 
76.7 ± 3.7 
p‐value <.05 
‐‐  % abnormal: 
≥4 cups coffee/day: 
31 ± 1.4; 
1‐2 cups coffee/day 
28 ± 0.7; 
No coffee: 
28 ± 0.8 
p‐value <.05 
≥4 cups coffee/day: 
57.0 ± 2.5; 
1‐2 cups coffee/day 
62.0 ± 1.2; 
No coffee: 
59.0 ± 1.5 
p‐value N.S. 
‐‐ 
Oldereid, et 
al., 1992 
Norway  Cross‐
sectional 
252 men attending 
infertility clinic: 
45 men no coffee; 
133 men 1‐5 cups/day; 
60 men ≥ 6 cups/day  
‐‐  No  
coffee/day: 
69.5 ± 9.6; 
1‐5 cups coffee/day 
87.8 ± 7.1; 
≥ 6 cups/day: 
82.1 ± 9.9 
p‐value NS 
‐‐  % abnormal: 
No  
coffee/day: 
58.5 ± 3.0; 
1‐5 cups coffee/day 
54.2 ± 1.8; 
≥ 6 cups/day: 
56.8 ± 2.7 
p‐value NS 
 No  
coffee/day: 
20.1 ± 2.1; 
1‐5 cups coffee/day 
22.7 ± 1.4; 
≥ 6 cups/day: 
22.1 ± 2.1 
p‐value NS 
‐‐ 
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      Table 3.  (cont.) Previous epidemiologic studies of caffeine intake and sperm quality parameters  
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between caffeine  
intake and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy, other 
outcomes 
Parazzini et al., 
1993 
Italy  Case‐ 
control 
97 cases were 
infertile men from 
infertility clinic: 15 
drink 0‐5 cups 
coffee/day; 
37 2‐3 cups/d; 
44 ≥ 4 cups/d; 
Two ctrl grps: 
1. 121 men from 
infertile couple 
w/normal sperm 
studies: 37 drink 0‐
1 cup coffee/day 
50 2‐3 cups/day; 33  
≥ 4 cups/d 
 2. 105 partners 
with recent 
delivery 
34 drink 0‐5 cups 
coffee/day; 
51 2‐3 cups/d; 
20 ≥ 4 cups/d; 
 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  ‐‐Ctrl grp 1: 
2‐3 cups/d v. none: 
OR=1.8(95% 
CI:.0.8‐4.0) 
≥ 4 cups/d  v. none: 
OR=3.0(95% CI:1.3‐
6.9); 
p‐value<.01 
Ctrl grp 2: 
2‐3 cups/d v. none: 
OR=1.3 (95% 
CI:.0.5‐2.9) 
≥ 4 cups/d  v. none: 
OR=4.2(95% CI:1.7‐
10.1); 
p‐value<.001 
Controlled for age, 
education, alcohol 
and smoking 
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   Table 3.  (cont.) Previous epidemiologic studies of caffeine intake and sperm quality parameters 
Reference  Country  Study 
Design 
Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between caffeine intake and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motile) 
DNA  damage, 
aneuploidy 
Robbins, et al., 
1997 
USA  Cross‐
sectional 
Group 1 (no 
caffeine intake) 
Group 2 (1 cup 
equivalent/dy) 
Group 3 
(2+ cup 
equivalent/dy) 
Community 
volunteers 18‐40 
years of age 
‐‐  no  ‐‐  no  no  Scored sperm cells 
YY18 
Group 1: 
1.3 ± 1.4; 
Group 2: 
0.6 ± 0.8; 
Group 3: 
1.6 ± 2.6; 
p‐value<.05 (for grp 
2 v. 1 and 3 v. 1) 
XY18 
Group 1: 
9.0 ± 5.8; 
Group 2: 
10.5 ± 6.5*; 
Group 3: 
12.1 ± 10.0*; 
p‐value<.05 
18‐18 
Group 1: 
3.5 ± 2.5; 
Group 2: 
3.2 ± 2.1*; 
Group 3: 
4.8 ± 3.5*; 
p‐value N.S. 
Wong et al., 2003  Nether‐ 
lands 
Case‐ 
Control  
73 subfertile cases; 
92 fertile controls 
with preg partner 
w/in last year & nl. 
sperm 
‐‐  ‐‐  ‐‐  ‐‐  ‐‐  OR for coffee 
drinker  v. no 
coffee drinking 
1.9 (95% CI: 0.6 – 
6.3) p‐value N.S. 
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Table 3.  (cont.) Previous epidemiologic studies of caffeine intake and sperm quality parameters 
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between caffeine 
 intake and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy, other 
measures 
Lucon et al., 
2002 
Brazil  Cross‐sectional  330 men reporting 
for voluntary 
vasectomy 
Group 1: 69 
smokers only; 
Group 2: 90 with 
caffeine intake 
only;  
Group 3 use of 
caffeine and 
smoker; 
Group 4 neither 
smoker or use of 
caffeine 
‐‐  Group 1: 
127.54 ± 76.5; 
Group 2: 
109.8 ± 74.9; 
Group 3: 
129.3 ± 38.9; 
Group 4: 
106.2 ± 73.2; 
p‐value N.S. 
‐‐  no  Group 1: 
59.2 ± 14.7 
Group 2: 
57.4 ± 17.2; 
Group 3: 
59.0 ± 15.3; 
Group 4: 
58.1 ± 14.4; 
p‐value N.S. 
‐‐ Testosterone 
levels: 
Group 1: 
625.7 ± 181.3 
Group 2: 
610.5 ± 176.8; 
Group 3: 
631 ± 182; 
Group 4: 
595.8 ± 216.6; 
p‐value N.S. 
Sobreiro et 
al., 2005 
Brazil  Cross‐sectional  151 non‐coffee 
drinkers; 
Mild: 
249 drank 1‐3 
cups/day; 
Moderate: 
48 drank 4‐6 
cups/day 
Heavy 
52 drank >6 cups 
per day 
 vasectomy clinic  
Heavy: 
2.7 ± 1.7; 
Moderate: 
2.7 ± 1.3; 
Mild: 
2.6 ± 1.4; 
No coffee: 
2.7 ± 1.5  
p‐value N.S.  
Heavy: 
127.2 ± 82.4; 
Moderate: 
111.0 ± 94.8; 
Mild: 
113.6 ± 82.0; 
No coffee: 
110.8 ± 79.7  
p‐value N.S. 
‐‐   % normal: 
18.0 ± 9.2; 
Moderate: 
17.9 ± 8.3; 
Mild: 
17.5 ± 10.0; 
No coffee: 
17.3 ± 8.2  
p‐value N.S. 
Heavy: 
62.4 ± 16.0; 
Moderate: 
61.2 ± 15.5; 
Mild: 
60.7 ± 14.6; 
No coffee: 
57.1 ± 16.2  
p‐value N.S. 
‐‐ 
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   Table A.4.  Previous epidemiologic studies of BMI and sperm quality parameters  
Reference  Country  Study Design  Study Population  Effect estimates and Standard Deviations or p‐values (where reported)  for relationship between BMI  
 and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or % abnormal) 
Motility 
(% motility) 
DNA  damage, 
aneuploidy 
Jensen et al., 
2004 
Denmark  Cross‐
sectional 
217 BMI <20; 
1024 BMI 20‐25; 
299 BMI ≥ 25 
From mandatory 
examine for military 
service 
BMI <20: 
3.0 ± 1.5; 
BMI 20‐25: 
3.2 ± 1.4; 
BMI ≥ 25: 
3.2 ± 1.6 
 
 
BMI <20: 
40.0 (17‐75); 
BMI 20‐25: 
46.0 (23‐84); 
BMI ≥ 25: 
30.0 (20‐60) 
 
 
 
BMI <20: 
105.0 (47‐240); 
BMI 20‐25: 
138.0 (59‐259); 
BMI ≥ 25: 
116.0 (46‐213) 
 
 
% normal 
BMI <20: 
6.8 ± 4.4; 
BMI 20‐25: 
7.4 ± 5.0; 
BMI ≥ 25: 
7.1 ± 4.6 
 
 
BMI <20: 
63.7 ± 14.5; 
BMI 20‐25: 
65.4 ± 12.4; 
BMI ≥ 25: 
65.5 ± 12.5 
 
 
‐‐ 
Magnus 
dottir, et al., 2005 
Iceland  Cross‐
sectional 
72 men attending 
infertility clinic: 
25 men with male 
factor subferility 
(MSS); 
20 men with 
idiopathic infertility 
(IS); 
27 men with female 
factor infertility (FFS)  
‐‐  For IS and FSS:  
r= ‐0.33 
p<.05 
 
For MFS:  
r=‐0.16 
P<.05 
 
With increasing BMI 
For IS and FSS:  
r= ‐0.30 
p‐value NS 
 
For MFS:  
r=‐0.27 
P value NS 
 
With increasing BMI 
‐‐  ‐‐  ‐‐ 
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      Table A.4.  Previous epidemiologic studies of BMI and sperm quality parameters  
Reference  Country  Study Design  Study Population  Effect estimates and standard deviations or p‐values (where reported)  for relationship between BMI  
 and semen quality parameters 
  Volume 
(ml) 
Concentration 
(millions/ml) 
 
Count 
(absolute number) 
Morphology 
(% normal or  
 % abnormal) 
Motility 
(% motile) 
DNA  damage,  
aneuploidy 
Kort et al., 
2006 
USA  Cross‐sectional  520 men from 
infertility clinic 
 
‐‐  For normal, motile 
sperm cells only 
Normal Wt. 
BMI (20‐24): 
18.6; 
Overweight BMI (25‐30): 
3.6; 
Obese weight 
BMI (>30): 
0.7 
‐‐  ‐‐  ‐‐  SCSC  
%DFI 
Normal Wt. 
BMI (20‐24): 
19.9 ± 1.96; 
Overweight BMI 
(25‐30): 
25.8 ± 2.23; 
Obese weight 
BMI (>30): 
27.0 ± 3.16 
Koloszar et 
al., 2005 
Hungary  Cross‐sectional  Group 1: 29 
underweight men 
with BMI  
≤ 20; 
Group 2: 96 normal 
weight men with BMI 
20.1 to 25; 
Group 3: 91 
overweight men with 
BMI 25.1 to 30;  
Group 4: 58 obese 
men with BMI >30 
  Group 1: 
38 ± 14; 
Group 2: 
39 ± 14; 
Group 3: 
37 ± 14; 
Group 4: 
29 ± 12; 
p‐value <.05 
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Table A.5  Interview Guide
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Table A.6  HMS Recruitment Results 
    Raleigh  Memphis  Galveston  Total 
A  Eligible RFTS Women, Approached   360  403  197  960 
B  Eligible RFTS Women, Unable to Contact  55  53  46  154 
C  Eligible RFTS Women or Man, Refused  164  213  83  460 
D  Eligible RFTS Women Agree and Provide  
Man’s Contact Information 
117  124  64  305 
E  Eligible RFTS Women Report Man is Ineligible  24  13  4  41 
F  HMS Man, Unable to contact  0  5  3  8 
G  HMS Man Total Ineligible  28  19  5  52 
H  HMS Man, Refused Screen  7  4  1  12 
I  HMS Man, Eligible  106  109  59  274 
J  HMS Man, Refused Study or Unable to Contact  3  5  2  10 
K  HMS Man, Interview Completed  103  104  57  264 
L  HMS Man, Refused or Unable to Contact  10  8  10  28 
M  HMS Man, Semen Sample Inadequate  1  4  0  5 
N  HMS Man, Semen Sample Adequate  92  92  46  230 
  Participation Rate for HMS Interview and Semen Sample 
(N / I) 
87%  84%  78%  84% 
           
  Response Rate for HMS Interview and Semen Sample  28%  24%  24%  25% 
  [ N / (A‐G) ]         
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Table A.7  Power Analysis formulas and Calculations 
 
Calculations conducted for:    
 
Exposures†: 
A. Tobacco exposure #1 (smoker v. non-smoker) 
B. Tobacco exposure #2 (ever v. never) 
C. Alcohol use past 3 months (yes v. no) 
D. Caffeine intake (based on number of coffee cups drunk per day) (yes v. no) 
E. BMI Exposure (very obese/obese v. overweight and normal weight) 
 
Outcomes: 
A.  Difference of means:  total sperm count, sperm concentration 
B.  Difference of proportions: % normal sperm cells, % abnormal head, % abnormal midpiece,  
      % abnormal tail, % DFI, % xxx, % sperm cells with retained cytoplasm 
 
 
Assumptions:  2 samples drawn from one population, nA ≠n B, 2-sided test, alpha=.05, δ1= δ2* 
 
Rationale for “small”, “medium” and “large” effects size approach:  although there is a large amount of 
literature that has accumulated regarding smoking and semen quality parameters, the observed size 
of effects has been small to medium.  For the other exposures (alcohol consumption, caffeine intake, 
and BMI), much less research has been done and therefore data is lacking from which to gauge the 
expected effect size index.  Moreover, given the context of the analysis it is helpful to observe the 
consequences in power when varying the relative magnitude of the effects sizes.   
 
 
A.  Difference of Means and Proportions 
1. Means effect size (d) formula:  d=|m1-m2|/ δ  Proportions effect size (h) formula:  h=|Ф-Ф| 
       Where Ф=2 arcsin sq.root(P) 
2. Definitions of effect sizes: 
    a. Small effect size d/h=.20 
    b. Medium effect size d/h=.50 
    c. Large effect size d/h=.80 
 
3. Estimated exposure prevalences 
    a. tobacco current use – 15% 
    b. tobacco everr – 40% 
    c. alcohol use in past 3 months – 76% 
    d. coffee past 3 months – 40% 
    e. very obese or obese – 26% 
 
4. Calculations and procedures 
    a. compute sample sizes based on preliminary exposure prevalence data and total study 
population          (229) e.g. (.15)229= 34.35 (tobacco users); 229-34.35=194.65 (non-users) 
 
    b. compute harmonic mean (necessary due to unequal sample sizes) 
    harmonic mean (n’) for nA ≠  nB = 2 nA nB/ nA + nB 
 
c. table look up based on harmonic mean (sample sizes), effect size (.20, .50 and .80), two sided-
test                                            and alpha=.05 
     
 
 
† Based on preliminary data of exposure prevalences 
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Table A.7  Power Analysis formulas and Calculations 
 
Calculations (means and proportions) 
 
A.  Tobacco Exposure #1 (current smoker v. current non-smoker) 
.15(229)=34.35 or 34 exposed (nA) 
229-34.35=194.65 or 195 unexposed (nB) 
 
n’=2(34)(195)/34+195 
  = 13,260/229 
  = 57.90  --------------------------------------------------------------? Difference of mean power = .19, .77, .99 
                --------------------------------------------------------------? Difference of proportion power =  .19, .77, 
1.0 
 
B. Tobacco Exposure #2 (ever smoked v. never smoked) 
.40(229)=91.6 or 92 exposed ((nA) 
229-92=137 unexposed (nB) 
 
n’=2(92)(137)/92+137 
  = 25,208/229 
  = 110.08 --------------------------------------------------------------? Difference of mean power = .29, .94. 1.0 
                 --------------------------------------------------------------? Difference of proportion power =  .29, 
.94, 1.0 
C.  Alcohol Exposure (alcohol in previous 3 months v. none in previous 3 months) 
.76(229)=174.04 or 174 exposed (nA) 
229-174.04=54.96 or 55 unexposed (nB) 
 
n’=2(174)(55)/174+55 
  = 19,140/229 
  = 83.58  --------------------------------------------------------------? Difference of mean power = .25, .90, 1.0 
                --------------------------------------------------------------? Difference of proportion power =  .25, .90, 
1.0 
 
D. Caffeine Exposure – based on number cups coffee per day (coffee drinker v. non-drinker) 
.40(229)=91.6 or 92 exposed (nA) 
229-92=137 unexposed (nB) 
 
n’=2(92)(137)/92+137 
  = 25,208/229 
  = 110.08 -------------------------------------------------------------? Difference of mean power = .29, .94, 1.0 
                 -------------------------------------------------------------? Difference of proportion power =  .29, .94, 
1.0 
 
E. BMI Exposure – (very obese/obese v. overweight or normal weight) 
.26(229)=59.54 or 60 exposed (nA) 
229-59.54=169.46 or 169 unexposed (nB) 
 
n’=2(60)(169)/60+169 
  = 20,280/229 
  = 88.55 ---------------------------------------------------------------? Difference of mean power = .26, .91, 1.00 
                 -------------------------------------------------------------? Difference of proportion power =  .26, .91, 
1.0 
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Table A.8. Categorical socio‐demographic characteristics of  HMS participants by 
site  
    Study site 
         Raleigh       Memphis    Galveston Covariate/Exposure 
           n      %         n    %       n    % 
Age (years) 
19 to 24   3 3.26 14  15.38 9 19.57
25 to 29   24 26.09 31 34.07 15 32.61
30 to 34  44 47.83 32 35.16 13 28.26
35 to 40   21 22.83 14 15.38 9 19.57
Household income (US $/year) 
missing  1 1.09 1  1.10 1 2.17
≤ 40,000  10 10.87 25 27.47 18 39.13
40,001 to 80,000  48 52.17 41 45.05 20 43.48
≥ 80,000  33 35.87 24 26.37 7 15.22
Level of education 
High school  3 3.26 18  19.78 15 32.61
Some college  16 17.39 16 17.58 14 30.43
Graduated college  73 79.35 57 62.64 17 36.96
Days abstinence 
2 to 3  49 53.26 47  51.65 17 36.96
4 to 5   26 28.26 26 28.57 11 23.91
≥ 6   17 18.48 18 19.78 18 39.13
Smoking status 
never smoked  65 70.65 61  67.03 26 56.52
current smoker  11 11.96 15 16.48 15 32.61
ex‐smoker  16 17.39 15 16.48 5 10.87
Alcohol  consumption (drinks/week) 
non‐drinker  19 20.65 35  38.46 13 28.26
> 0 to ≤ 7   54 58.70 48 52.75 25 54.35
> 7 to ≤ 14   12 13.04 4 4.40 5 10.87
> 14   7 7.61 4 4.40 3 6.52
Caffeine intake (mgs/day) 
no caffeine  19 20.65 18  19.78 3 6.52
> 0 to ≤ 150  29 31.52 26 28.57 13 28.26
> 150 to ≤ 300  22 23.91 25 27.47 14 30.43
> 300  22 23.91 22 24.18 16 34.78
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Table A.9. Continuous socio‐demographic characteristics and sperm outcomes of HMS 
participants by study site 
Study site 
Covariate/Exposure 
Raleigh    Memphis     Galveston 
n  92 91 46 Total 
%  100.00 100.00 100.00 
N  92 91 46 
Mean  31.98 29.79 29.50 
Std  3.98 4.65 5.18 
Age (years) 
P50  32.00 30.00 29.00 
N  91 90 45 
Mean  7.69 7.22 6.53 
Std  1.35 1.68 2.01 
Household income 
P50  8.00 8.00 7.00 
N  92 91 46 
Mean  2.76 2.43 2.04 
Std  0.50 0.80 0.84 
Education 
P50  3.00 3.00 2.00 
N  92 91 46 
Mean  2.99 4.66 5.24 
Std  5.76 8.62 8.53 
# cigs smoked 
P50  0.00 0.00 0.00 
N  92 91 46 
Mean  2.30 2.98 4.00 
Std  4.34 4.88 5.92 
# yrs smoked 
P50  0.00 0.00 0.00 
N  92 91 46 
Mean  1.40 2.26 2.96 
Std  3.18 4.74 6.25 
pack‐years (dose) 
P50  0.00 0.00 0.00 
N  92 91 46 
Mean  4.61 3.10 3.76 
Std  6.16 5.92 5.52 
Alcohol consumption 
(drinks/week) 
P50  2.23 0.93 1.74 
N  92 91 46 
Mean  203.12 211.78 265.63 
Std  255.29 246.85 201.68 
Caffeine intake 
(mgs/day) 
P50  129.10 157.00 244.53 
N  91 91 46 
Mean  114.06 110.36 102.76 
Std  93.29 79.43 68.63 
Sperm concentration 
P50  81.60 88.38 99.65 
N  91 91 46 
Mean  374.38 334.64 323.09 
Std  304.79 277.92 316.24 
Sperm count 
P50  256.89 252.77 238.86 
N  92 91 46 
Mean  0.17 0.12 0.12 
Std  0.07 0.04 0.04 
Percent normal forms 
P50  0.16 0.12 0.11 
N  88 90 46 
Mean  0.15 0.22 0.22 
Std  0.08 0.12 0.13 
Percent DFI 
P50  0.14 0.19 0.19 
N  88 90 46 
Mean  0.08 0.09 0.08 
Std  0.05 0.05 0.04 
Percent HDS 
P50  0.06 0.08 0.07 
  
Table A.10.  Selected socio‐demographic characteristics of HMS participants by lifestyle exposure 
                    Smoking status         Alcohol  consumption (drinks/week)              Caffeine intake (mgs/day) 
 never 
smoked 
current 
smoker  ex‐smoker  non‐drinker  > 0 to ≤ 7  > 7 to ≤14      >14   no caffeine 
≥ 0 to  
≤ 150 
> 150 to 
≤ 300  > 300 
Covariate/Exposure 
n  %  n  %  n  %  n  %  n  %  n  %  n  %  n  %  n  %  n  %  n  % 
Paternal age (years) 
19 to 24   11  7.24  10  24.39  5  13.89  10  14.93  11  8.66  3  14.29  2  14.29  1  2.50  10 14.71  6  9.84  9  15.00 
25 to 29   43  28.29  14  34.15  13  36.11  23  34.33  38  29.92  3  14.29  6  42.86  16  40.00  19 27.94  19 31.15  16 26.67 
30 to 34   66  43.42  10  24.39  13  36.11  26  38.81  50  39.37  10  47.62  3  21.43  19  47.50  30 44.12  21 34.43  19 31.67 
35 to 40   32  21.05  7  17.07  5  13.89  8  11.94  28  22.05  5  23.81  3  21.43  4  10.00  9  13.24  15 24.59  16 26.67 
Household income ($/year) 
missing  2  1.32  .  .  1  2.78  1  1.49  2  1.57  .  .  .  .  1  2.50  .  .  1  1.64  1  1.67 
le $40,000/yr  27  17.76  19  46.34  7  19.44  30  44.78  17  13.39  2  9.52  4  28.57  8  20.00  15 22.06  13 21.31  17 28.33 
$40,001 to 80,000/yr  74  48.68  18  43.90  17  47.22  28  41.79  63  49.61  12  57.14  6  42.86  20  50.00  41 60.29  30 49.18  18 30.00 
gt $80,000  49  32.24  4  9.76  11  30.56  8  11.94  45  35.43  7  33.33  4  28.57  11  27.50  12 17.65  17 27.87  24 40.00 
Education 
High school   17  11.18  16  39.02  3  8.33  15  22.39  16  12.60  2  9.52  3  21.43  6  15.00  5  7.35  6  9.84  19 31.67 
Some college  18  11.84  17  41.46  11  30.56  15  22.39  24  18.90  4  19.05  3  21.43  10  25.00  18 26.47  6  9.84  12 20.00 
Graduated college  117  76.97  8  19.51  22  61.11  37  55.22  87  68.50  15  71.43  8  57.14  24  60.00  45 66.18  49 80.33  29 48.33 
Days of abstinence 
2 to 3  79  51.97  19  46.34  15  41.67  31  46.27  64  50.39  11  52.38  7  50.00  20  50.00  26 38.24  34 55.74  33 55.00 
4 to 5   41  26.97  11  26.83  11  30.56  20  29.85  34  26.77  5  23.81  4  28.57  14  35.00  26 38.24  15 24.59  8  13.33 
≥  6   32  21.05  11  26.83  10  27.78  16  23.88  29  22.83  5  23.81  3  21.43  6  15.00  16 23.53  12 19.67  19 31.67 
Standard BMI categories 
≥18.5 to <  25 (normal)  47  30.92  6  14.63  9  25.00  18  26.87  33  25.98  6  28.57  5  35.71  18  45.00  18 26.47  18 29.51  8  13.33 
≥25.0 to < 30 (overweight)  77  50.66  19  46.34  13  36.11  25  37.31  69  54.33  10  47.62  5  35.71  9  22.50  34 50.00  32 52.46  34 56.67 
≥ 30 (obese)  28  18.42  16  39.02  14  38.89  24  35.82  25  19.69  5  23.81  4  28.57  13  32.50  16 23.53  11 18.03  18 30.00 
Smoking status 
never smoked              49  73.13  87  68.50  11  52.38  5  35.71  28  70.00  48 70.59  42 68.85  34 56.67 
current smoker              11  16.42  21  16.54  4  19.05  5  35.71  5  12.50  13 19.12  7  11.48  16 26.67 
ex‐smoker              7  10.45  19  14.96  6  28.57  4  28.57  7  17.50  7  10.29  12 19.67  10 16.67 
Alcohol  consumption 
non‐drinker  49  32.24  11  26.83  7  19.44                  14  35.00  20 29.41  19 31.15  14 23.33 
> 0 to ≤ 7 drinks/week  87  57.24  21  51.22  19  52.78                  22  55.00  37 54.41  33 54.10  35 58.33 
> 7 to ≤ 14 drinks/week  11  7.24  4  9.76  6  16.67                  3  7.50  6  8.82  7  11.48  5  8.33 
>14 drinks/week  5  3.29  5  12.20  4  11.11                  1  2.50  5  7.35  2  3.28  6  10.00 
Caffeine intake (mg/day) 
no caffeine  28  18.42  5  12.20  7  19.44  14  20.90  22  17.32  3  14.29  1  7.14                 
> 0 to ≤ 150  48  31.58  13  31.71  7  19.44  20  29.85  37  29.13  6  28.57  5  35.71                 
> 150 to ≤ 300  42  27.63  7  17.07  12  33.33  19  28.36  33  25.98  7  33.33  2  14.29                 
> 300  34  22.37  16  39.02  10  27.78  14  20.90  35  27.56  5  23.81  6  42.86                 
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Table A.11  Results of multivariable linear regression for different parameterizations of cigarette smoking exposure by sperm outcome 
 
 
 
Smoking Exposure 
Sperm  
  count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphologyb  
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Smoking status           
  Crude Model           
    non‐smoker                           referent  referent  referent  referent  referent 
    ex‐smoker    0.38 (0.05, 0.71)*   0.14  (0.01, 0.27) *  0.01 (‐0.01, 0.04)  ‐0.03 (‐0.07, 0.02)     ‐0.02 (‐0.04, ‐0.01)** 
    smoker   ‐0.06 (‐0.37, 0.25)   0.07 (‐0.05, 0.19)  ‐0.00 (‐0.03, 0.02)  ‐0.00 (‐0.05, 0.04)      ‐0.01 (‐0.02, 0.01) 
  Final Model           
    non‐smoker                           referent  referent  referent  referent  referent 
    ex‐smoker   0.21 (‐0.11, 0.52)c  0.10 (‐0.03, 0.23)d  0.01 (‐0.01, 0.03)e  ‐0.00 (‐0.05, 0.04)e  ‐0.03 (‐0.05, ‐0.01)f** 
    smoker   0.08 (‐0.26, 0.41)c  0.10 (‐0.03, 0.24)d  0.00 (‐0.02, 0.02)e  ‐0.00 (‐0.04, 0.05)e     ‐0.01 (‐0.03, 0.01)f 
Cigarettes per day (#)           
  Crude Model           
    0  referent  referent  referent  referent  referent 
    1 to 10   0.13 (‐0.18, 0.44)   0.08 (‐0.04, 0.20)  0.01 (‐0.01, 0.03)  ‐0.03 (‐0.07, 0.01)       ‐0.01 (‐0.03, 0.00) 
    ≥ 11    0.16 (‐0.18, 0.50)   0.13 ( 0.01, 0.26)*  0.00 (‐0.02, 0.02)     0.01 (‐0.04, 0.05)  ‐0.02 (‐0.04, 0.00) 
  Final Model           
    0  referent  referent  referent  referent  referent 
    1 to 10   0.14 (‐0.16, 0.44)g  0.08 (‐0.04, 0.20)g  0.00 (‐0.02, 0.02)e  ‐0.01 (‐0.06, 0.03)g      ‐0.01 (‐0.03, 0.00)h 
    ≥ 11   0.16 (‐0.19, 0.51)g  0.12 (‐0.02, 0.26)g  0.01 (‐0.02, 0.03)e   0.02 (‐0.03, 0.07)g  ‐0.02 (‐0.04, ‐0.00)h* 
Years smoked (#)           
  Crude Model           
     0  referent  referent  referent  referent  referent 
     1 to 5  0.21 (‐0.22, 0.64)  0.14 (‐0.03, 0.30)   0.01 (‐0.02, 0.04)   ‐0.01 (‐0.07, 0.04)   ‐0.02 (‐0.05, ‐0.00)* 
     6 to 10  0.16 (‐0.19, 0.51)  0.05 (‐0.09, 0.18)     ‐0.00 (‐0.03, 0.02)   ‐0.03 (‐0.07, 0.02)  ‐0.00 (‐0.02, 0.01) 
     ≥ 11   0.07 (‐0.32, 0.46)  0.15 (0.00, 0.30)*  0.01 (‐0.02, 0.03)   ‐0.00 (‐0.06, 0.05)   ‐0.02 (‐0.04, ‐0.00)* 
  Final Model           
     0  referent  referent  referent  referent  referent 
     1 to 5  0.25 (‐0.15, 0.67)e  0.15 (‐0.01, 0.31)h   0.01 (‐0.01, 0.04) e   0.01 (‐0.05, 0.07)h  ‐0.03 (‐0.05, ‐0.00)h* 
     6 to 10  0.10 (‐0.25, 0.46)e  0.02 (‐0.11, 0.16)h  ‐0.01 (‐0.03, 0.01) e  ‐0.00 (‐0.05, 0.05)h      ‐0.01 (‐0.03, 0.01)h 
     ≥ 11   0.09 (‐0.29, 0.47)e  0.12 (‐0.02, 0.27)h   0.01 (‐0.01, 0.04) e  ‐0.01 (‐0.06, 0.05)h  ‐0.03 (‐0.05, ‐0.01)h* 
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Table A.11 (cont.) 
 
 
 
Smoking Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Dose (pack‐years)           
  Crude Model           
     0  referent  referent  referent  referent  referent 
     1 to 5  0.12 (‐0.20, 0.44)  0.06 (‐0.07, 0.18)   0.01 (‐0.02, 0.03)    ‐0.03 (‐0.07, 0.02)  ‐0.01 (‐0.03, 0.01) 
     6 to 10  0.21 (‐0.19, 0.61)  0.14 (‐0.01, 0.30)  ‐0.01 (‐0.03, 0.02)  ‐0.02 (‐0.08, 0.03)      ‐0.02 (‐0.04, 0.00) 
     ≥ 11   0.11 (‐0.40, 0.61)  0.17 (‐0.02, 0.36)   0.02 (‐0.01, 0.05)     0.03 (‐0.04, 0.10)  ‐0.02 (‐0.05, 0.01) 
  Final Model           
     0  referent  referent  referent  referent  referent 
     1 to 5   0.12 (‐0.20, 0.43)i    0.05 (‐0.07, 0.17)g   0.00 (‐0.02, 0.03) e   ‐0.00 (‐0.05, 0.04)e  ‐0.01 (‐0.03, 0.01)j 
     6 to 10  0.24 (‐0.15, 0.64)i  0.15 (‐0.00, 0.31)g  ‐0.00 (‐0.03, 0.02) e  ‐0.02 (‐0.08, 0.03)e     ‐0.02 (‐0.05, ‐0.01)j* 
     ≥ 11   0.11 (‐0.40, 0.62)i  0.15 (‐0.05, 0.34)g   0.02 (‐0.01, 0.06) e   0.03 (‐0.04, 0.10)e  ‐0.02 (‐0.05,  0.00)j 
 
a.  Natural log transformation applied 
b.  Arc sine applied 
c.  Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI, chronic  illness and stress 
d.  Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education and BMI. 
e.  Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, BMI, chronic  illness, stress, caffeine intake. 
f. Adjusted for geographic region, age, length of sexual abstinence, and income, weekly alcohol intake, education, chronic illness. 
g. Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, education, chronic illness and BMI 
h. Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake. 
i. Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake, chronic illness and BMI 
j.  Adjusted for geographic region, age, length of sexual abstinence, income, weekly alcohol intake and chronic illness.   
 
*p<.05 
**p<.01 
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     Table A.12.  Crude, stratified and multivariable (final) linear and logistic regression models for cigarette smoking by sperm outcome 
 
 
 
Smoking Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Smoking status           
  Crude Model           
    non‐smoker                       referent  referent  referent  referent  referent 
    ex‐smoker   0.38 (0.05, 0.71) *   0.14 (0.01, 0.27)*   0.01 (‐0.01, 0.04)  ‐0.03 (‐0.07, 0.02)  ‐0.02 (‐0.04, ‐0.01)**   
    smoker  ‐0.06 (‐0.37, 0.25)   0.07 (‐0.05, 0.19)  ‐0.00 (‐0.03, 0.02)  ‐0.00 (‐0.05, 0.04)  ‐0.01 (‐0.03, 0.01) 
  Raleigh Model           
    non‐smoker                       referent  referent  referent  referent  referent 
    ex‐smoker  0.37 (‐0.13, 0.87)  0.10 (‐0.10, 0.30)  0.03 (‐0.01, 0.06)  ‐0.02 (‐0.07, 0.03)    ‐0.03 (‐0.05,‐ 0.00)* 
    smoker  0.05 (‐0.54, 0.63)  ‐0.01 (‐0.24, 0.22)  ‐0.01 (‐0.06, 0.03)  ‐0.02 (‐0.07, 0.04)    ‐0.02 (‐0.05, 0.01) 
 Memphis  Model           
    non‐smoker                       referent  referent  referent  referent  referent 
    ex‐smoker   0.37 (‐0.11, 0.85)  0.20 (0.01, 0.38)*  ‐0.00 (‐0.03, 0.02)  ‐0.01 (‐0.09, 0.07)  ‐0.02 (‐0.05, 0.01) 
    smoker  ‐0.31 (‐0.80, 0.17)  0.08 (‐0.10, 0.26)  ‐0.00 (‐0.03, 0.02)  0.00 (‐0.07, 0.08)  ‐0.01 (‐0.04, 0.03) 
 Galveston Model           
    non‐smoker                       referent  referent  referent  referent  referent 
    ex‐smoker  0.36 (‐0.66, 1.38)  0.08 (‐0.30, 0.47)  0.01 (‐0.03, 0.05)  ‐0.10 (‐0.23, 0.04)      ‐0.03 (‐0.08, 0.01) 
    smoker    0.25 (‐0.43, 0.93)    0.16 (‐0.09, 0.42)   0.03 (‐0.00, 0.06)   ‐0.05 (‐0.14, 0.04)  0.00 (‐0.03, 0.03) 
  Site adjusted Model           
    non‐smoker                       referent  referent  referent  referent  referent 
    ex‐smoker    0.37 (0.04, 0.70)*    0.14 (0.01, 0.26)*  0.01 (‐0.01, 0.03)  ‐0.03 (‐0.07, 0.02)  ‐0.02 (‐0.04, ‐0.01) * 
    smoker  ‐ 0.03 (‐0.35, 0.29)   0.08 (‐0.04, 0.20)  0.00 (‐0.02, 0.02)  ‐0.02 (‐0.06, 0.02)     ‐0.01 (‐0.02, 0.01) 
  Final Model†           
    non‐smoker                       referent  referent  referent  referent  referent 
    ex‐smoker  0.21 (‐0.11, 0.52)  0.10 (‐0.03, 0.23)  0.01 (‐0.01, 0.03)  ‐0.00 (‐0.05, 0.04)  ‐0.03 (‐0.04, ‐0.01)** 
    smoker  0.08 (‐0.26, 0.41)  0.10 (‐0.03, 0.24)  0.00 (‐0.02, 0.02)  ‐0.00 (‐0.05, 0.05)    ‐0.01 (‐0.03, 0.01) 
Crude LR model           
    non‐smoker                       Not done  Not done  referent  referent  Not done  
    ex‐smoker  Insufficient # cases  Insufficient # cases  0.77 (0.37, 1.60)  0.49 (0.14, 1.72)  No reference value 
    smoker      1.19 (0.59, 2.44)  1.11 (0.44, 2.80)   
Final LR model†           
    non‐smoker                       Not done  Not done  referent  referent  Note done 
    ex‐smoker  Insufficient # cases  Insufficient # cases  0.82 (0.34, 1.96)  0.76 (0.19, 3.12)  No reference value 
    smoker      1.04 (0.41, 2.64)  1.15 0.35, 3.75)   
a  Natural log transformation applied 
b  Arcsine applied 
*p<.05 
**p<.01 
† Adjusted for confounders listed on Table 4.4 
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   Table A.13.  Crude, stratified and multivariable (final) linear and logistic regression models for alcohol consumption and type  by sperm outcomes  
 
 
Alcohol Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Drinks per week           
  Crude Model           
    none  referent  referent  referent  referent  referent 
    > 0 & le 7 drinks  0.49 (0.23, 0.75)**  0.14 (0.04, 0.24)**  0.00 (‐0.02, 0.02)  ‐0.03 (‐0.06, 0.01)       0.01 (‐0.01, 0.02) 
    > 7 & le 14 drinks   0.38 (‐0.06, 0.81)   0.06 (‐0.11, 0.23)    0.04 (0.01, 0.07) **   ‐0.07 (‐0.13, ‐0.01)*  0.00 (‐0.02, 0.03) 
    > 14 drinks  0.69 (0.18, 1.20) **  0.20 (0.00, 0.40) *    0.05 (0.02, 0.08) **  ‐0.06 (‐0.13, 0.01)  ‐0.01 (‐0.04, 0.02) 
  Raleigh Model           
    none  referent  referent  referent  referent  referent 
    > 0 & le 7 drinks  0.56 (0.09, 1.03)*  0.18 (0.00, 0.37)*  0.03 (‐0.00, 0.07)  ‐0.05 (‐0.10, ‐0.01)*    ‐0.00 (‐0.03, 0.02) 
    > 7 & le 14 drinks  0.68 (0.03, 1.32)*  0.24 (‐0.01, 0.49)  0.06 (0.01, 0.10)**  ‐0.08 (‐0.15,‐ 0.02)**    ‐0.02 (‐0.06, 0.01) 
    > 14 drinks  0.84 (0.07, 1.61)*  0.30 (0.00, 0.61)*  0.10 (0.05, 0.16)**   ‐0.06 (‐0.13, 0.01)    ‐0.03 (‐0.08, 0.01) 
 Memphis  Model           
    none  referent  referent  referent  referent  referent 
    > 0 & le 7 drinks  0.43 (0.06, 0.80)*  0.16 (0.03, 0.30)*     ‐0.02 (‐0.04, ‐0.00)*  0.01 (‐0.05, 0.07)    0.01 (‐0.01, 0.03) 
    > 7 & le 14 drinks  ‐0.14 (‐1.02, 0.74)  ‐0.16 (‐0.49, 0.17)  0.02 (‐0.03, 0.06)  ‐0.10 (‐0.23, 0.05)    0.02 (‐0.03, 0.08) 
    > 14 drinks   0.50 (‐0.37, 1.39)  0.18 (‐0.15, 0.51)  ‐0.00 (‐0.05, 0.04)  ‐0.10 (‐0.24, 0.03)    0.02 (‐0.04, 0.07) 
 Galveston Model           
    none  referent  referent  referent  referent  referent 
    > 0 & le 7 drinks  0.57 (‐0.14, 1.27)  0.06 (‐0.21, 0.34)  ‐0.02 (‐0.05, 0.01)  ‐0.04 (‐0.13, 0.06)    0.03 (0.00, 0.06)* 
    > 7 & le 14 drinks  0.31 (‐0.77, 1.40)  ‐0.08 (‐0.51, 0.34)   0.01 (‐0.04, 0.05)   0.01 (‐0.14, 0.16)    0.04 (‐0.01, 0.08) 
    > 14 drinks  0.77 (‐0.55, 2.10)  0.07 (‐0.45, 0.59)  ‐0.01 (‐0.06, 0.05)  0.02 (‐0.16, 0.20)    0.02 (‐0.03, 0.08) 
  Site adjusted Model           
    none  referent  referent  referent  referent  referent 
    > 0 & le 7 drinks  0.49 (0.23, 0.76)**  0.15 (0.04, 0.25)  ‐0.00 (‐0.02, 0.01)  ‐0.02 (‐0.05, 0.02)    0.01 (‐0.00, 0.02) 
    > 7 & le 14 drinks   0.39 (‐0.06, 0.83)  0.07 (‐0.10, 0.25)  0.03 (‐0.00, 0.05)  ‐0.05 (‐0.11, 0.01)     0.01 (‐0.01, 0.03) 
    > 14 drinks  0.70 (0.18, 1.21)**  0.21 (0.01, 0.41)  0.04 (0.01, 0.07)*  ‐0.05 (‐0.11, 0.02)   ‐ 0.01 (‐0.03, 0.02) 
  Final Model†           
    none  referent  referent  referent  referent  referent 
    > 0 & le 7 drinks  0.42 (0.16, 0.69)**  0.13 (0.02, 0.23)*  ‐0.00 (‐0.02, 0.02)  ‐0.03 (‐0.08, ‐0.00) *  0.02 (0.00, 0.04) * 
    > 7 & le 14 drinks   0.36 (‐0.07, 0.80)  0.07 (‐0.10, 0.25)  0.03 (‐0.00, 0.06)  ‐0.07 (‐0.13, ‐0.01)*  0.02 (‐0.00, 0.05) 
    > 14 drinks  0.63 (0.13, 1.13)*  0.18 (‐0.02, 0.38)  0.04 (0.01, 0.08)*   ‐0.06 (‐0.13,  0.01)  0.01 (‐0.02, 0.04) 
 
 
 
 
214
  
Table A.13.  (cont.) 
 
 
Alcohol Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
 Crude LR Model           
    none  Not done  Not done  referent  referent  referent 
    > 0 & le 7 drinks      0.92 (0.50, 1.70)  0.79 (0.36, 1.75)  Not done 
    > 7 & le 14 drinks       0.22 (0.08, 0.65)    0.49 (0.10, 2.41)    
    > 14 drinks      0.56 (0.18, 1.78)  0.34 (0.04, 2.85)   
Adjusted LR Model†           
    none  Not done  Not done  referent  referent  Not done  
    > 0 & le 7 drinks      0.99 (0.50, 1.99)  0.63 (0.24, 1.64)   
    > 7 & le 14 drinks      0.26 (0.08, 0.82)   0.47 (0.08, 2.82)    
    > 14 drinks      0.63 (0.18, 2.27)  0.35 (0.04, 3.37)   
Beverage Type           
Crude Model            
      no alcohol  referent  referent  referent  referent  referent 
      beer only     0.38 (0.08, 0.67)*   0.11 (‐0.01, 0.22)  0.01 (‐0.01, 0.03)  ‐0.01 (‐0.05, 0.03)       0.01 (‐0.01, 0.03) 
    wine and hard    0.72 (0.06, 1.37)*    0.22 (‐0.03, 0.49)  0.00 (‐0.04, 0.05)  ‐0.01 (‐0.10, 0.08)  0.00 (‐0.03, 0.04)  
    beer and hard    0.63 (0.22, 1.05)**   0.17 (0.01, 0.34)*  0.01 (‐0.02, 0.04)  ‐0.07 (‐0.13, ‐0.01) *    ‐ 0.01 (‐0.03, 0.01) 
    beer and wine     0.48 (0.10, 0.87)*    0.13 (‐0.02, 0.28)  0.01 (‐0.02, 0.03)  ‐0.06 (‐0.11, ‐0.01)*  0.01 (‐0.01, 0.03)  
   beer, wine, hard    0.60 (0.22, 0.99)**   0.16 (0.01, 0.30)*  0.02 (‐0.00, 0.05)  ‐0.04 (‐0.10, 0.01)       0.01 (‐0.01, 0.03) 
Final Model †           
      no alcohol  referent  referent  referent  referent  referent 
      beer only     0.27 (‐0.05, 0.58)   0.07 (‐0.06, 0.20)  0.00 (‐0.02, 0.02)  ‐0.03 (‐0.07, 0.02)       0.02 (0.00, 0.04)* 
    wine and hard    0.75 (0.11, 1.38)*    0.24 (‐0.01, 0.49)  ‐0.01 (‐0.06, 0.03)  ‐0.02 (‐0.11, 0.07)  0.02 (‐0.02, 0.05)  
    beer and hard    0.65 (0.23, 1.08)**   0.21 (0.04, 0.38)*  0.01 (‐0.02, 0.04)  ‐0.06 (‐0.12, ‐0.00) *      0.00 (‐0.02, 0.03) 
    beer and wine     0.39 (‐0.00, 0.79)*    0.13 (‐0.03, 0.28)  ‐0.01 (‐0.04, 0.02)  ‐0.06 (‐0.11, ‐0.00)*  0.03 (0.00, 0.05) * 
   beer, wine, hard    0.45 (0.02, 0.88)*   0.12 (‐0.05, 0.29)  ‐0.01 (‐0.04, 0.02)  ‐0.04 (‐0.10, 0.02)   0.03 0.01, 0.06)* 
 
a Natural log transformation applied 
b Arcsine applied 
*p<.05 
**p<.01 
† Adjusted confounders listed in Table 4.4 
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Table A.14. Crude, site‐stratified and multivariable (final) linear and logistic regression models for caffeine intake and source by sperm outcome 
 
 
Caffeine  Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Milligrams per day           
  Crude Model           
    none   referent  referent  referent  referent  referent 
   > 0 & le 150 mgs  0.06 (‐0.29, 0.42)  ‐0.04 (‐0.17, 0.10)    ‐0.03 (‐0.05, ‐0.00)*  0.01 (‐0.04, 0.05)      ‐0.00 (‐0.02, 0.02) 
   > 150 & le 300 mgs   ‐0.00 (‐0.37, 0.36)   ‐0.04 (‐0.18, 0.10)  ‐0.01 (‐0.04, 0.01)   0.03 (‐0.02, 0.08)  ‐0.01 (‐0.03, 0.01) 
   > 300 mgs   0.14 (‐0.23, 0.50)    0.04  (‐0.10, 0.18)     ‐0.03 (‐0.05, ‐0.00) *  0.04 (‐0.01, 0.09)  ‐0.00 (‐0.02, 0.02) 
  Raleigh Model           
    none   referent  referent  referent  referent  referent 
   > 0 & le 150 mgs  0.28 (‐0.24, 0.81)  0.01 (‐0.19, 0.21)     ‐0.02 (‐0.06, 0.02)   0.01 (‐0.04, 0.06)    ‐0.01 (‐0.03, 0.02) 
   > 150 & le 300 mgs  0.07 (‐0.49, 0.63)  0.01 (‐0.21, 0.23)  0.01 (‐0.03, 0.05)   0.01 (‐0.04, 0.06)    ‐0.01 (‐0.04, 0.02) 
   > 300 mgs  0.51 (‐0.04, 1.07)  0.20 (‐0.01, 0.42)  ‐0.01 (‐0.05, 0.03)      0.04 (‐0.01, 0.10)    ‐0.02 (‐0.05, 0.01) 
 Memphis  Model           
    none   referent  referent  referent  referent  referent 
   > 0 & le 150 mgs  ‐0.11 (‐0.63, 0.42)   ‐0.10 (‐0.30, 0.10)    ‐0.03 (‐0.06, ‐0.01)*  ‐0.00 (‐0.08, 0.08)     0.00 (‐0.03, 0.03) 
   > 150 & le 300 mgs  0.07 (‐0.47, 0.60)  ‐0.07 (‐0.27, 0.13)  ‐0.02 (‐0.05, 0.01)  0.02 (‐0.07, 0.10)    ‐0.01 (‐0.04, 0.02) 
   > 300 mgs  ‐ 0.00 (‐0.55, 0.55)  ‐0.04 (‐0.25, 0.17)   ‐0.03 (‐0.06, ‐0.01)*  0.01 (‐0.07, 0.10)     0.02 (‐0.02, 0.05) 
 Galveston Model           
    none   referent  referent  referent  referent  referent 
   > 0 & le 150 mgs  ‐0.27 (‐1.63, 1.09)  ‐0.05 (‐0.56, 0.47)  ‐0.01 (‐0.07, 0.05)  0.02 (‐0.15, 0.20)    0.01 (‐0.05, 0.07) 
   > 150 & le 300 mgs  ‐0.46 (‐1.81, 0.89)  ‐0.13 (‐0.64, 0.39)   ‐0.01 (‐0.07, 0.04)   0.09 (‐0.08, 0.27)    0.01 (‐0.05, 0.07) 
   > 300 mgs  ‐0.40 (‐1.74, 0.93)  ‐0.12 (‐0.63, 0.39)  ‐0.03 (‐0.09, 0.03)  0.07 (‐0.11, 0.24)    0.01 (‐0.04, 0.07) 
  Site adjusted Model           
    none   referent  referent  referent  referent  referent 
   > 0 & le 150 mgs  0.08 (‐0.28, 0.44)  ‐0.03 (‐0.17, 0.10)  ‐0.02 (‐0.05, ‐0.00)*  0.00 (‐0.04, 0.05)   ‐ 0.00 (‐0.02, 0.02) 
   > 150 & le 300 mgs    0.03 (‐0.34, 0.40)  ‐0.04 (‐0.18, 0.11)    ‐0.01 (‐0.03, 0.01)  0.03 (‐0.02, 0.07)     ‐0.01 (‐0.03, 0.01) 
   > 300 mgs  0.18 (0.20, 0.55)   0.05 (‐0.10, 0.19)  ‐0.02 (‐0.05, ‐0.00)*  0.03 (‐0.02, 0.08)   ‐ 0.00 (‐0.02, 0.02) 
  Final Model†           
    none   referent  referent  referent  referent  referent 
   > 0 & le 150 mgs  ‐0.04 (‐0.39, 0.30)  ‐0.08 (‐0.22, 0.05)     ‐0.03 (‐0.05, ‐0.01)*  ‐0.00 (‐0.05, 0.05)   0.00 (‐0.01, 0.03)  
   > 150 & le 300 mgs   ‐0.05 (‐0.41, 0.30)  ‐0.07 (‐0.21, 0.07)  ‐0.01 (‐0.03, 0.01)  0.00 (‐0.05, 0.05)  ‐0.00 (‐0.02, 0.02) 
   > 300 mgs  0.05 (‐0.31, 0.42)  ‐0.02 (‐0.16, 0.13)    ‐0.03 (‐0.05, ‐0.00)*     0.00 (‐0.05,  0.06)  0.01 (‐0.01, 0.03) 
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Table A.14  (cont.) 
 
 
Caffeine Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Crude LR Model           
    none   Not done  Not done  referent  referent  Not done 
   > 0 & le 150 mgs      1.75 (0.79, 3.80)   2.20 (0.43, 11.14)   
   > 150 & le 300 mgs       1.65 (0.74, 3.70)    4.20 (0.87, 19.89)    
   > 300 mgs         2.85 (1.24, 6.60)*   5.60 (1.22, 26.96)   
Raleigh LR Model           
    none   Not done  Not done  referent  Not done  Not done 
   > 0 & le 150 mgs      0.97 (0.30, 3.14)  Empty cells   
   > 150 & le 300 mgs       0.79 (0.22, 2.77)      
   > 300 mgs       1.66 (0.48, 5.70)     
Memphis LR Model           
    none   Not done  Not done  referent  referent  Not done 
   > 0 & le 150 mgs         5.25 (1.37, 20.20) *    2.00 (0.34, 11.70)    
   > 150 & le 300 mgs       2.66 (0.76, 9.30)      2.00 (0.34, 11.70)    
   > 300 mgs         5.62 (1.35, 23.45)*  3.00 (0.53, 17.16)   
Galveston LR Model           
    none   Not done  Not done  referent  Not done  Not done 
   > 0 & le 150 mgs      0.58 (0.04, 8.15)  Empty cells   
   > 150 & le 300 mgs       1.25 (0.09, 17.98)      
   > 300 mgs        1.50 (0.11, 21.30)     
Adjusted LR Model            
    none   Not done  Not done  referent  referent  Not done 
   > 0 & le 150 mgs      1.77 (0.78, 4.04)   2.16 (0.42, 11.12)   
   > 150 & le 300 mgs       1.55 (0.67, 3.59)    3.87 (0.80, 18.90)    
   > 300 mgs         2.83 (1.19, 6.78)*    5.50 (1.14, 26.38) *   
 Final LR Model†           
    none   Not done  Not done  referent  referent  Not done  
   > 0 & le 150 mgs      2.04 (0.84, 4.93)   1.92 (0.33, 11.20)   
   > 150 & le 300 mgs      1.69 (0.69, 4.17)   2.82 (0.52, 15.38)    
   > 300 mgs        3.31 (1.27, 8.61)*   3.35 (0.61, 18.41)   
 Final LR Model†           
    none   Not done  Not done  referent  referent  Not done  
   > 0 mgs       2.17 (0.99, 4.71)   2.68 (0.54, 13.20)   
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Table A.14  (cont.) 
 
 
Caffeine Exposure 
Sperm  
count a 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphology b 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
Beverage Type            
    Crude Model            
     no caffeine  referent  referent  referent  referent  referent 
     coffee only      0.18 (‐0.24, 0.60)   0.05 (‐0.11, 0.21)  ‐0.01 (‐0.04, 0.02)  0.01 (‐0.05, 0.07)       ‐0.00 (‐0.02, 0.02) 
     tea only      0.16 (‐0.38, 0.71)    0.01 (‐0.19, 0.22)   ‐0.04 (‐0.07, ‐0.01)*   ‐0.00 (‐0.08, 0.07)  ‐0.02 (‐0.05, 0.01)  
     soda only     ‐0.01 (‐0.37, 0.36)   ‐0.08 (‐0.22, 0.06)  ‐0.02 (‐0.04, 0.00)   0.02 (‐0.03, 0.07)       0.00 (‐0.02, 0.02) 
     coffee & tea     0.52 (‐0.12, 1.15)    0.09 (‐0.15, 0.33)  ‐0.01 (‐0.05, 0.03)    ‐0.01 (‐0.09, 0.08)  0.01 (‐0.02, 0.04)  
     coffee & soda    ‐0.15 (‐0.56, 0.27)   ‐0.08 (‐0.24, 0.07)  ‐0.03 (‐0.05, 0.00)   0.04 (‐0.01, 0.10)       ‐0.01 (‐0.03, 0.01) 
     tea & soda     0.07 (‐0.42, 0.56)    0.05 (‐0.14, 0.23)    ‐0.03 (‐0.06, ‐0.00)*    0.04 (‐0.03, 0.10)   ‐0.00 (‐0.03, 0.02)  
     coffee, tea, soda     0.18 (‐0.38, 0.74)   0.08 (‐0.13, 0.29)  ‐0.03 (‐0.04, 0.01)   0.06 (‐0.02, 0.14)       ‐0.00 (‐0.03, 0.03) 
    Final Model            
     no caffeine  referent  referent  referent  referent  referent 
     coffee only    ‐ 0.04 (‐0.49, 0.41)   0.01 (‐0.19, 0.17)  ‐0.01 (‐0.04, 0.02)  ‐0.02 (‐0.08, 0.05)       0.01 (‐0.02, 0.04) 
     tea only      0.15 (‐0.35, 0.66)    ‐0.02 (‐0.23, 0.18)   ‐0.03 (‐0.07, 0.00)   ‐0.01 (‐0.09, 0.06)  ‐0.02 (‐0.05, 0.01)  
     soda only     ‐0.00 (‐0.35, 0.35)   ‐0.12 (‐0.26, 0.03)   ‐0.02 (‐0.04, 0.01)    0.01 (‐0.04, 0.07)       0.01 (‐0.01, 0.03) 
     coffee & tea     0.25 (‐0.38, 0.88)    0.06 (‐0.19, 0.31)  ‐0.01 (‐0.05, 0.03)  ‐0.02 (‐0.10, 0.07)  0.02 (‐0.02, 0.06)  
     coffee & soda    ‐0.35 (‐0.79, 0.10)   ‐0.16 (‐0.34, 0.01)  ‐0.02 (‐0.05, 0.01)  0.01 (‐0.06, 0.07)       0.00 (‐0.03, 0.03) 
      tea & soda    ‐0.04 (‐0.56, 0.48)    0.01 (‐0.19, 0.22)   ‐0.02 (‐0.06, 0.01)   0.01 (‐0.06, 0.09)  ‐0.00 (‐0.03, 0.03)  
     coffee, tea, soda     0.41 (‐0.19, 1.00)   0.10 (‐0.14, 0.34)   ‐0.02 (‐0.06, 0.02)  0.05 (‐0.04, 0.14)       ‐0.00 (‐0.04, 0.04) 
  Crude Model            
     coffee v. none     0.05 (‐0.18, 0.30)   0.03 (‐0.06, 0.12)   ‐0.00 (‐0.02, 0.01)   0.01 (‐0.02, 0.05)       ‐0.00 (‐0.01, 0.01) 
     tea v. none     0.19 (‐0.08, 0.47)     0.09 (‐0.01, 0.19)   ‐0.02 (‐0.03, 0.00)    0.00 (‐0.03, 0.04)  ‐0.00 (‐0.02, 0.01)  
     soda v. none    ‐0.15 (‐0.39, 0.09)   ‐0.07 (‐0.16, 0.02)   ‐0.01 (‐0.03, 0.00)    0.03 (0.00, 0.07) *      ‐0.00 (‐0.01, 0.01) 
   Final Model †           
     coffee v. none   ‐ 0.03 (‐0.26, 0.20)   0.00 (‐0.09, 0.10)  ‐0.00 (‐0.02, 0.01)  ‐0.01 (‐0.04, 0.03)       0.01 (‐0.01, 0.02) 
     tea v. none     0.27 (0.00, 0.53)*     0.10 (‐0.01, 0.20)   ‐0.01 (‐0.03, 0.01)    0.00 (‐0.03, 0.04)  ‐0.01 (‐0.02, 0.01)  
     soda v. none    ‐0.08 (‐0.31, 0.15)   ‐0.10 (‐0.19, 0.00)   ‐0.01 (‐0.02, 0.01)    0.02 (‐0.01, 0.06)       0.00 (‐0.01, 0.01) 
 
a Natural log transformation applied 
b Arc sine applied 
*p<.05 
**p<.01 
†Adjusted confounders listed in Table 4.4 
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   Table A.15.  Crude, site‐stratified and multivariable (final) linear and logistic regression models for body mass index by sperm outcome 
 
 
Body Mass Index 
Sperm  
 counta 
β (95% CL) 
Sperm 
concentrationa 
β (95% CL) 
Percent normal 
morphologyb 
β (95% CL) 
Percent 
DFIb 
β (95% CL) 
Percent 
HDSb 
β (95% CL) 
          kg/m2           
  Crude Model           
    18.5‐24.9                              referent  referent  referent  referent  referent 
    25.0‐29.9   0.08 (‐0.20, 0.37)   0.11 (‐0.00, 0.21)   ‐0.02 (‐0.03, 0.00)  0.04 (0.01, 0.08)*  ‐0.00 (‐0.02, 0.01)   
    30.0+  0.07 (‐0.25, 0.40)   0.15 (0.03, 0.27)*  ‐0.02 (‐0.04, 0.01)  0.02 (‐0.03, 0.06)  ‐0.01 (‐0.03, 0.01) 
  Raleigh Model           
    18.5‐24.9                              referent  referent  referent  referent  referent 
    25.0‐29.9  0.13 (‐0.30, 0.56)  0.08 (‐0.08, 0.25)  ‐0.03 (‐0.06, 0.00)   0.02 (‐0.02, 0.06)    0.00 (‐0.02, 0.02) 
    30.0+  0.12 (‐0.46, 0.69)  0.03 (‐0.19, 0.25)  ‐0.02 (‐0.06, 0.02)  ‐0.02 (‐0.08, 0.03)    0.00 (‐0.03, 0.03) 
 Memphis Model           
    18.5‐24.9                              referent  referent  referent  referent  referent 
    25.0‐29.9   ‐0.08 (‐0.52, 0.37)    0.06 (‐0.10, 0.23)  ‐0.01 (‐0.03, 0.02)  0.09 (0.02, 0.16)*    ‐0.01 (‐0.04, 0.02) 
    30.0+    ‐0.02 (‐0.51, 0.47)   0.19 ( 0.01, 0.37)*  ‐0.01 (‐0.04, 0.01)  0.04 (‐0.04, 0.11)    ‐0.02 (‐0.05, 0.01) 
 Galveston Model           
    18.5‐24.9                              referent  referent  referent  referent  referent 
    25.0‐29.9  0.34 (‐0.47, 1.15)  0.27 (‐0.03, 0.57)   0.01 (‐0.02, 0.05)  ‐0.01 (‐0.12, 0.10)       0.01 (‐0.02, 0.04) 
    30.0+    0.34 (‐0.51, 1.18)    0.29 (‐0.02, 0.60)   0.03 (‐0.00, 0.07)   ‐0.03 (‐0.14, 0.09)  ‐0.01 (‐0.05, 0.02) 
 Site adjusted Model           
    18.5‐24.9                              referent  referent  referent  referent  referent 
    25.0‐29.9    0.09 (‐0.20, 0.37)   0.11 (‐0.00, 0.21)  ‐0.01 (‐0.03, 0.00)  0.04 (0.01, 0.08)*    ‐0.00 (‐0.02, 0.01)  
    30.0+    0.11 (‐0.23, 0.44)    0.16  (0.03, 0.28)*  ‐0.01 (‐0.03, 0.01)  0.00 (‐0.04, 0.05)     ‐0.01 (‐0.03, 0.01) 
 Final Model           
    18.5‐24.9                              referent  referent  referent  referent  referent 
    25.0‐29.9  0.06 (‐0.22, 0.34)c  0.11 (‐0.00, 0.21)d  ‐0.01 (‐0.02, 0.01)e  0.03 (‐0.01, 0.06)f     ‐0.00 (‐0.02, 0.01)g 
    30.0+  0.12 (‐0.22, 0.45)c   0.15 (0.02, 0.28)d*  ‐0.01 (‐0.03, 0.02)e  0.01 (‐0.04, 0.05)f     ‐0.01 (‐0.03, 0.01)g 
Crude LR model           
    18.5‐24.9                              Not done  Not done  referent  referent  Not done  
    25.0‐29.9  Insufficient # cases  Insufficient # cases  1.26 (0.67, 2.38)  2.26 (0.86, 5.93)  No reference value 
    30.0+      1.25 (0.61, 2.59)  1.04 (0.32, 3.43)   
Final LR model            
    18.5‐24.9                              Not done  Not done  referent  referent  Not done 
    25.0‐29.9  Insufficient # cases  Insufficient # cases  0.94 (0.44, 2.01)e  1.88 (0.62, 5.69)f  No reference value 
    30.0+      0.88 (0.36, 2.17)e  0.72 (0.18, 2.83)f   
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a Natural log transformation applied 
b Arc sine applied 
c Adjusted for geographic region, age, length of sexual abstinence, education, stress, chronic illness, income, alcohol consumption, caffeine intake, smoking status. 
d Adjusted for geographic region, age, length of sexual abstinence, education, and stress. 
e Adjusted for geographic region, age, length of sexual abstinence, education, stress, alcohol consumption, caffeine  intake, and smoking status.   
f Adjusted for geographic region, age, length of sexual abstinence, education, stress, chronic illness, income, and alcohol consumption. 
g Adjusted for geographic region, age, length of sexual abstinence, education, chronic illness,  income,  alcohol consumption, caffeine intake, and smoking status. 
 
*p<.05
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Figure 3.  HMS Recruitment Methods 
 
 
 
 
All RFTS women who have completed follow‐up or 
modified follow‐up interview  
(after 20 weeks gestation)
RFTS Women 
determined to be 
eligible for HMS 
recruiting.  Names and 
contact info delivered 
to HMS and letter 
mailed 
RFTS woman received 
letter, agrees to contact 
and gives man’s contact 
information. 
RFTS woman reports 
man ineligible. RFTS woman lost to follow‐
up  
Refusal: RFTS 
woman refuses 
to contact dad or 
man refuses. 
Letter mailed to HMS man.  Man called for screening.
Man lost to follow‐
up. 
Man eligible and agrees 
to participate. 
Man ineligible on screening. Man eligible but refuses to
participate. 
Interview attempted,  
man lost to follow‐up  Man completes interview.
Semen specimen adequate
Specimen damaged or 
inadequate, man asked to 
repeat collection 
Man refused semen 
sample collection. 
No adequate semen 
specimen obtained 
